| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 171,960  0.5% | USD 75,476,683 -1.9% | USD 438.92-2.4% | |
| AMGN (Amgen Inc) | 215,839 0.5% | USD 71,233,3450.8% | USD 330.030.3% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,816 0.5% | USD 52,539,807-1.2% | USD 741.92-1.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 90,597 0.5% | USD 32,547,878-1.6% | USD 359.26-2.1% | |
| INSM (Insmed Inc) | 146,232 0.5% | USD 23,290,371-2.1% | USD 159.27-2.6% | |
| BIIB (Biogen Inc) | 100,586 0.5% | USD 16,955,7820.0% | USD 168.57-0.4% | |
| RVMD (Revolution Medicines Inc) | 132,550 0.5% | USD 16,339,4392.2% | USD 123.271.7% | |
| ARGX (argenx NV ADR) | 19,960 0.5% | USD 16,232,2702.2% | USD 813.241.7% | |
| ILMN (Illumina Inc) | 104,768 0.5% | USD 15,222,7901.4% | USD 145.30.9% | |
| INCY (Incyte Corporation) | 134,609 0.5% | USD 14,166,251-0.2% | USD 105.24-0.7% | |
| UTHR (United Therapeutics Corporation) | 29,522 0.5% | USD 13,934,089-0.3% | USD 471.99-0.8% | |
| MEDP (Medpace Holdings Inc) | 19,314 0.5% | USD 11,936,8250.7% | USD 618.040.3% | |
| RPRX (Royalty Pharma Plc) | 292,943 0.5% | USD 11,635,696-0.8% | USD 39.72-1.2% | |
| ROIV (Roivant Sciences Ltd) | 476,865 0.5% | USD 11,110,955-1.7% | USD 23.3-2.1% | |
| MRNA (Moderna Inc) | 267,870 0.5% | USD 10,543,363-2.6% | USD 39.36-3.0% | |
| VTRS (Viatris Inc) | 789,713 0.5% | USD 10,139,915-1.9% | USD 12.84-2.4% | |
| BBIO (BridgeBio Pharma Inc) | 132,131 0.5% | USD 10,076,310-1.7% | USD 76.26-2.1% | |
| GH (Guardant Health Inc) | 88,706 0.5% | USD 9,933,2983.6% | USD 111.983.1% | |
| NBIX (Neurocrine Biosciences Inc) | 68,363 0.5% | USD 9,116,206-1.0% | USD 133.35-1.5% | |
| ASND (Ascendis Pharma AS) | 42,109 0.5% | USD 9,055,119-0.6% | USD 215.04-1.0% | |
| SMMT (Summit Therapeutics PLC) | 510,428 0.5% | USD 8,815,092-1.7% | USD 17.27-2.2% | |
| SNY (Sanofi ADR) | 181,440 0.5% | USD 8,612,957-0.4% | USD 47.47-0.9% | |
| IONS (Ionis Pharmaceuticals Inc) | 111,058 0.5% | USD 8,574,788-1.7% | USD 77.21-2.1% | |
| EXEL (Exelixis Inc) | 183,831 0.5% | USD 8,353,2810.9% | USD 45.440.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,572 0.5% | USD 7,721,843-1.4% | USD 495.88-1.9% | |
| RNA (Avidity Biosciences Inc) | 103,311 0.5% | USD 7,500,3790.5% | USD 72.60.1% | |
| BNTX (BioNTech SE) | 69,321 0.5% | USD 7,352,878-2.4% | USD 106.07-2.8% | |
| BMRN (Biomarin Pharmaceutical Inc) | 131,724 0.5% | USD 7,254,041-1.4% | USD 55.07-1.8% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,664 0.5% | USD 7,131,2100.7% | USD 171.160.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 93,118 0.5% | USD 6,169,0681.0% | USD 66.250.5% | |
| AXSM (Axsome Therapeutics Inc) | 34,565 0.5% | USD 6,019,149-1.2% | USD 174.14-1.6% | |
| HALO (Halozyme Therapeutics Inc) | 80,631 0.5% | USD 5,790,918-1.1% | USD 71.82-1.6% | |
| KRYS (Krystal Biotech Inc) | 19,882 0.5% | USD 5,606,923-2.9% | USD 282.01-3.4% | |
| CYTK (Cytokinetics Inc) | 83,831 0.5% | USD 5,317,819-1.4% | USD 63.435-1.8% | |
| NUVL (Nuvalent Inc) | 49,334 0.5% | USD 5,237,297-1.1% | USD 106.16-1.6% | |
| PRAX (Praxis Precision Medicines Inc) | 17,146 0.5% | USD 5,105,0500.2% | USD 297.74-0.2% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,758 0.5% | USD 4,853,093-6.0% | USD 106.06-6.4% | |
| PCVX (Vaxcyte Inc) | 89,756 0.5% | USD 4,311,878-0.5% | USD 48.04-1.0% | |
| PTCT (PTC Therapeutics Inc) | 55,050 0.5% | USD 4,163,982-1.7% | USD 75.64-2.1% | |
| COGT (Cogent Biosciences Inc) | 105,252 0.5% | USD 4,131,1414.3% | USD 39.253.9% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,815 0.5% | USD 3,895,1911.3% | USD 85.020.8% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 65,063 0.5% | USD 3,671,5052.3% | USD 56.431.8% | |
| PTGX (Protagonist Therapeutics Inc) | 42,864 0.5% | USD 3,632,724-0.1% | USD 84.75-0.6% | |
| CRSP (Crispr Therapeutics AG) | 65,343 0.5% | USD 3,542,244-4.3% | USD 54.21-4.7% | |
| ALKS (Alkermes Plc) | 113,213 0.5% | USD 3,534,5102.4% | USD 31.222.0% | |
| KYMR (Kymera Therapeutics Inc) | 49,332 0.5% | USD 3,508,492-5.0% | USD 71.12-5.4% | |
| SRRK (Scholar Rock Holding Corp) | 70,719 0.5% | USD 3,290,5552.5% | USD 46.532.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 35,238 0.5% | USD 3,253,1722.3% | USD 92.321.8% | |
| IMVT (Immunovant Inc) | 120,179 0.5% | USD 3,124,654-4.5% | USD 26-4.9% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 116,000 0.5% | USD 3,077,480-0.8% | USD 26.53-1.2% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,596 0.5% | USD 3,035,877-1.6% | USD 80.75-2.0% | |
| FOLD (Amicus Therapeutics Inc) | 211,537 0.5% | USD 3,027,0940.0% | USD 14.31-0.5% | |
| CGON (CG Oncology, Inc. Common stock) | 55,041 0.5% | USD 2,921,026-4.0% | USD 53.07-4.4% | |
| ADMA (ADMA Biologics Inc) | 163,184 0.5% | USD 2,855,720-3.8% | USD 17.5-4.3% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 215,544 0.5% | USD 2,843,0250.0% | USD 13.19-0.5% | |
| ACLX (Arcellx Inc) | 39,646 0.5% | USD 2,708,615-1.8% | USD 68.32-2.2% | |
| IBRX (Immunitybio Inc) | 671,883 | USD 2,653,93830.8% | USD 3.9530.8% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,495 0.5% | USD 2,646,1000.2% | USD 196.08-0.2% | |
| GRAL (GRAIL, LLC) | 26,612 0.5% | USD 2,593,073-6.6% | USD 97.44-7.0% | |
| BEAM (Beam Therapeutics Inc) | 69,577 0.5% | USD 2,229,943-9.1% | USD 32.05-9.5% | |
| VCYT (Veracyte Inc) | 54,200 0.5% | USD 2,222,200-3.0% | USD 41-3.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,987 0.5% | USD 2,213,897-0.9% | USD 26.36-1.4% | |
| IDYA (Ideaya Biosciences Inc) | 60,108 0.5% | USD 2,167,494-2.2% | USD 36.06-2.6% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,984 0.5% | USD 2,158,568-1.6% | USD 40.74-2.0% | |
| TARS (Tarsus Pharmaceuticals Inc) | 29,105 0.5% | USD 2,143,583-1.7% | USD 73.65-2.1% | |
| VERA (Vera Therapeutics Inc) | 43,832 0.5% | USD 2,028,545-4.0% | USD 46.28-4.4% | |
| SUPN (Supernus Pharmaceuticals Inc) | 39,315 0.5% | USD 1,975,972-2.5% | USD 50.26-3.0% | |
| EWTX (Edgewise Therapeutics Inc) | 72,589 0.5% | USD 1,930,867-5.1% | USD 26.6-5.6% | |
| DNLI (Denali Therapeutics Inc) | 100,556 0.5% | USD 1,888,4423.3% | USD 18.782.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 104,676 0.5% | USD 1,861,139-1.0% | USD 17.78-1.4% | |
| ERAS (Erasca Inc) | 194,490 0.5% | USD 1,859,32415.6% | USD 9.5615.0% | |
| APLS (Apellis Pharmaceuticals Inc) | 86,752 0.5% | USD 1,781,0191.4% | USD 20.531.0% | |
| SYRE (Spyre Therapeutics Inc.) | 53,201 0.5% | USD 1,760,4210.2% | USD 33.09-0.2% | |
| TVTX (Travere Therapeutics Inc) | 61,347 0.5% | USD 1,742,255-1.4% | USD 28.4-1.8% | |
| TWST (Twist Bioscience Corp) | 41,926 0.5% | USD 1,730,2863.6% | USD 41.273.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 54,262 0.5% | USD 1,702,742-5.7% | USD 31.38-6.1% | |
| TXG (10X Genomics Inc) | 79,851 0.5% | USD 1,692,8411.8% | USD 21.21.3% | |
| OCUL (Ocular Therapeutix Inc) | 146,065 0.5% | USD 1,647,6132.4% | USD 11.281.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 352,543 0.5% | USD 1,635,800-3.9% | USD 4.64-4.3% | |
| WVE (Wave Life Sciences Ltd) | 114,627 0.5% | USD 1,612,802-2.6% | USD 14.07-3.0% | |
| DYN (Dyne Therapeutics Inc) | 97,927 0.5% | USD 1,607,961-5.5% | USD 16.42-5.9% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,921 0.5% | USD 1,573,9541.9% | USD 29.191.5% | |
| SRPT (Sarepta Therapeutics Inc) | 72,972 0.5% | USD 1,555,033-6.1% | USD 21.31-6.5% | |
| RARE (Ultragenyx) | 66,150 0.5% | USD 1,554,525-1.9% | USD 23.5-2.4% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 66,150 0.5% | USD 1,481,7601.9% | USD 22.41.4% | |
| HRMY (Harmony Biosciences Holdings) | 39,491 0.5% | USD 1,437,8671.5% | USD 36.411.0% | |
| GMAB (Genmab AS) | 40,078 0.5% | USD 1,356,640-3.8% | USD 33.85-4.2% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 90,398 0.5% | USD 1,344,218-1.9% | USD 14.87-2.4% | |
| VCEL (Vericel Corp Ord) | 34,676 0.5% | USD 1,337,4533.8% | USD 38.573.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,399 0.5% | USD 1,313,3810.8% | USD 85.290.3% | |
| NRIX (Nurix Therapeutics Inc) | 69,504 0.5% | USD 1,310,845-0.5% | USD 18.86-0.9% | |
| LEGN (Legend Biotech Corp) | 57,733 0.5% | USD 1,276,477-4.6% | USD 22.11-5.0% | |
| DVAX (Dynavax Technologies Corporation) | 80,501 0.5% | USD 1,257,4260.6% | USD 15.620.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,581 0.5% | USD 1,231,539-3.2% | USD 20.67-3.6% | |
| HROW (Harrow Health Inc) | 25,395 0.5% | USD 1,231,4041.1% | USD 48.490.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 51,312 0.5% | USD 1,212,503-3.6% | USD 23.63-4.0% | |
| MNKD (MannKind Corp) | 210,534 0.5% | USD 1,174,780-0.1% | USD 5.58-0.5% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,934 0.5% | USD 1,173,017-3.7% | USD 37.92-4.1% | |
| ARDX (Ardelyx Inc) | 166,584 0.5% | USD 1,172,7512.6% | USD 7.042.2% | |
| STOK (Stoke Therapeutics Inc) | 39,163 0.5% | USD 1,146,693-5.0% | USD 29.28-5.5% | |
| PHVS (Pharvaris BV) | 43,920 0.5% | USD 1,126,5480.5% | USD 25.650.1% | |
| AGIO (Agios Pharm) | 39,983 0.5% | USD 1,111,527-2.8% | USD 27.8-3.2% | |
| TNGX (Tango Therapeutics Inc) | 92,322 0.5% | USD 1,079,244-5.2% | USD 11.69-5.6% | |
| NVCR (Novocure Ltd) | 76,781 0.5% | USD 1,059,5780.7% | USD 13.80.2% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 144,349 0.5% | USD 1,034,9826.2% | USD 7.175.8% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 75,297 0.5% | USD 1,018,015-3.5% | USD 13.52-3.9% | |
| COLL (Collegium Pharmaceutical Inc) | 21,674 0.5% | USD 1,016,5111.2% | USD 46.90.7% | |
| INVA (Innoviva Inc) | 51,266 0.5% | USD 1,013,0160.6% | USD 19.760.1% | |
| ELVN (Enliven Therapeutics Inc.) | 40,174 0.5% | USD 1,011,180-2.9% | USD 25.17-3.4% | |
| FTRE (Fortrea Holdings Inc.) | 63,252 0.5% | USD 1,009,502-4.4% | USD 15.96-4.8% | |
| PGEN (Precigen Inc) | 242,581 0.5% | USD 1,004,285-5.7% | USD 4.14-6.1% | |
| IMCR (Immunocore Holdings Ltd) | 29,879 0.5% | USD 978,537-0.7% | USD 32.75-1.1% | |
| QURE (Uniqure NV) | 42,710 0.5% | USD 938,766-1.2% | USD 21.98-1.7% | |
| NTLA (Intellia Therapeutics Inc) | 79,028 0.5% | USD 938,062-0.8% | USD 11.87-1.2% | |
| TSHA (Taysha Gene Therapies Inc) | 187,814 0.5% | USD 920,289-2.3% | USD 4.9-2.8% | |
| RLAY (Relay Therapeutics Inc) | 118,828 0.5% | USD 906,658-5.0% | USD 7.63-5.5% | |
| ANAB (AnaptysBio Inc) | 18,985 0.5% | USD 879,195-7.4% | USD 46.31-7.9% | |
| NVAX (Novavax Inc) | 111,176 0.5% | USD 864,949-4.6% | USD 7.78-5.0% | |
| ABCL (Abcellera Biologics Inc) | 203,841 0.5% | USD 852,055-2.1% | USD 4.18-2.6% | |
| SANA (Sana Biotechnology Inc) | 181,626 0.5% | USD 848,193-1.0% | USD 4.67-1.5% | |
| XERS (Xeris Pharmaceuticals Inc) | 113,751 0.5% | USD 842,895-1.8% | USD 7.41-2.2% | |
| SVRA (Savara Inc) | 139,509 0.5% | USD 820,313-1.6% | USD 5.88-2.0% | |
| AMPH (Amphastar P) | 31,506 0.5% | USD 819,156-5.9% | USD 26-6.3% | |
| CSTL (Castle Biosciences Inc) | 20,000 0.5% | USD 815,0000.4% | USD 40.750.0% | |
| SPRY (Silverback Therapeutics Inc) | 67,775 0.5% | USD 751,625-5.5% | USD 11.09-5.9% | |
| ORIC (Oric Pharmaceuticals Inc) | 65,058 0.5% | USD 749,4682.9% | USD 11.522.4% | |
| GRFS (Grifols SA ADR) | 83,635 0.5% | USD 746,861-2.9% | USD 8.93001-3.4% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,777 0.5% | USD 730,679-0.6% | USD 14.98-1.1% | |
| DAWN (Day One Biopharmaceuticals Inc) | 68,794 0.5% | USD 722,337-1.7% | USD 10.5-2.1% | |
| TBPH (Theravance Biopharma Inc) | 34,126 0.5% | USD 686,274-2.0% | USD 20.11-2.4% | |
| VTYX (Ventyx Biosciences Inc) | 48,916 0.5% | USD 677,9760.5% | USD 13.86 | |
| XNCR (Xencor Inc) | 48,964 0.5% | USD 646,814-8.2% | USD 13.21-8.6% | |
| URGN (UroGen Pharma Ltd) | 32,095 0.5% | USD 627,1364.7% | USD 19.544.3% | |
| ABUS (Arbutus Biopharma Corp) | 131,858 0.5% | USD 619,733-1.2% | USD 4.7-1.7% | |
| RAPT (RAPT Therapeutics Inc) | 19,000 0.5% | USD 611,610-6.9% | USD 32.19-7.3% | |
| PCRX (Pacira BioSciences, Inc.) | 29,498 0.5% | USD 609,134-6.7% | USD 20.65-7.1% | |
| PAHC (Phibro Animal Health Corporation) | 14,608 0.5% | USD 585,1960.9% | USD 40.060.5% | |
| VIR (Vir Biotechnology Inc) | 93,008 0.5% | USD 576,650-8.7% | USD 6.2-9.1% | |
| IOVA (Iovance Biotherapeutics Inc) | 258,182 0.5% | USD 573,164-6.3% | USD 2.22-6.7% | |
| GERN (Geron Corporation) | 427,549 0.5% | USD 555,814-3.3% | USD 1.3-3.7% | |
| JANX (Janux Therapeutics Inc) | 40,424 0.5% | USD 554,617-2.4% | USD 13.72-2.8% | |
| ARVN (Arvinas Inc) | 44,037 0.5% | USD 534,169-0.1% | USD 12.13-0.6% | |
| KURA (Kura Oncology Inc) | 59,652 0.5% | USD 531,499-4.4% | USD 8.91-4.8% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,658 0.5% | USD 518,484-1.4% | USD 14.96-1.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,282 0.5% | USD 507,855-7.0% | USD 3.99-7.4% | |
| ZLAB (Zai Lab Ltd) | 26,834 0.5% | USD 505,016-3.6% | USD 18.82-4.0% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 111,511 0.5% | USD 504,0300.0% | USD 4.52-0.4% | |
| PACB (Pacific Biosciences of California) | 206,958 0.5% | USD 486,3510.0% | USD 2.35-0.4% | |
| RGNX (Regenxbio Inc) | 34,698 0.5% | USD 477,444-7.5% | USD 13.76-8.0% | |
| CGEM (Cullinan Oncology LLC) | 39,796 0.5% | USD 424,225-1.5% | USD 10.66-1.9% | |
| MGTX (MeiraGTx Holdings PLC) | 53,051 0.5% | USD 407,9623.7% | USD 7.693.2% | |
| KROS (Keros Therapeutics Inc) | 20,890 0.5% | USD 402,341-0.9% | USD 19.26-1.4% | |
| REPL (Replimune Group Inc) | 53,499 0.5% | USD 390,543-4.9% | USD 7.30001-5.3% | |
| FULC (Fulcrum Therapeutics Inc) | 37,107 0.5% | USD 385,1710.7% | USD 10.380.2% | |
| PRTA (Prothena Corporation plc) | 40,002 0.5% | USD 370,4191.1% | USD 9.260010.7% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 99,416 0.5% | USD 366,845-5.9% | USD 3.69-6.3% | |
| SIGA (SIGA Technologies Inc) | 51,288 0.5% | USD 339,014-1.2% | USD 6.61001-1.6% | |
| GLPG (Galapagos NV ADR) | 9,570 0.5% | USD 325,6670.2% | USD 34.03-0.3% | |
| LYEL (Lyell Immunopharma Inc) | 13,989 0.5% | USD 320,768-1.8% | USD 22.93-2.3% | |
| AVXL (Anavex Life Sciences Corp) | 62,670 0.5% | USD 303,9501.1% | USD 4.850010.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 40,095 0.5% | USD 298,708-2.8% | USD 7.45001-3.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,936 0.5% | USD 289,143-5.9% | USD 3.71001-6.3% | |
| TRDA (Entrada Therapeutics Inc) | 25,824 0.5% | USD 279,4162.7% | USD 10.822.3% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,450 0.5% | USD 277,385-12.7% | USD 7.61001-13.1% | |
| ACIU (AC Immune Ltd) | 72,956 0.5% | USD 264,830-0.6% | USD 3.63-1.1% | |
| ALLO (Allogene Therapeutics Inc) | 160,012 0.5% | USD 257,619-4.9% | USD 1.61-5.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,577 0.5% | USD 223,713-1.8% | USD 6.46999-2.3% | |
| EOLS (Evolus Inc) | 44,446 0.5% | USD 222,2300.1% | USD 5-0.4% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,230 0.5% | USD 210,631-2.4% | USD 3.44-2.8% | |
| ACRS (Aclaris Therapeutics Inc) | 74,277 0.5% | USD 198,320-2.1% | USD 2.67001-2.6% | |
| AUTL (Autolus Therapeutics Ltd) | 129,751 0.5% | USD 186,8411.9% | USD 1.441.4% | |
| OABI (OmniAb Inc.) | 90,151 0.5% | USD 173,0901.0% | USD 1.920.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,826 0.5% | USD 158,486-1.1% | USD 7.61001-1.6% | |
| EDIT (Editas Medicine Inc) | 70,075 0.5% | USD 146,457-5.4% | USD 2.09-5.9% | |
| VYGR (Voyager Therapeutics Inc) | 37,595 0.5% | USD 143,613-7.1% | USD 3.82-7.5% | |
| CABA (Cabaletta Bio Inc) | 66,002 0.5% | USD 137,284-2.8% | USD 2.08-3.3% | |
| HUMA (Humacyte Inc) | 118,886 0.5% | USD 130,775-3.0% | USD 1.1-3.5% | |
| CRBU (Caribou Biosciences Inc) | 64,093 0.5% | USD 99,985-2.6% | USD 1.56-3.1% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 171,180 0.5% | USD 76,950,545-0.7% | USD 449.53-1.1% | |
| AMGN (Amgen Inc) | 214,859 0.5% | USD 70,682,1651.9% | USD 328.971.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,494 0.5% | USD 53,162,345-0.2% | USD 754.14-0.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 90,185 0.5% | USD 33,085,269-0.4% | USD 366.86-0.8% | |
| INSM (Insmed Inc) | 145,568 0.5% | USD 23,794,5450.3% | USD 163.46-0.2% | |
| BIIB (Biogen Inc) | 100,130 0.5% | USD 16,953,010-4.6% | USD 169.31-5.0% | |
| RVMD (Revolution Medicines Inc) | 131,948 0.5% | USD 15,994,7371.5% | USD 121.221.1% | |
| ARGX (argenx NV ADR) | 19,870 0.5% | USD 15,882,687-0.9% | USD 799.33-1.4% | |
| ILMN (Illumina Inc) | 104,292 0.5% | USD 15,014,919-1.6% | USD 143.97-2.1% | |
| INCY (Incyte Corporation) | 133,999 0.5% | USD 14,197,1942.9% | USD 105.952.4% | |
| UTHR (United Therapeutics Corporation) | 29,388 0.5% | USD 13,980,7530.2% | USD 475.73-0.2% | |
| MEDP (Medpace Holdings Inc) | 19,226 0.5% | USD 11,851,8681.8% | USD 616.451.3% | |
| RPRX (Royalty Pharma Plc) | 291,613 0.5% | USD 11,725,7590.1% | USD 40.21-0.4% | |
| ROIV (Roivant Sciences Ltd) | 474,701 0.5% | USD 11,302,6312.0% | USD 23.811.6% | |
| MRNA (Moderna Inc) | 266,654 0.5% | USD 10,820,8192.9% | USD 40.582.5% | |
| VTRS (Viatris Inc) | 786,129 0.5% | USD 10,337,596-1.2% | USD 13.15-1.6% | |
| BBIO (BridgeBio Pharma Inc) | 131,531 0.5% | USD 10,246,265-1.1% | USD 77.9-1.5% | |
| GH (Guardant Health Inc) | 88,304 0.5% | USD 9,589,8142.1% | USD 108.61.6% | |
| NBIX (Neurocrine Biosciences Inc) | 68,053 0.5% | USD 9,209,6122.8% | USD 135.332.3% | |
| ASND (Ascendis Pharma AS) | 41,917 0.5% | USD 9,109,4021.5% | USD 217.321.1% | |
| SMMT (Summit Therapeutics PLC) | 508,112 0.5% | USD 8,968,1775.5% | USD 17.655.0% | |
| IONS (Ionis Pharmaceuticals Inc) | 110,554 0.5% | USD 8,719,394-0.3% | USD 78.87-0.8% | |
| SNY (Sanofi ADR) | 180,616 0.5% | USD 8,649,7001.9% | USD 47.891.5% | |
| EXEL (Exelixis Inc) | 182,997 0.5% | USD 8,276,9543.1% | USD 45.232.6% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,502 0.5% | USD 7,832,0752.8% | USD 505.232.3% | |
| BNTX (BioNTech SE) | 69,007 0.5% | USD 7,530,0442.3% | USD 109.121.8% | |
| RNA (Avidity Biosciences Inc) | 102,843 0.5% | USD 7,460,2310.6% | USD 72.540.2% | |
| BMRN (Biomarin Pharmaceutical Inc) | 131,126 0.5% | USD 7,353,5462.1% | USD 56.081.6% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,474 0.5% | USD 7,084,1745.6% | USD 170.815.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 92,696 0.5% | USD 6,109,5931.0% | USD 65.910.6% | |
| AXSM (Axsome Therapeutics Inc) | 34,409 0.5% | USD 6,090,7372.0% | USD 177.011.5% | |
| HALO (Halozyme Therapeutics Inc) | 80,265 0.5% | USD 5,856,1342.3% | USD 72.961.8% | |
| KRYS (Krystal Biotech Inc) | 19,792 0.5% | USD 5,775,1080.4% | USD 291.790.0% | |
| CYTK (Cytokinetics Inc) | 83,451 0.5% | USD 5,390,9352.5% | USD 64.62.0% | |
| NUVL (Nuvalent Inc) | 49,110 0.5% | USD 5,296,0227.1% | USD 107.846.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,550 0.5% | USD 5,162,6375.6% | USD 113.345.1% | |
| PRAX (Praxis Precision Medicines Inc) | 17,068 0.5% | USD 5,094,1156.8% | USD 298.466.3% | |
| PCVX (Vaxcyte Inc) | 89,348 0.5% | USD 4,334,2715.9% | USD 48.515.4% | |
| PTCT (PTC Therapeutics Inc) | 54,800 0.5% | USD 4,235,4923.0% | USD 77.292.5% | |
| COGT (Cogent Biosciences Inc) | 104,774 0.5% | USD 3,959,4097.6% | USD 37.797.1% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,607 0.5% | USD 3,846,0388.7% | USD 84.338.2% | |
| CRSP (Crispr Therapeutics AG) | 65,047 0.5% | USD 3,700,5241.7% | USD 56.891.3% | |
| KYMR (Kymera Therapeutics Inc) | 49,108 0.5% | USD 3,693,4131.9% | USD 75.211.5% | |
| PTGX (Protagonist Therapeutics Inc) | 42,670 0.5% | USD 3,636,7645.2% | USD 85.234.8% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,767 0.5% | USD 3,589,3872.5% | USD 55.422.0% | |
| ALKS (Alkermes Plc) | 112,699 0.5% | USD 3,450,8435.5% | USD 30.625.0% | |
| IMVT (Immunovant Inc) | 119,633 0.5% | USD 3,271,9634.9% | USD 27.354.5% | |
| SRRK (Scholar Rock Holding Corp) | 70,399 0.5% | USD 3,208,7864.7% | USD 45.584.2% | |
| MIRM (Mirum Pharmaceuticals Inc) | 35,078 0.5% | USD 3,179,8210.7% | USD 90.650.2% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 115,474 0.5% | USD 3,101,6322.0% | USD 26.861.5% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,426 0.5% | USD 3,085,0254.8% | USD 82.434.3% | |
| CGON (CG Oncology, Inc. Common stock) | 54,791 0.5% | USD 3,041,4486.1% | USD 55.515.6% | |
| FOLD (Amicus Therapeutics Inc) | 210,577 0.5% | USD 3,028,0970.9% | USD 14.380.4% | |
| ADMA (ADMA Biologics Inc) | 162,442 0.5% | USD 2,969,4403.8% | USD 18.283.3% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 214,564 0.5% | USD 2,842,9732.6% | USD 13.252.2% | |
| GRAL (GRAIL, LLC) | 26,492 0.5% | USD 2,775,0373.2% | USD 104.752.7% | |
| ACLX (Arcellx Inc) | 39,466 0.5% | USD 2,757,0955.1% | USD 69.864.7% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,433 0.5% | USD 2,640,1224.6% | USD 196.544.1% | |
| BEAM (Beam Therapeutics Inc) | 69,261 0.5% | USD 2,452,5323.0% | USD 35.412.5% | |
| VCYT (Veracyte Inc) | 53,954 0.5% | USD 2,290,347-0.9% | USD 42.45-1.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,605 0.5% | USD 2,234,7623.1% | USD 26.732.6% | |
| IDYA (Ideaya Biosciences Inc) | 59,836 0.5% | USD 2,215,7276.0% | USD 37.035.5% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,744 0.5% | USD 2,193,0963.5% | USD 41.583.0% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,973 0.5% | USD 2,179,639-0.2% | USD 75.23-0.7% | |
| VERA (Vera Therapeutics Inc) | 43,634 0.5% | USD 2,112,322-1.0% | USD 48.41-1.4% | |
| EWTX (Edgewise Therapeutics Inc) | 72,259 0.5% | USD 2,035,53613.4% | USD 28.1712.9% | |
| IBRX (Immunitybio Inc) | 671,883 0.5% | USD 2,029,0877.6% | USD 3.027.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 39,137 0.5% | USD 2,027,2971.1% | USD 51.80.7% | |
| ADPT (Adaptive Biotechnologies Corp) | 104,200 0.5% | USD 1,879,7680.3% | USD 18.04-0.2% | |
| DNLI (Denali Therapeutics Inc) | 100,100 0.5% | USD 1,828,8271.3% | USD 18.270.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 54,016 0.5% | USD 1,804,9451.9% | USD 33.4151.4% | |
| TVTX (Travere Therapeutics Inc) | 61,069 0.5% | USD 1,766,726-0.2% | USD 28.93-0.6% | |
| SYRE (Spyre Therapeutics Inc.) | 52,959 0.5% | USD 1,756,1205.7% | USD 33.165.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 86,358 0.5% | USD 1,755,658-4.3% | USD 20.33-4.7% | |
| RXRX (Recursion Pharmaceuticals Inc) | 350,939 0.5% | USD 1,702,0543.9% | USD 4.853.4% | |
| DYN (Dyne Therapeutics Inc) | 97,481 0.5% | USD 1,701,0432.9% | USD 17.452.4% | |
| TWST (Twist Bioscience Corp) | 41,736 0.5% | USD 1,670,6920.0% | USD 40.03-0.5% | |
| TXG (10X Genomics Inc) | 79,489 0.5% | USD 1,662,9102.4% | USD 20.921.9% | |
| SRPT (Sarepta Therapeutics Inc) | 72,640 0.5% | USD 1,656,1926.7% | USD 22.86.2% | |
| WVE (Wave Life Sciences Ltd) | 114,105 0.5% | USD 1,655,6642.5% | USD 14.512.0% | |
| OCUL (Ocular Therapeutix Inc) | 145,401 0.5% | USD 1,609,5896.6% | USD 11.076.1% | |
| ERAS (Erasca Inc) | 193,604 0.5% | USD 1,608,84911.2% | USD 8.3110.7% | |
| RARE (Ultragenyx) | 65,850 0.5% | USD 1,585,0100.3% | USD 24.07-0.2% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,677 0.5% | USD 1,544,2873.6% | USD 28.773.2% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 65,850 0.5% | USD 1,454,627-0.1% | USD 22.09-0.6% | |
| HRMY (Harmony Biosciences Holdings) | 39,311 0.5% | USD 1,416,7681.2% | USD 36.040.8% | |
| GMAB (Genmab AS) | 39,896 0.5% | USD 1,409,9254.8% | USD 35.344.3% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 89,986 0.5% | USD 1,370,4872.1% | USD 15.231.6% | |
| LEGN (Legend Biotech Corp) | 57,471 0.5% | USD 1,337,9253.6% | USD 23.283.1% | |
| NRIX (Nurix Therapeutics Inc) | 69,188 0.5% | USD 1,317,3401.0% | USD 19.040.6% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,329 0.5% | USD 1,303,4253.8% | USD 85.033.3% | |
| VCEL (Vericel Corp Ord) | 34,518 0.5% | USD 1,288,5571.2% | USD 37.330.8% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,311 0.5% | USD 1,271,6285.2% | USD 21.444.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 51,078 0.5% | USD 1,257,5403.4% | USD 24.622.9% | |
| DVAX (Dynavax Technologies Corporation) | 80,135 0.5% | USD 1,250,106-0.3% | USD 15.6-0.8% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,794 0.5% | USD 1,218,2113.0% | USD 39.562.5% | |
| HROW (Harrow Health Inc) | 25,279 0.5% | USD 1,217,4372.5% | USD 48.162.1% | |
| STOK (Stoke Therapeutics Inc) | 38,985 0.5% | USD 1,207,3651.7% | USD 30.971.3% | |
| MNKD (MannKind Corp) | 209,574 0.5% | USD 1,175,710-0.1% | USD 5.61-0.5% | |
| AGIO (Agios Pharm) | 39,801 0.5% | USD 1,143,4833.8% | USD 28.733.3% | |
| ARDX (Ardelyx Inc) | 165,824 0.5% | USD 1,142,527-1.7% | USD 6.89-2.1% | |
| TNGX (Tango Therapeutics Inc) | 91,902 0.5% | USD 1,138,66619.2% | USD 12.3918.7% | |
| PHVS (Pharvaris BV) | 43,720 0.5% | USD 1,120,544-1.0% | USD 25.63-1.4% | |
| PGEN (Precigen Inc) | 241,475 0.5% | USD 1,064,9056.2% | USD 4.415.8% | |
| FTRE (Fortrea Holdings Inc.) | 62,964 0.5% | USD 1,055,906-3.0% | USD 16.77-3.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 74,955 0.5% | USD 1,054,61712.2% | USD 14.0711.7% | |
| NVCR (Novocure Ltd) | 76,431 0.5% | USD 1,052,4551.3% | USD 13.770.9% | |
| ELVN (Enliven Therapeutics Inc.) | 39,992 0.5% | USD 1,041,7921.6% | USD 26.051.2% | |
| MNMD (Mind Medicine Inc) | 67,236 0.5% | USD 1,009,8851.5% | USD 15.021.0% | |
| INVA (Innoviva Inc) | 51,032 0.5% | USD 1,007,3721.6% | USD 19.741.2% | |
| COLL (Collegium Pharmaceutical Inc) | 21,576 0.5% | USD 1,004,794-1.1% | USD 46.57-1.5% | |
| IMCR (Immunocore Holdings Ltd) | 29,743 0.5% | USD 985,3863.0% | USD 33.132.6% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 143,691 0.5% | USD 974,2250.9% | USD 6.780.4% | |
| RLAY (Relay Therapeutics Inc) | 118,286 0.5% | USD 954,5682.1% | USD 8.071.6% | |
| QURE (Uniqure NV) | 42,516 0.5% | USD 950,2334.4% | USD 22.354.0% | |
| ANAB (AnaptysBio Inc) | 18,899 0.5% | USD 949,8644.9% | USD 50.264.4% | |
| NTLA (Intellia Therapeutics Inc) | 78,668 0.5% | USD 945,5892.9% | USD 12.022.4% | |
| TSHA (Taysha Gene Therapies Inc) | 186,956 0.5% | USD 942,2583.3% | USD 5.042.9% | |
| NVAX (Novavax Inc) | 110,668 0.5% | USD 906,371-5.1% | USD 8.19-5.5% | |
| AMPH (Amphastar P) | 31,362 0.5% | USD 870,609-3.5% | USD 27.76-4.0% | |
| ABCL (Abcellera Biologics Inc) | 202,911 0.5% | USD 870,4880.9% | USD 4.290.5% | |
| XERS (Xeris Pharmaceuticals Inc) | 113,231 0.5% | USD 858,291-1.2% | USD 7.58-1.7% | |
| SANA (Sana Biotechnology Inc) | 180,796 0.5% | USD 856,9731.3% | USD 4.740.9% | |
| SVRA (Savara Inc) | 138,873 0.5% | USD 833,2381.8% | USD 61.4% | |
| CSTL (Castle Biosciences Inc) | 19,910 0.5% | USD 811,7313.3% | USD 40.772.9% | |
| SPRY (Silverback Therapeutics Inc) | 67,465 0.5% | USD 795,4124.7% | USD 11.794.2% | |
| GRFS (Grifols SA ADR) | 83,253 0.5% | USD 769,2585.0% | USD 9.244.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,555 0.5% | USD 735,123-2.7% | USD 15.14-3.1% | |
| DAWN (Day One Biopharmaceuticals Inc) | 68,480 0.5% | USD 734,7901.8% | USD 10.731.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,762 0.5% | USD 728,57311.5% | USD 11.2510.9% | |
| XNCR (Xencor Inc) | 48,740 0.5% | USD 704,2934.1% | USD 14.453.7% | |
| TBPH (Theravance Biopharma Inc) | 33,970 0.5% | USD 700,1221.8% | USD 20.611.4% | |
| VTYX (Ventyx Biosciences Inc) | 48,692 0.5% | USD 674,8710.5% | USD 13.86 | |
| RAPT (RAPT Therapeutics Inc) | 18,914 0.5% | USD 656,8832.4% | USD 34.732.0% | |
| PCRX (Pacira BioSciences, Inc.) | 29,364 0.5% | USD 653,0553.4% | USD 22.243.0% | |
| VIR (Vir Biotechnology Inc) | 92,582 0.5% | USD 631,4098.6% | USD 6.828.1% | |
| ABUS (Arbutus Biopharma Corp) | 131,254 0.5% | USD 627,3941.3% | USD 4.780.8% | |
| IOVA (Iovance Biotherapeutics Inc) | 256,998 0.5% | USD 611,6551.7% | USD 2.381.3% | |
| URGN (UroGen Pharma Ltd) | 31,949 0.5% | USD 598,724-5.1% | USD 18.74-5.5% | |
| PAHC (Phibro Animal Health Corporation) | 14,542 0.5% | USD 579,790-1.0% | USD 39.87-1.5% | |
| GERN (Geron Corporation) | 425,587 0.5% | USD 574,5423.5% | USD 1.353.1% | |
| JANX (Janux Therapeutics Inc) | 40,240 0.5% | USD 568,1892.9% | USD 14.122.4% | |
| KURA (Kura Oncology Inc) | 59,380 0.5% | USD 555,7972.1% | USD 9.361.6% | |
| PRME (Prime Medicine, Inc. Common Stock) | 126,698 0.5% | USD 546,0684.1% | USD 4.313.6% | |
| ARVN (Arvinas Inc) | 43,835 0.5% | USD 534,787-0.3% | USD 12.2-0.7% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,500 0.5% | USD 525,7802.5% | USD 15.242.0% | |
| ZLAB (Zai Lab Ltd) | 26,712 0.5% | USD 523,8225.2% | USD 19.614.8% | |
| RGNX (Regenxbio Inc) | 34,540 0.5% | USD 516,373-0.2% | USD 14.95-0.7% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 110,999 0.5% | USD 503,935-1.7% | USD 4.54-2.2% | |
| PACB (Pacific Biosciences of California) | 206,008 0.5% | USD 486,17911.3% | USD 2.3610.8% | |
| CGEM (Cullinan Oncology LLC) | 39,614 0.5% | USD 430,6041.8% | USD 10.871.3% | |
| REPL (Replimune Group Inc) | 53,253 0.5% | USD 410,581-3.7% | USD 7.71001-4.1% | |
| KROS (Keros Therapeutics Inc) | 20,794 0.5% | USD 406,1070.6% | USD 19.530.2% | |
| MGTX (MeiraGTx Holdings PLC) | 52,807 0.5% | USD 393,4121.4% | USD 7.450.9% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 98,958 0.5% | USD 389,895-1.5% | USD 3.94-2.0% | |
| FULC (Fulcrum Therapeutics Inc) | 36,937 0.5% | USD 382,6671.5% | USD 10.361.1% | |
| PRTA (Prothena Corporation plc) | 39,818 0.5% | USD 366,3262.9% | USD 9.200012.5% | |
| SIGA (SIGA Technologies Inc) | 51,052 0.5% | USD 343,0692.3% | USD 6.719991.8% | |
| LYEL (Lyell Immunopharma Inc) | 13,925 0.5% | USD 326,681-0.6% | USD 23.46-1.1% | |
| GLPG (Galapagos NV ADR) | 9,526 0.5% | USD 325,0273.1% | USD 34.122.6% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,282 0.5% | USD 317,83012.0% | USD 8.7599911.5% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,911 0.5% | USD 307,3154.0% | USD 7.700013.5% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,576 0.5% | USD 307,2014.7% | USD 3.964.2% | |
| AVXL (Anavex Life Sciences Corp) | 62,380 0.5% | USD 300,6724.4% | USD 4.820013.9% | |
| TRDA (Entrada Therapeutics Inc) | 25,704 0.5% | USD 271,9481.6% | USD 10.581.1% | |
| ALLO (Allogene Therapeutics Inc) | 159,270 0.5% | USD 270,7594.1% | USD 1.73.7% | |
| ACIU (AC Immune Ltd) | 72,618 0.5% | USD 266,508-0.3% | USD 3.67-0.8% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,417 0.5% | USD 227,8412.5% | USD 6.620012.0% | |
| EOLS (Evolus Inc) | 44,240 0.5% | USD 222,085-11.8% | USD 5.02-12.2% | |
| AVIR (Atea Pharmaceuticals Inc) | 60,944 0.5% | USD 215,7421.3% | USD 3.540.9% | |
| ACRS (Aclaris Therapeutics Inc) | 73,931 0.5% | USD 202,5711.6% | USD 2.741.1% | |
| AUTL (Autolus Therapeutics Ltd) | 129,143 0.5% | USD 183,3834.1% | USD 1.423.6% | |
| OABI (OmniAb Inc.) | 89,727 0.5% | USD 171,3791.0% | USD 1.910.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,728 0.5% | USD 160,2272.6% | USD 7.729982.1% | |
| EDIT (Editas Medicine Inc) | 69,745 0.5% | USD 154,8346.7% | USD 2.226.2% | |
| VYGR (Voyager Therapeutics Inc) | 37,419 0.5% | USD 154,5403.2% | USD 4.129992.7% | |
| CABA (Cabaletta Bio Inc) | 65,690 0.5% | USD 141,2340.5% | USD 2.150010.0% | |
| HUMA (Humacyte Inc) | 118,322 0.5% | USD 134,8873.2% | USD 1.142.7% | |
| CRBU (Caribou Biosciences Inc) | 63,789 0.5% | USD 102,7001.7% | USD 1.611.3% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 170,400 | USD 77,475,768-1.3% | USD 454.67-1.3% | |
| AMGN (Amgen Inc) | 213,879 | USD 69,360,960-0.4% | USD 324.3-0.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,172 | USD 53,254,233-1.2% | USD 758.91-1.2% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 89,773 | USD 33,212,419-0.3% | USD 369.96-0.3% | |
| INSM (Insmed Inc) | 144,904 | USD 23,723,683-2.4% | USD 163.72-2.4% | |
| BIIB (Biogen Inc) | 99,674 | USD 17,771,874-3.9% | USD 178.3-3.9% | |
| ARGX (argenx NV ADR) | 19,780 | USD 16,031,8881.8% | USD 810.511.8% | |
| RVMD (Revolution Medicines Inc) | 131,346 | USD 15,754,9532.4% | USD 119.952.4% | |
| ILMN (Illumina Inc) | 103,816 | USD 15,259,9141.0% | USD 146.991.0% | |
| UTHR (United Therapeutics Corporation) | 29,254 | USD 13,950,062-1.1% | USD 476.86-1.1% | |
| INCY (Incyte Corporation) | 133,389 | USD 13,796,424-2.7% | USD 103.43-2.7% | |
| RPRX (Royalty Pharma Plc) | 290,283 | USD 11,715,8220.2% | USD 40.360.2% | |
| MEDP (Medpace Holdings Inc) | 19,138 | USD 11,644,1331.5% | USD 608.431.5% | |
| ROIV (Roivant Sciences Ltd) | 472,537 | USD 11,076,2675.8% | USD 23.445.8% | |
| MRNA (Moderna Inc) | 265,438 | USD 10,511,34517.0% | USD 39.617.0% | |
| VTRS (Viatris Inc) | 782,545 | USD 10,462,6275.4% | USD 13.375.4% | |
| BBIO (BridgeBio Pharma Inc) | 130,931 | USD 10,357,9513.0% | USD 79.113.0% | |
| GH (Guardant Health Inc) | 87,902 | USD 9,395,845-0.6% | USD 106.89-0.6% | |
| ASND (Ascendis Pharma AS) | 41,725 | USD 8,972,9613.0% | USD 215.053.0% | |
| NBIX (Neurocrine Biosciences Inc) | 67,743 | USD 8,959,689-0.3% | USD 132.26-0.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 110,050 | USD 8,746,774-2.7% | USD 79.48-2.7% | |
| SMMT (Summit Therapeutics PLC) | 505,796 | USD 8,502,431-1.3% | USD 16.81-1.3% | |
| SNY (Sanofi ADR) | 179,792 | USD 8,486,182-0.8% | USD 47.2-0.8% | |
| EXEL (Exelixis Inc) | 182,163 | USD 8,029,7450.0% | USD 44.080.0% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,432 | USD 7,621,865-3.3% | USD 493.9-3.3% | |
| RNA (Avidity Biosciences Inc) | 102,375 | USD 7,415,0210.1% | USD 72.430.1% | |
| BNTX (BioNTech SE) | 68,693 | USD 7,363,2034.9% | USD 107.194.9% | |
| BMRN (Biomarin Pharmaceutical Inc) | 130,528 | USD 7,205,146-4.3% | USD 55.2-4.3% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,284 | USD 6,705,760-0.8% | USD 162.43-0.8% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 92,274 | USD 6,048,099-0.6% | USD 65.545-0.6% | |
| AXSM (Axsome Therapeutics Inc) | 34,253 | USD 5,971,325-1.4% | USD 174.33-1.4% | |
| KRYS (Krystal Biotech Inc) | 19,702 | USD 5,751,6057.3% | USD 291.937.3% | |
| HALO (Halozyme Therapeutics Inc) | 79,899 | USD 5,726,361-1.0% | USD 71.67-1.0% | |
| CYTK (Cytokinetics Inc) | 83,071 | USD 5,260,886-2.0% | USD 63.33-2.0% | |
| NUVL (Nuvalent Inc) | 48,886 | USD 4,945,7972.0% | USD 101.172.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,342 | USD 4,887,8682.8% | USD 107.82.8% | |
| PRAX (Praxis Precision Medicines Inc) | 16,990 | USD 4,771,3021.8% | USD 280.831.8% | |
| PTCT (PTC Therapeutics Inc) | 54,550 | USD 4,113,070-2.8% | USD 75.4-2.8% | |
| PCVX (Vaxcyte Inc) | 88,940 | USD 4,093,0190.4% | USD 46.020.4% | |
| COGT (Cogent Biosciences Inc) | 104,296 | USD 3,679,5631.5% | USD 35.281.5% | |
| CRSP (Crispr Therapeutics AG) | 64,751 | USD 3,637,7111.6% | USD 56.181.6% | |
| KYMR (Kymera Therapeutics Inc) | 48,884 | USD 3,623,7711.4% | USD 74.131.4% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,399 | USD 3,537,49012.3% | USD 77.9212.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,471 | USD 3,501,420-1.9% | USD 54.31-1.9% | |
| PTGX (Protagonist Therapeutics Inc) | 42,476 | USD 3,455,8471.4% | USD 81.361.4% | |
| ALKS (Alkermes Plc) | 112,185 | USD 3,270,193-1.6% | USD 29.15-1.6% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,918 | USD 3,157,9841.1% | USD 90.441.1% | |
| IMVT (Immunovant Inc) | 119,087 | USD 3,117,6981.4% | USD 26.181.4% | |
| SRRK (Scholar Rock Holding Corp) | 70,079 | USD 3,065,9560.4% | USD 43.750.4% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 114,948 | USD 3,041,524-0.5% | USD 26.46-0.5% | |
| FOLD (Amicus Therapeutics Inc) | 209,617 | USD 3,001,7150.3% | USD 14.320.3% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,256 | USD 2,943,2241.7% | USD 791.7% | |
| CGON (CG Oncology, Inc. Common stock) | 54,541 | USD 2,867,766-2.1% | USD 52.58-2.1% | |
| ADMA (ADMA Biologics Inc) | 161,700 | USD 2,862,090-1.3% | USD 17.7-1.3% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 213,584 | USD 2,770,184-0.1% | USD 12.97-0.1% | |
| GRAL (GRAIL, LLC) | 26,372 | USD 2,689,153-3.7% | USD 101.97-3.7% | |
| ACLX (Arcellx Inc) | 39,286 | USD 2,622,3412.9% | USD 66.752.9% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,371 | USD 2,524,177-8.7% | USD 188.78-8.7% | |
| BEAM (Beam Therapeutics Inc) | 68,945 0.5% | USD 2,382,0503.0% | USD 34.552.6% | |
| VCYT (Veracyte Inc) | 53,708 | USD 2,312,129-0.9% | USD 43.05-0.9% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,841 | USD 2,184,1290.3% | USD 75.730.3% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,223 | USD 2,167,959-2.7% | USD 26.05-2.7% | |
| VERA (Vera Therapeutics Inc) | 43,436 | USD 2,132,7085.7% | USD 49.15.7% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,504 | USD 2,119,061-2.1% | USD 40.36-2.1% | |
| IDYA (Ideaya Biosciences Inc) | 59,564 | USD 2,090,101-4.8% | USD 35.09-4.8% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,959 | USD 2,004,4410.2% | USD 51.450.2% | |
| IBRX (Immunitybio Inc) | 668,813 | USD 1,886,0538.9% | USD 2.828.9% | |
| ADPT (Adaptive Biotechnologies Corp) | 103,724 | USD 1,874,293-1.0% | USD 18.07-1.0% | |
| APLS (Apellis Pharmaceuticals Inc) | 85,964 | USD 1,833,612-8.1% | USD 21.33-8.1% | |
| DNLI (Denali Therapeutics Inc) | 99,644 | USD 1,804,5530.9% | USD 18.110.9% | |
| EWTX (Edgewise Therapeutics Inc) | 71,929 | USD 1,794,6293.4% | USD 24.953.4% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 53,770 | USD 1,771,184-0.1% | USD 32.94-0.1% | |
| TVTX (Travere Therapeutics Inc) | 60,791 | USD 1,769,626-14.6% | USD 29.11-14.6% | |
| TWST (Twist Bioscience Corp) | 41,546 | USD 1,670,9805.7% | USD 40.225.7% | |
| SYRE (Spyre Therapeutics Inc.) | 52,717 | USD 1,662,167-3.9% | USD 31.53-3.9% | |
| DYN (Dyne Therapeutics Inc) | 97,035 | USD 1,653,476-2.4% | USD 17.04-2.4% | |
| RXRX (Recursion Pharmaceuticals Inc) | 349,335 | USD 1,638,381-2.5% | USD 4.69-2.5% | |
| TXG (10X Genomics Inc) | 79,127 | USD 1,623,6863.6% | USD 20.523.6% | |
| WVE (Wave Life Sciences Ltd) | 113,583 | USD 1,615,1502.2% | USD 14.222.2% | |
| RARE (Ultragenyx) | 65,550 | USD 1,580,411-1.1% | USD 24.11-1.1% | |
| SRPT (Sarepta Therapeutics Inc) | 72,308 | USD 1,551,7301.5% | USD 21.461.5% | |
| OCUL (Ocular Therapeutix Inc) | 144,737 | USD 1,509,607-2.4% | USD 10.43-2.4% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,433 | USD 1,490,246-3.1% | USD 27.89-3.1% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 65,550 | USD 1,456,5210.9% | USD 22.220.9% | |
| ERAS (Erasca Inc) | 192,718 | USD 1,446,34920.5% | USD 7.50520.5% | |
| HRMY (Harmony Biosciences Holdings) | 39,131 | USD 1,399,325-6.6% | USD 35.76-6.6% | |
| GMAB (Genmab AS) | 39,714 | USD 1,345,113-0.2% | USD 33.87-0.2% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 89,574 | USD 1,342,714-1.9% | USD 14.99-1.9% | |
| NRIX (Nurix Therapeutics Inc) | 68,872 | USD 1,303,7473.0% | USD 18.933.0% | |
| LEGN (Legend Biotech Corp) | 57,209 | USD 1,291,207-4.8% | USD 22.57-4.8% | |
| VCEL (Vericel Corp Ord) | 34,360 | USD 1,273,0381.3% | USD 37.051.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,259 | USD 1,255,511-2.5% | USD 82.28-2.5% | |
| DVAX (Dynavax Technologies Corporation) | 79,769 | USD 1,253,9690.3% | USD 15.720.3% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,844 | USD 1,216,1883.3% | USD 23.923.3% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,041 | USD 1,208,569-1.2% | USD 20.47-1.2% | |
| HROW (Harrow Health Inc) | 25,163 | USD 1,187,442-1.4% | USD 47.19-1.4% | |
| STOK (Stoke Therapeutics Inc) | 38,807 | USD 1,186,7183.9% | USD 30.583.9% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,654 | USD 1,183,244-6.1% | USD 38.6-6.1% | |
| MNKD (MannKind Corp) | 208,614 | USD 1,176,583-2.3% | USD 5.64-2.3% | |
| ARDX (Ardelyx Inc) | 165,064 | USD 1,162,051-4.3% | USD 7.04-4.3% | |
| PHVS (Pharvaris BV) | 43,520 | USD 1,131,520-0.4% | USD 26-0.4% | |
| AGIO (Agios Pharm) | 39,619 | USD 1,101,408-1.8% | USD 27.8-1.8% | |
| FTRE (Fortrea Holdings Inc.) | 62,676 | USD 1,088,682-5.6% | USD 17.37-5.6% | |
| NVCR (Novocure Ltd) | 76,081 | USD 1,038,506-3.7% | USD 13.65-3.7% | |
| ELVN (Enliven Therapeutics Inc.) | 39,810 | USD 1,025,1082.9% | USD 25.752.9% | |
| COLL (Collegium Pharmaceutical Inc) | 21,478 | USD 1,015,480-1.8% | USD 47.28-1.8% | |
| PGEN (Precigen Inc) | 240,369 | USD 1,002,3390.8% | USD 4.170.8% | |
| MNMD (Mind Medicine Inc) | 66,928 | USD 995,2197.1% | USD 14.877.1% | |
| INVA (Innoviva Inc) | 50,798 | USD 991,0690.4% | USD 19.510.4% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 143,033 | USD 965,473-4.8% | USD 6.75-4.8% | |
| IMCR (Immunocore Holdings Ltd) | 29,607 | USD 956,306-1.0% | USD 32.3-1.0% | |
| NVAX (Novavax Inc) | 110,162 | USD 955,10511.9% | USD 8.6711.9% | |
| TNGX (Tango Therapeutics Inc) | 91,482 | USD 955,072-2.1% | USD 10.44-2.1% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 74,611 | USD 940,0991.7% | USD 12.61.7% | |
| RLAY (Relay Therapeutics Inc) | 117,744 | USD 934,8871.8% | USD 7.941.8% | |
| NTLA (Intellia Therapeutics Inc) | 78,308 | USD 919,3362.7% | USD 11.742.7% | |
| TSHA (Taysha Gene Therapies Inc) | 186,098 | USD 911,8800.8% | USD 4.90.8% | |
| QURE (Uniqure NV) | 42,322 | USD 909,923-6.7% | USD 21.5-6.7% | |
| ANAB (AnaptysBio Inc) | 18,813 | USD 905,376-1.8% | USD 48.125-1.8% | |
| AMPH (Amphastar P) | 31,220 | USD 902,570-1.7% | USD 28.91-1.7% | |
| XERS (Xeris Pharmaceuticals Inc) | 112,711 | USD 869,002-2.0% | USD 7.71-2.0% | |
| ABCL (Abcellera Biologics Inc) | 201,981 | USD 862,459-5.5% | USD 4.27-5.5% | |
| SANA (Sana Biotechnology Inc) | 179,966 | USD 845,8402.6% | USD 4.72.6% | |
| SVRA (Savara Inc) | 138,235 | USD 818,3512.6% | USD 5.922.6% | |
| CSTL (Castle Biosciences Inc) | 19,820 | USD 785,665-0.1% | USD 39.64-0.1% | |
| SPRY (Silverback Therapeutics Inc) | 67,155 | USD 759,523-0.6% | USD 11.31-0.6% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,333 | USD 755,4458.0% | USD 15.638.0% | |
| GRFS (Grifols SA ADR) | 82,871 | USD 732,580-3.3% | USD 8.84-3.3% | |
| DAWN (Day One Biopharmaceuticals Inc) | 68,166 0.5% | USD 721,878-6.1% | USD 10.59-6.5% | |
| TBPH (Theravance Biopharma Inc) | 33,814 | USD 687,4393.5% | USD 20.333.5% | |
| XNCR (Xencor Inc) | 48,516 | USD 676,313-1.6% | USD 13.94-1.6% | |
| VTYX (Ventyx Biosciences Inc) | 48,468 | USD 671,7660.1% | USD 13.860.1% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,464 | USD 653,66510.8% | USD 10.1410.8% | |
| RAPT (RAPT Therapeutics Inc) | 18,828 | USD 641,282-1.0% | USD 34.06-1.0% | |
| PCRX (Pacira BioSciences, Inc.) | 29,230 | USD 631,368-5.8% | USD 21.6-5.8% | |
| URGN (UroGen Pharma Ltd) | 31,803 | USD 630,653-7.6% | USD 19.83-7.6% | |
| ABUS (Arbutus Biopharma Corp) | 130,650 | USD 619,2815.3% | USD 4.745.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 255,814 | USD 601,163-2.1% | USD 2.35-2.1% | |
| PAHC (Phibro Animal Health Corporation) | 14,476 | USD 585,6991.6% | USD 40.461.6% | |
| VIR (Vir Biotechnology Inc) | 92,156 | USD 581,5046.6% | USD 6.316.6% | |
| GERN (Geron Corporation) | 423,625 | USD 554,949-8.4% | USD 1.31-8.4% | |
| JANX (Janux Therapeutics Inc) | 40,056 | USD 552,372-1.7% | USD 13.79-1.7% | |
| KURA (Kura Oncology Inc) | 59,108 | USD 544,3850.4% | USD 9.210010.4% | |
| ARVN (Arvinas Inc) | 43,633 | USD 536,2501.2% | USD 12.291.2% | |
| PRME (Prime Medicine, Inc. Common Stock) | 126,114 | USD 524,634-2.8% | USD 4.16-2.8% | |
| RGNX (Regenxbio Inc) | 34,382 | USD 517,449-0.2% | USD 15.05-0.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,342 | USD 513,069-8.8% | USD 14.94-8.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 110,487 | USD 512,6603.8% | USD 4.643.8% | |
| ZLAB (Zai Lab Ltd) | 26,590 | USD 497,7651.8% | USD 18.721.8% | |
| PACB (Pacific Biosciences of California) | 205,056 | USD 436,7696.0% | USD 2.136.0% | |
| REPL (Replimune Group Inc) | 53,007 | USD 426,176-0.8% | USD 8.04-0.8% | |
| CGEM (Cullinan Oncology LLC) | 39,432 | USD 423,1051.1% | USD 10.731.1% | |
| KROS (Keros Therapeutics Inc) | 20,698 | USD 403,6113.3% | USD 19.53.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 98,500 | USD 395,9702.0% | USD 4.022.0% | |
| MGTX (MeiraGTx Holdings PLC) | 52,563 | USD 387,9151.9% | USD 7.381.9% | |
| FULC (Fulcrum Therapeutics Inc) | 36,767 | USD 376,8627.8% | USD 10.257.8% | |
| PRTA (Prothena Corporation plc) | 39,634 | USD 355,9130.8% | USD 8.979990.8% | |
| SIGA (SIGA Technologies Inc) | 50,816 | USD 335,3860.2% | USD 6.600010.2% | |
| LYEL (Lyell Immunopharma Inc) | 13,861 | USD 328,644-0.3% | USD 23.71-0.3% | |
| GLPG (Galapagos NV ADR) | 9,482 | USD 315,2770.4% | USD 33.25010.4% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,727 | USD 295,5690.4% | USD 7.440.4% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,216 | USD 293,4215.6% | USD 3.85.6% | |
| AVXL (Anavex Life Sciences Corp) | 62,090 | USD 288,0988.2% | USD 4.640018.2% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,114 | USD 283,8564.8% | USD 7.864.8% | |
| TRDA (Entrada Therapeutics Inc) | 25,584 | USD 267,6095.1% | USD 10.465.1% | |
| ACIU (AC Immune Ltd) | 72,280 | USD 267,4365.1% | USD 3.75.1% | |
| ALLO (Allogene Therapeutics Inc) | 158,526 | USD 259,983-1.8% | USD 1.64-1.8% | |
| EOLS (Evolus Inc) | 44,034 | USD 251,874-0.9% | USD 5.71999-0.9% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,257 | USD 222,328-1.4% | USD 6.49-1.4% | |
| AVIR (Atea Pharmaceuticals Inc) | 60,658 | USD 212,910-2.8% | USD 3.51001-2.8% | |
| ACRS (Aclaris Therapeutics Inc) | 73,583 | USD 199,4101.9% | USD 2.711.9% | |
| AUTL (Autolus Therapeutics Ltd) | 128,533 | USD 176,090-8.7% | USD 1.37-8.7% | |
| OABI (OmniAb Inc.) | 89,303 | USD 169,676-0.5% | USD 1.9-0.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,630 | USD 156,1690.5% | USD 7.569990.5% | |
| VYGR (Voyager Therapeutics Inc) | 37,241 | USD 149,7093.1% | USD 4.023.1% | |
| EDIT (Editas Medicine Inc) | 69,413 | USD 145,073-1.9% | USD 2.09-1.9% | |
| CABA (Cabaletta Bio Inc) | 65,378 | USD 140,563-2.7% | USD 2.15-2.7% | |
| HUMA (Humacyte Inc) | 117,756 | USD 130,709-1.8% | USD 1.11-1.8% | |
| CRBU (Caribou Biosciences Inc) | 63,485 | USD 100,9410.6% | USD 1.590.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 170,400 0.5% | USD 78,484,536-0.2% | USD 460.59-0.7% | |
| AMGN (Amgen Inc) | 213,879 0.5% | USD 69,626,1700.3% | USD 325.54-0.2% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,172 0.5% | USD 53,892,096-3.1% | USD 768-3.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 89,773 0.5% | USD 33,297,703-6.4% | USD 370.91-6.9% | |
| INSM (Insmed Inc) | 144,904 0.5% | USD 24,303,299-4.2% | USD 167.72-4.7% | |
| BIIB (Biogen Inc) | 99,674 0.5% | USD 18,502,485-0.6% | USD 185.63-1.1% | |
| ARGX (argenx NV ADR) | 19,780 0.5% | USD 15,744,8801.4% | USD 7961.0% | |
| RVMD (Revolution Medicines Inc) | 131,346 0.5% | USD 15,389,811-0.8% | USD 117.17-1.2% | |
| ILMN (Illumina Inc) | 103,816 0.5% | USD 15,110,4193.7% | USD 145.553.2% | |
| INCY (Incyte Corporation) | 133,389 0.5% | USD 14,183,2520.0% | USD 106.33-0.5% | |
| UTHR (United Therapeutics Corporation) | 29,254 0.5% | USD 14,111,8370.3% | USD 482.39-0.2% | |
| RPRX (Royalty Pharma Plc) | 290,283 0.5% | USD 11,686,7940.7% | USD 40.260.2% | |
| MEDP (Medpace Holdings Inc) | 19,138 0.5% | USD 11,467,6811.2% | USD 599.210.7% | |
| ROIV (Roivant Sciences Ltd) | 472,537 0.5% | USD 10,471,4201.3% | USD 22.160.8% | |
| BBIO (BridgeBio Pharma Inc) | 130,931 0.5% | USD 10,060,738-0.1% | USD 76.84-0.5% | |
| VTRS (Viatris Inc) | 782,545 0.5% | USD 9,922,671-0.2% | USD 12.68-0.6% | |
| GH (Guardant Health Inc) | 87,902 0.5% | USD 9,455,618-1.9% | USD 107.57-2.4% | |
| NBIX (Neurocrine Biosciences Inc) | 67,743 0.5% | USD 8,986,786-1.9% | USD 132.66-2.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 110,050 0.5% | USD 8,986,6832.2% | USD 81.661.7% | |
| MRNA (Moderna Inc) | 265,438 0.5% | USD 8,982,422-0.9% | USD 33.84-1.3% | |
| ASND (Ascendis Pharma AS) | 41,725 0.5% | USD 8,710,5113.3% | USD 208.762.8% | |
| SMMT (Summit Therapeutics PLC) | 505,796 0.5% | USD 8,618,764-13.0% | USD 17.04-13.4% | |
| SNY (Sanofi ADR) | 179,792 0.5% | USD 8,558,099-2.5% | USD 47.6-2.9% | |
| EXEL (Exelixis Inc) | 182,163 0.5% | USD 8,026,1020.5% | USD 44.060.0% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,432 0.5% | USD 7,878,499-0.2% | USD 510.53-0.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 130,528 0.5% | USD 7,532,771-1.7% | USD 57.71-2.1% | |
| RNA (Avidity Biosciences Inc) | 102,375 0.5% | USD 7,406,8310.4% | USD 72.350.0% | |
| BNTX (BioNTech SE) | 68,693 0.5% | USD 7,019,0512.8% | USD 102.182.3% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,284 0.5% | USD 6,757,3652.1% | USD 163.681.6% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 92,274 0.5% | USD 6,083,6252.6% | USD 65.932.1% | |
| AXSM (Axsome Therapeutics Inc) | 34,253 0.5% | USD 6,056,6154.9% | USD 176.824.4% | |
| HALO (Halozyme Therapeutics Inc) | 79,899 0.5% | USD 5,786,2860.4% | USD 72.42-0.1% | |
| CYTK (Cytokinetics Inc) | 83,071 0.5% | USD 5,369,7093.9% | USD 64.643.4% | |
| KRYS (Krystal Biotech Inc) | 19,702 0.5% | USD 5,361,5054.6% | USD 272.134.1% | |
| NUVL (Nuvalent Inc) | 48,886 0.5% | USD 4,847,536-5.2% | USD 99.16-5.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,342 0.5% | USD 4,755,9224.3% | USD 104.893.8% | |
| PRAX (Praxis Precision Medicines Inc) | 16,990 0.5% | USD 4,684,823-4.0% | USD 275.74-4.4% | |
| PTCT (PTC Therapeutics Inc) | 54,550 0.5% | USD 4,232,5350.5% | USD 77.590.1% | |
| PCVX (Vaxcyte Inc) | 88,940 0.5% | USD 4,077,0100.0% | USD 45.84-0.5% | |
| COGT (Cogent Biosciences Inc) | 104,296 0.5% | USD 3,625,329-1.2% | USD 34.76-1.7% | |
| CRSP (Crispr Therapeutics AG) | 64,751 0.5% | USD 3,580,7303.2% | USD 55.32.7% | |
| KYMR (Kymera Therapeutics Inc) | 48,884 0.5% | USD 3,572,932-1.8% | USD 73.09-2.2% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,471 0.5% | USD 3,568,4704.4% | USD 55.353.9% | |
| PTGX (Protagonist Therapeutics Inc) | 42,476 0.5% | USD 3,408,6990.5% | USD 80.250.0% | |
| ALKS (Alkermes Plc) | 112,185 0.5% | USD 3,322,9200.3% | USD 29.62-0.1% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,399 0.5% | USD 3,148,8751.6% | USD 69.361.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,918 0.5% | USD 3,125,1613.9% | USD 89.53.4% | |
| IMVT (Immunovant Inc) | 119,087 0.5% | USD 3,073,635-0.4% | USD 25.81-0.8% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 114,948 0.5% | USD 3,056,467-0.3% | USD 26.59-0.7% | |
| SRRK (Scholar Rock Holding Corp) | 70,079 0.5% | USD 3,052,6413.7% | USD 43.563.3% | |
| FOLD (Amicus Therapeutics Inc) | 209,617 0.5% | USD 2,993,3310.5% | USD 14.28 | |
| CGON (CG Oncology, Inc. Common stock) | 54,541 1.2% | USD 2,929,9430.3% | USD 53.72-0.9% | |
| ADMA (ADMA Biologics Inc) | 161,700 0.5% | USD 2,899,2810.3% | USD 17.93-0.1% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,256 0.5% | USD 2,892,9280.0% | USD 77.65-0.4% | |
| GRAL (GRAIL, LLC) | 26,372 0.5% | USD 2,793,5866.3% | USD 105.935.8% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 213,584 0.5% | USD 2,772,3200.6% | USD 12.980.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,371 0.5% | USD 2,765,2570.5% | USD 206.810.1% | |
| ACLX (Arcellx Inc) | 39,286 0.5% | USD 2,548,483-1.7% | USD 64.87-2.1% | |
| VCYT (Veracyte Inc) | 53,708 0.5% | USD 2,333,6133.8% | USD 43.453.4% | |
| BEAM (Beam Therapeutics Inc) | 68,629 | USD 2,312,11122.3% | USD 33.6922.3% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,223 0.5% | USD 2,228,712-4.7% | USD 26.78-5.1% | |
| IDYA (Ideaya Biosciences Inc) | 59,564 0.5% | USD 2,194,338-1.0% | USD 36.84-1.4% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,841 0.5% | USD 2,178,361-1.3% | USD 75.53-1.7% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,504 0.5% | USD 2,164,740-1.7% | USD 41.23-2.2% | |
| TVTX (Travere Therapeutics Inc) | 60,791 0.5% | USD 2,072,973-0.9% | USD 34.1-1.4% | |
| VERA (Vera Therapeutics Inc) | 43,436 0.5% | USD 2,018,037-4.2% | USD 46.46-4.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,959 0.5% | USD 2,000,9341.0% | USD 51.360.5% | |
| APLS (Apellis Pharmaceuticals Inc) | 85,964 0.5% | USD 1,994,365-14.6% | USD 23.2-15.0% | |
| ADPT (Adaptive Biotechnologies Corp) | 103,724 0.5% | USD 1,894,00016.4% | USD 18.2615.9% | |
| DNLI (Denali Therapeutics Inc) | 99,644 0.5% | USD 1,788,6105.6% | USD 17.955.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 53,770 0.5% | USD 1,773,335-0.7% | USD 32.98-1.2% | |
| EWTX (Edgewise Therapeutics Inc) | 71,929 0.5% | USD 1,735,647-2.6% | USD 24.13-3.1% | |
| IBRX (Immunitybio Inc) | 668,813 0.5% | USD 1,732,22611.7% | USD 2.5911.2% | |
| SYRE (Spyre Therapeutics Inc.) | 52,717 0.5% | USD 1,729,1187.6% | USD 32.87.2% | |
| DYN (Dyne Therapeutics Inc) | 97,035 0.5% | USD 1,694,231-1.3% | USD 17.46-1.7% | |
| RXRX (Recursion Pharmaceuticals Inc) | 349,335 0.5% | USD 1,680,3013.7% | USD 4.813.2% | |
| RARE (Ultragenyx) | 65,550 0.5% | USD 1,597,4548.8% | USD 24.378.3% | |
| TWST (Twist Bioscience Corp) | 41,546 0.5% | USD 1,580,4108.2% | USD 38.047.7% | |
| WVE (Wave Life Sciences Ltd) | 113,583 0.5% | USD 1,579,9401.0% | USD 13.910.5% | |
| TXG (10X Genomics Inc) | 79,127 0.5% | USD 1,566,715-2.8% | USD 19.8-3.2% | |
| OCUL (Ocular Therapeutix Inc) | 144,737 0.5% | USD 1,547,239-4.6% | USD 10.69-5.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,433 0.5% | USD 1,538,3363.0% | USD 28.792.5% | |
| SRPT (Sarepta Therapeutics Inc) | 72,308 0.5% | USD 1,528,591-10.9% | USD 21.14-11.3% | |
| HRMY (Harmony Biosciences Holdings) | 39,131 0.5% | USD 1,497,543-0.3% | USD 38.27-0.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 65,550 0.5% | USD 1,443,411-1.3% | USD 22.02-1.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 89,574 0.5% | USD 1,368,6911.3% | USD 15.280.9% | |
| LEGN (Legend Biotech Corp) | 57,209 0.5% | USD 1,355,8530.9% | USD 23.70.4% | |
| GMAB (Genmab AS) | 39,714 0.5% | USD 1,348,290-0.4% | USD 33.95-0.9% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,259 0.5% | USD 1,287,09711.1% | USD 84.3510.6% | |
| NRIX (Nurix Therapeutics Inc) | 68,872 0.5% | USD 1,265,867-4.3% | USD 18.38-4.8% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,654 0.5% | USD 1,260,492-3.2% | USD 41.12-3.6% | |
| VCEL (Vericel Corp Ord) | 34,360 0.5% | USD 1,257,232-4.7% | USD 36.59-5.1% | |
| DVAX (Dynavax Technologies Corporation) | 79,769 0.5% | USD 1,250,7782.2% | USD 15.681.8% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,041 0.5% | USD 1,223,330-0.9% | USD 20.72-1.3% | |
| ARDX (Ardelyx Inc) | 165,064 0.5% | USD 1,214,871-4.5% | USD 7.36-4.9% | |
| HROW (Harrow Health Inc) | 25,163 0.5% | USD 1,203,7982.7% | USD 47.842.3% | |
| MNKD (MannKind Corp) | 208,614 0.5% | USD 1,203,703-0.9% | USD 5.77-1.4% | |
| ERAS (Erasca Inc) | 192,718 0.5% | USD 1,200,633-7.4% | USD 6.23-7.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,844 0.5% | USD 1,177,5470.4% | USD 23.160.0% | |
| FTRE (Fortrea Holdings Inc.) | 62,676 0.5% | USD 1,153,2386.3% | USD 18.45.8% | |
| STOK (Stoke Therapeutics Inc) | 38,807 0.5% | USD 1,141,702-10.0% | USD 29.42-10.4% | |
| PHVS (Pharvaris BV) | 43,520 0.5% | USD 1,135,8721.3% | USD 26.10.8% | |
| AGIO (Agios Pharm) | 39,619 0.5% | USD 1,122,0100.1% | USD 28.32-0.3% | |
| NVCR (Novocure Ltd) | 76,081 0.5% | USD 1,078,829-0.7% | USD 14.18-1.2% | |
| COLL (Collegium Pharmaceutical Inc) | 21,478 0.5% | USD 1,034,1666.2% | USD 48.155.7% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 143,033 0.5% | USD 1,014,104-3.7% | USD 7.09-4.2% | |
| ELVN (Enliven Therapeutics Inc.) | 39,810 0.5% | USD 996,444-3.3% | USD 25.03-3.7% | |
| PGEN (Precigen Inc) | 240,369 0.5% | USD 993,926-9.5% | USD 4.135-9.9% | |
| INVA (Innoviva Inc) | 50,798 0.5% | USD 987,513-0.3% | USD 19.44-0.7% | |
| TNGX (Tango Therapeutics Inc) | 91,482 0.5% | USD 975,198-8.9% | USD 10.66-9.3% | |
| QURE (Uniqure NV) | 42,322 0.5% | USD 975,099-8.6% | USD 23.04-9.0% | |
| IMCR (Immunocore Holdings Ltd) | 29,607 0.5% | USD 966,372-0.6% | USD 32.64-1.1% | |
| MNMD (Mind Medicine Inc) | 66,928 0.5% | USD 928,9610.8% | USD 13.880.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 74,611 0.5% | USD 924,4301.9% | USD 12.391.5% | |
| ANAB (AnaptysBio Inc) | 18,813 0.5% | USD 922,40110.3% | USD 49.039.8% | |
| RLAY (Relay Therapeutics Inc) | 117,744 0.5% | USD 918,403-1.9% | USD 7.8-2.4% | |
| AMPH (Amphastar P) | 31,220 0.5% | USD 917,8686.5% | USD 29.46.0% | |
| ABCL (Abcellera Biologics Inc) | 201,981 0.5% | USD 912,9543.9% | USD 4.523.4% | |
| TSHA (Taysha Gene Therapies Inc) | 186,098 0.5% | USD 904,436-2.0% | USD 4.86-2.4% | |
| NTLA (Intellia Therapeutics Inc) | 78,308 0.5% | USD 895,06010.6% | USD 11.4310.1% | |
| XERS (Xeris Pharmaceuticals Inc) | 112,711 0.5% | USD 887,036-0.3% | USD 7.87-0.8% | |
| NVAX (Novavax Inc) | 110,162 0.5% | USD 853,7567.1% | USD 7.756.6% | |
| SANA (Sana Biotechnology Inc) | 179,966 0.5% | USD 824,2440.9% | USD 4.580.4% | |
| SVRA (Savara Inc) | 138,235 0.5% | USD 797,616-0.2% | USD 5.77-0.7% | |
| CSTL (Castle Biosciences Inc) | 19,820 0.5% | USD 786,0611.3% | USD 39.660.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,852 | USD 768,76326.7% | USD 11.3326.7% | |
| SPRY (Silverback Therapeutics Inc) | 67,155 0.5% | USD 764,224-12.5% | USD 11.38-12.9% | |
| GRFS (Grifols SA ADR) | 82,871 0.5% | USD 757,441-2.0% | USD 9.14-2.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,333 0.5% | USD 699,379-3.2% | USD 14.47-3.6% | |
| XNCR (Xencor Inc) | 48,516 0.5% | USD 687,4722.5% | USD 14.172.0% | |
| URGN (UroGen Pharma Ltd) | 31,803 0.5% | USD 682,1741.4% | USD 21.450.9% | |
| VTYX (Ventyx Biosciences Inc) | 48,468 0.5% | USD 670,7970.7% | USD 13.840.2% | |
| PCRX (Pacira BioSciences, Inc.) | 29,230 0.5% | USD 670,244-2.1% | USD 22.93-2.5% | |
| TBPH (Theravance Biopharma Inc) | 33,814 0.5% | USD 664,4453.7% | USD 19.653.2% | |
| RAPT (RAPT Therapeutics Inc) | 18,828 0.5% | USD 647,6832.8% | USD 34.42.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 255,814 0.5% | USD 613,954-1.6% | USD 2.4-2.0% | |
| GERN (Geron Corporation) | 423,625 0.5% | USD 605,7847.2% | USD 1.436.7% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,464 0.5% | USD 589,8460.5% | USD 9.150010.0% | |
| ABUS (Arbutus Biopharma Corp) | 130,650 0.5% | USD 587,925-2.1% | USD 4.5-2.6% | |
| PAHC (Phibro Animal Health Corporation) | 14,476 0.5% | USD 576,5791.5% | USD 39.831.0% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,342 0.5% | USD 562,865-2.0% | USD 16.39-2.4% | |
| JANX (Janux Therapeutics Inc) | 40,056 0.5% | USD 561,986-0.5% | USD 14.03-0.9% | |
| VIR (Vir Biotechnology Inc) | 92,156 0.5% | USD 545,5641.7% | USD 5.920011.2% | |
| KURA (Kura Oncology Inc) | 59,108 0.5% | USD 542,020-2.1% | USD 9.16999-2.6% | |
| PRME (Prime Medicine, Inc. Common Stock) | 126,114 0.5% | USD 539,7689.1% | USD 4.288.6% | |
| ARVN (Arvinas Inc) | 43,633 0.5% | USD 530,1411.1% | USD 12.150.7% | |
| RGNX (Regenxbio Inc) | 34,382 0.5% | USD 518,4813.8% | USD 15.083.4% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 110,487 0.5% | USD 493,87710.6% | USD 4.4710.1% | |
| ZLAB (Zai Lab Ltd) | 26,590 0.5% | USD 488,990-0.4% | USD 18.39-0.9% | |
| REPL (Replimune Group Inc) | 53,007 0.5% | USD 429,6221.4% | USD 8.105010.9% | |
| CGEM (Cullinan Oncology LLC) | 39,432 0.5% | USD 418,374-2.2% | USD 10.61-2.7% | |
| PACB (Pacific Biosciences of California) | 205,056 0.5% | USD 412,1634.1% | USD 2.013.6% | |
| KROS (Keros Therapeutics Inc) | 20,698 0.5% | USD 390,778-1.2% | USD 18.88-1.7% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 98,500 0.5% | USD 388,0900.7% | USD 3.940.3% | |
| MGTX (MeiraGTx Holdings PLC) | 52,563 0.5% | USD 380,556-1.8% | USD 7.24-2.3% | |
| PRTA (Prothena Corporation plc) | 39,634 0.5% | USD 353,139-2.6% | USD 8.91-3.0% | |
| FULC (Fulcrum Therapeutics Inc) | 36,767 0.5% | USD 349,654-3.0% | USD 9.51-3.5% | |
| SIGA (SIGA Technologies Inc) | 50,816 0.5% | USD 334,8770.2% | USD 6.58999-0.3% | |
| LYEL (Lyell Immunopharma Inc) | 13,861 0.5% | USD 329,476-2.7% | USD 23.77-3.2% | |
| GLPG (Galapagos NV ADR) | 9,482 0.5% | USD 313,9490.5% | USD 33.11 | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,727 0.5% | USD 294,3771.6% | USD 7.411.1% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,216 0.5% | USD 277,978-3.0% | USD 3.60001-3.5% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,114 0.5% | USD 270,8550.5% | USD 7.5 | |
| AVXL (Anavex Life Sciences Corp) | 62,090 0.5% | USD 266,3660.7% | USD 4.290.2% | |
| ALLO (Allogene Therapeutics Inc) | 158,526 0.5% | USD 264,738-1.9% | USD 1.67-2.3% | |
| TRDA (Entrada Therapeutics Inc) | 25,584 0.5% | USD 254,561-0.2% | USD 9.95001-0.7% | |
| ACIU (AC Immune Ltd) | 72,280 0.5% | USD 254,4263.7% | USD 3.520013.2% | |
| EOLS (Evolus Inc) | 44,034 0.5% | USD 254,0762.6% | USD 5.772.1% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,257 0.5% | USD 225,411-0.4% | USD 6.58-0.9% | |
| AVIR (Atea Pharmaceuticals Inc) | 60,658 0.5% | USD 218,9755.1% | USD 3.609994.6% | |
| ACRS (Aclaris Therapeutics Inc) | 73,583 0.5% | USD 195,7311.2% | USD 2.660.8% | |
| AUTL (Autolus Therapeutics Ltd) | 128,533 0.5% | USD 192,800-16.7% | USD 1.5-17.1% | |
| OABI (OmniAb Inc.) | 89,303 0.5% | USD 170,5690.5% | USD 1.91 | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,630 0.5% | USD 155,34411.6% | USD 7.5311.1% | |
| EDIT (Editas Medicine Inc) | 69,413 0.5% | USD 147,8503.4% | USD 2.132.9% | |
| VYGR (Voyager Therapeutics Inc) | 37,241 0.5% | USD 145,240-2.5% | USD 3.9-3.0% | |
| CABA (Cabaletta Bio Inc) | 65,378 0.5% | USD 144,4855.7% | USD 2.209995.2% | |
| HUMA (Humacyte Inc) | 117,756 0.5% | USD 133,064-3.0% | USD 1.13-3.4% | |
| CRBU (Caribou Biosciences Inc) | 63,485 0.5% | USD 100,306-4.4% | USD 1.58-4.8% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 169,620 0.7% | USD 78,679,933-0.6% | USD 463.86-1.2% | |
| AMGN (Amgen Inc) | 212,899 0.7% | USD 69,426,364-0.5% | USD 326.1-1.2% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,850 0.7% | USD 55,639,0180.1% | USD 796.55-0.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 89,361 0.7% | USD 35,591,5930.4% | USD 398.29-0.3% | |
| INSM (Insmed Inc) | 144,240 0.7% | USD 25,381,9134.1% | USD 175.973.3% | |
| BIIB (Biogen Inc) | 99,218 0.7% | USD 18,615,2811.6% | USD 187.620.9% | |
| ARGX (argenx NV ADR) | 19,690 0.7% | USD 15,525,368-0.2% | USD 788.49-0.9% | |
| RVMD (Revolution Medicines Inc) | 130,744 0.7% | USD 15,511,46811.2% | USD 118.6410.5% | |
| ILMN (Illumina Inc) | 103,340 0.7% | USD 14,578,174-2.6% | USD 141.07-3.3% | |
| INCY (Incyte Corporation) | 132,779 0.7% | USD 14,190,0921.6% | USD 106.870.9% | |
| UTHR (United Therapeutics Corporation) | 29,120 0.7% | USD 14,071,658-0.9% | USD 483.23-1.5% | |
| RPRX (Royalty Pharma Plc) | 288,953 0.7% | USD 11,607,2420.5% | USD 40.17-0.2% | |
| MEDP (Medpace Holdings Inc) | 19,050 0.7% | USD 11,334,750-0.1% | USD 595-0.8% | |
| ROIV (Roivant Sciences Ltd) | 470,373 0.7% | USD 10,338,7991.6% | USD 21.980.9% | |
| BBIO (BridgeBio Pharma Inc) | 130,331 0.7% | USD 10,068,0705.4% | USD 77.254.6% | |
| VTRS (Viatris Inc) | 778,961 0.7% | USD 9,939,5422.0% | USD 12.761.3% | |
| SMMT (Summit Therapeutics PLC) | 503,480 0.7% | USD 9,908,4865.2% | USD 19.684.5% | |
| GH (Guardant Health Inc) | 87,500 0.7% | USD 9,639,8752.0% | USD 110.171.3% | |
| NBIX (Neurocrine Biosciences Inc) | 67,433 0.7% | USD 9,156,7270.9% | USD 135.790.2% | |
| MRNA (Moderna Inc) | 264,222 0.7% | USD 9,062,8152.0% | USD 34.31.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 109,546 0.7% | USD 8,796,544-0.8% | USD 80.3-1.5% | |
| SNY (Sanofi ADR) | 178,968 0.7% | USD 8,774,8012.6% | USD 49.031.9% | |
| ASND (Ascendis Pharma AS) | 41,533 0.7% | USD 8,430,784-2.1% | USD 202.99-2.8% | |
| EXEL (Exelixis Inc) | 181,329 0.7% | USD 7,985,7290.4% | USD 44.04-0.2% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,362 0.7% | USD 7,896,990-6.9% | USD 514.06-7.6% | |
| BMRN (Biomarin Pharmaceutical Inc) | 129,930 0.7% | USD 7,659,374-1.6% | USD 58.95-2.3% | |
| RNA (Avidity Biosciences Inc) | 101,907 0.7% | USD 7,375,0100.7% | USD 72.37 | |
| BNTX (BioNTech SE) | 68,379 0.7% | USD 6,827,6431.7% | USD 99.851.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,094 0.7% | USD 6,621,4761.3% | USD 161.130.5% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 91,852 0.7% | USD 5,929,9650.0% | USD 64.56-0.7% | |
| AXSM (Axsome Therapeutics Inc) | 34,097 0.7% | USD 5,775,3501.8% | USD 169.381.1% | |
| HALO (Halozyme Therapeutics Inc) | 79,533 0.7% | USD 5,763,7571.2% | USD 72.470.5% | |
| CYTK (Cytokinetics Inc) | 82,691 0.7% | USD 5,169,014-0.6% | USD 62.51-1.3% | |
| KRYS (Krystal Biotech Inc) | 19,612 0.7% | USD 5,126,7735.7% | USD 261.415.0% | |
| NUVL (Nuvalent Inc) | 48,662 0.7% | USD 5,111,9433.0% | USD 105.052.3% | |
| PRAX (Praxis Precision Medicines Inc) | 16,912 0.7% | USD 4,878,266-1.3% | USD 288.45-2.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,134 0.7% | USD 4,559,4374.4% | USD 101.023.7% | |
| PTCT (PTC Therapeutics Inc) | 54,300 0.7% | USD 4,209,8791.6% | USD 77.530.9% | |
| PCVX (Vaxcyte Inc) | 88,532 0.7% | USD 4,076,8992.3% | USD 46.051.6% | |
| COGT (Cogent Biosciences Inc) | 103,818 0.7% | USD 3,669,9660.1% | USD 35.35-0.6% | |
| KYMR (Kymera Therapeutics Inc) | 48,660 0.7% | USD 3,638,3080.4% | USD 74.77-0.3% | |
| CRSP (Crispr Therapeutics AG) | 64,455 0.7% | USD 3,470,257-3.9% | USD 53.84-4.5% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,175 0.7% | USD 3,417,3190.7% | USD 53.250.0% | |
| PTGX (Protagonist Therapeutics Inc) | 42,282 0.7% | USD 3,391,8620.7% | USD 80.220.0% | |
| ALKS (Alkermes Plc) | 111,671 0.7% | USD 3,312,1620.9% | USD 29.660.2% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,191 0.7% | USD 3,100,5553.1% | USD 68.612.4% | |
| IMVT (Immunovant Inc) | 118,541 0.7% | USD 3,085,622-0.4% | USD 26.03-1.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 114,422 0.7% | USD 3,064,2210.2% | USD 26.78-0.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,758 0.7% | USD 3,009,0006.8% | USD 86.576.1% | |
| FOLD (Amicus Therapeutics Inc) | 208,657 0.7% | USD 2,979,6220.7% | USD 14.28 | |
| SRRK (Scholar Rock Holding Corp) | 69,759 0.7% | USD 2,942,4351.9% | USD 42.181.2% | |
| CGON (CG Oncology, Inc. Common stock) | 53,916 | USD 2,922,24729.3% | USD 54.229.3% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,086 0.7% | USD 2,892,3371.4% | USD 77.990.7% | |
| ADMA (ADMA Biologics Inc) | 160,958 0.7% | USD 2,889,1960.0% | USD 17.95-0.7% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 212,604 0.7% | USD 2,755,348-1.1% | USD 12.96-1.8% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,309 0.7% | USD 2,750,3054.0% | USD 206.653.3% | |
| GRAL (GRAIL, LLC) | 26,252 0.7% | USD 2,627,8252.8% | USD 100.12.1% | |
| ACLX (Arcellx Inc) | 39,106 0.7% | USD 2,591,5553.8% | USD 66.273.0% | |
| ARQT (Arcutis Biotherapeutics Inc) | 82,841 0.7% | USD 2,337,773-4.9% | USD 28.22-5.6% | |
| APLS (Apellis Pharmaceuticals Inc) | 85,570 0.7% | USD 2,336,0614.7% | USD 27.34.0% | |
| VCYT (Veracyte Inc) | 53,462 0.7% | USD 2,247,542-2.8% | USD 42.04-3.5% | |
| IDYA (Ideaya Biosciences Inc) | 59,292 0.7% | USD 2,216,3353.3% | USD 37.382.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,709 0.7% | USD 2,206,861-1.0% | USD 76.87-1.7% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,264 0.7% | USD 2,202,9283.0% | USD 42.152.3% | |
| VERA (Vera Therapeutics Inc) | 43,238 0.7% | USD 2,106,1232.8% | USD 48.712.1% | |
| TVTX (Travere Therapeutics Inc) | 60,513 0.7% | USD 2,092,540-2.2% | USD 34.58-2.9% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,781 0.7% | USD 1,982,0970.6% | USD 51.11-0.1% | |
| BEAM (Beam Therapeutics Inc) | 68,629 0.7% | USD 1,890,729-0.9% | USD 27.55-1.6% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 53,524 0.7% | USD 1,786,0961.4% | USD 33.370.7% | |
| EWTX (Edgewise Therapeutics Inc) | 71,599 0.7% | USD 1,782,8150.4% | USD 24.9-0.3% | |
| DYN (Dyne Therapeutics Inc) | 96,589 0.7% | USD 1,716,387-2.0% | USD 17.77-2.7% | |
| SRPT (Sarepta Therapeutics Inc) | 71,976 0.7% | USD 1,715,1883.7% | USD 23.832.9% | |
| DNLI (Denali Therapeutics Inc) | 99,186 0.7% | USD 1,694,0970.8% | USD 17.080.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 103,248 0.7% | USD 1,627,188-0.6% | USD 15.76-1.3% | |
| OCUL (Ocular Therapeutix Inc) | 144,073 0.7% | USD 1,622,262-0.4% | USD 11.26-1.1% | |
| RXRX (Recursion Pharmaceuticals Inc) | 347,729 0.7% | USD 1,620,417-0.2% | USD 4.66-0.9% | |
| TXG (10X Genomics Inc) | 78,765 0.7% | USD 1,611,5326.8% | USD 20.466.1% | |
| SYRE (Spyre Therapeutics Inc.) | 52,475 0.7% | USD 1,606,2602.3% | USD 30.611.6% | |
| WVE (Wave Life Sciences Ltd) | 113,061 0.7% | USD 1,564,764-6.0% | USD 13.84-6.7% | |
| IBRX (Immunitybio Inc) | 665,739 0.7% | USD 1,551,1724.7% | USD 2.334.0% | |
| HRMY (Harmony Biosciences Holdings) | 38,951 0.7% | USD 1,501,5612.5% | USD 38.551.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,189 0.7% | USD 1,493,54710.6% | USD 28.089.8% | |
| RARE (Ultragenyx) | 65,250 0.7% | USD 1,468,778-2.3% | USD 22.51-3.0% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 65,250 0.7% | USD 1,462,9052.4% | USD 22.421.7% | |
| TWST (Twist Bioscience Corp) | 41,356 0.7% | USD 1,460,6942.4% | USD 35.321.7% | |
| GMAB (Genmab AS) | 39,532 0.7% | USD 1,354,3662.6% | USD 34.261.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 89,162 0.7% | USD 1,350,804-0.5% | USD 15.15-1.2% | |
| LEGN (Legend Biotech Corp) | 56,947 0.7% | USD 1,343,9493.2% | USD 23.62.5% | |
| NRIX (Nurix Therapeutics Inc) | 68,556 0.7% | USD 1,323,1314.3% | USD 19.33.6% | |
| VCEL (Vericel Corp Ord) | 34,202 0.7% | USD 1,318,829-4.7% | USD 38.56-5.3% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,514 0.7% | USD 1,302,0323.0% | USD 42.672.3% | |
| ERAS (Erasca Inc) | 191,832 0.7% | USD 1,296,78417.2% | USD 6.7616.4% | |
| ARDX (Ardelyx Inc) | 164,306 0.7% | USD 1,271,72811.3% | USD 7.7410.6% | |
| STOK (Stoke Therapeutics Inc) | 38,629 0.7% | USD 1,268,963-1.8% | USD 32.85-2.5% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,771 0.7% | USD 1,234,191-1.1% | USD 21-1.8% | |
| DVAX (Dynavax Technologies Corporation) | 79,403 0.7% | USD 1,223,6000.7% | USD 15.41 | |
| MNKD (MannKind Corp) | 207,654 0.7% | USD 1,214,776-2.0% | USD 5.85-2.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,610 0.7% | USD 1,172,6341.0% | USD 23.170.3% | |
| HROW (Harrow Health Inc) | 25,047 0.7% | USD 1,171,699-7.7% | USD 46.78-8.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,189 0.7% | USD 1,158,617-5.2% | USD 76.28-5.9% | |
| PHVS (Pharvaris BV) | 43,320 0.7% | USD 1,121,5554.3% | USD 25.893.6% | |
| AGIO (Agios Pharm) | 39,437 0.7% | USD 1,120,4051.6% | USD 28.410.9% | |
| PGEN (Precigen Inc) | 239,263 0.7% | USD 1,098,2170.3% | USD 4.59-0.4% | |
| NVCR (Novocure Ltd) | 75,731 0.7% | USD 1,086,740-2.8% | USD 14.35-3.5% | |
| FTRE (Fortrea Holdings Inc.) | 62,388 0.7% | USD 1,084,9270.4% | USD 17.39-0.3% | |
| TNGX (Tango Therapeutics Inc) | 91,062 0.7% | USD 1,069,9797.0% | USD 11.756.3% | |
| QURE (Uniqure NV) | 42,128 0.7% | USD 1,066,68110.1% | USD 25.329.4% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 142,375 0.7% | USD 1,053,575-2.2% | USD 7.4-2.9% | |
| ELVN (Enliven Therapeutics Inc.) | 39,628 0.7% | USD 1,030,32812.6% | USD 2611.8% | |
| INVA (Innoviva Inc) | 50,564 0.7% | USD 990,0430.3% | USD 19.58-0.4% | |
| COLL (Collegium Pharmaceutical Inc) | 21,380 0.7% | USD 973,645-6.0% | USD 45.54-6.6% | |
| IMCR (Immunocore Holdings Ltd) | 29,471 0.7% | USD 972,5430.5% | USD 33-0.2% | |
| RLAY (Relay Therapeutics Inc) | 117,202 0.7% | USD 936,4440.6% | USD 7.99-0.1% | |
| TSHA (Taysha Gene Therapies Inc) | 185,240 0.7% | USD 922,495-2.4% | USD 4.98-3.1% | |
| MNMD (Mind Medicine Inc) | 66,620 0.7% | USD 922,021-5.2% | USD 13.84-5.9% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 74,267 0.7% | USD 906,8003.9% | USD 12.213.2% | |
| XERS (Xeris Pharmaceuticals Inc) | 112,193 0.7% | USD 889,690-1.8% | USD 7.93-2.5% | |
| ABCL (Abcellera Biologics Inc) | 201,051 0.7% | USD 878,5937.1% | USD 4.376.3% | |
| SPRY (Silverback Therapeutics Inc) | 66,847 0.7% | USD 873,02220.1% | USD 13.0619.3% | |
| AMPH (Amphastar P) | 31,076 0.7% | USD 862,0480.7% | USD 27.74 | |
| ANAB (AnaptysBio Inc) | 18,727 0.7% | USD 836,5352.7% | USD 44.672.0% | |
| SANA (Sana Biotechnology Inc) | 179,136 0.7% | USD 816,8601.6% | USD 4.560.9% | |
| NTLA (Intellia Therapeutics Inc) | 77,948 0.7% | USD 809,100-0.6% | USD 10.38-1.3% | |
| SVRA (Savara Inc) | 137,597 0.7% | USD 799,4391.6% | USD 5.810.9% | |
| NVAX (Novavax Inc) | 109,654 0.7% | USD 797,185-0.3% | USD 7.27-1.0% | |
| CSTL (Castle Biosciences Inc) | 19,730 0.7% | USD 776,178-0.7% | USD 39.34-1.4% | |
| GRFS (Grifols SA ADR) | 82,489 0.7% | USD 772,922-0.6% | USD 9.37-1.3% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,111 0.7% | USD 722,387-3.1% | USD 15.015-3.7% | |
| PCRX (Pacira BioSciences, Inc.) | 29,096 0.7% | USD 684,629-8.9% | USD 23.53-9.6% | |
| URGN (UroGen Pharma Ltd) | 31,657 0.7% | USD 672,711-8.8% | USD 21.25-9.5% | |
| XNCR (Xencor Inc) | 48,292 0.7% | USD 670,776-1.4% | USD 13.89-2.1% | |
| VTYX (Ventyx Biosciences Inc) | 48,244 0.7% | USD 666,2500.5% | USD 13.81-0.2% | |
| TBPH (Theravance Biopharma Inc) | 33,658 0.7% | USD 640,8480.8% | USD 19.040.1% | |
| RAPT (RAPT Therapeutics Inc) | 18,742 0.7% | USD 630,1068.5% | USD 33.627.8% | |
| IOVA (Iovance Biotherapeutics Inc) | 254,632 0.7% | USD 623,848-5.5% | USD 2.45-6.1% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,852 0.7% | USD 606,597-2.7% | USD 8.94-3.4% | |
| ABUS (Arbutus Biopharma Corp) | 130,046 0.7% | USD 600,8130.1% | USD 4.62-0.6% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,166 0.7% | USD 587,1199.0% | USD 9.158.3% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,184 0.7% | USD 574,2916.9% | USD 16.86.2% | |
| PAHC (Phibro Animal Health Corporation) | 14,410 0.7% | USD 568,3300.0% | USD 39.44-0.7% | |
| GERN (Geron Corporation) | 421,663 0.7% | USD 565,028-1.5% | USD 1.34-2.2% | |
| JANX (Janux Therapeutics Inc) | 39,872 0.7% | USD 564,5882.5% | USD 14.161.8% | |
| KURA (Kura Oncology Inc) | 58,836 0.7% | USD 553,647-0.8% | USD 9.41-1.5% | |
| VIR (Vir Biotechnology Inc) | 91,730 0.7% | USD 536,621-1.0% | USD 5.85001-1.7% | |
| ARVN (Arvinas Inc) | 43,431 0.7% | USD 524,212-0.2% | USD 12.07-0.9% | |
| RGNX (Regenxbio Inc) | 34,224 0.7% | USD 499,328-2.1% | USD 14.59-2.7% | |
| PRME (Prime Medicine, Inc. Common Stock) | 125,530 0.7% | USD 494,5881.2% | USD 3.940.5% | |
| ZLAB (Zai Lab Ltd) | 26,468 0.7% | USD 490,9811.0% | USD 18.550.3% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 109,975 0.7% | USD 446,4992.7% | USD 4.062.0% | |
| CGEM (Cullinan Oncology LLC) | 39,250 0.7% | USD 427,825-1.5% | USD 10.9-2.2% | |
| REPL (Replimune Group Inc) | 52,761 0.7% | USD 423,671-1.7% | USD 8.03-2.4% | |
| PACB (Pacific Biosciences of California) | 204,102 0.7% | USD 395,958-4.2% | USD 1.94-4.9% | |
| KROS (Keros Therapeutics Inc) | 20,602 0.7% | USD 395,5584.1% | USD 19.23.3% | |
| MGTX (MeiraGTx Holdings PLC) | 52,319 0.7% | USD 387,6842.5% | USD 7.411.8% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 98,042 0.7% | USD 385,3052.8% | USD 3.932.1% | |
| PRTA (Prothena Corporation plc) | 39,450 0.7% | USD 362,5462.3% | USD 9.190011.5% | |
| FULC (Fulcrum Therapeutics Inc) | 36,597 0.7% | USD 360,480-1.9% | USD 9.84999-2.6% | |
| LYEL (Lyell Immunopharma Inc) | 13,797 0.7% | USD 338,7161.7% | USD 24.551.0% | |
| SIGA (SIGA Technologies Inc) | 50,580 0.7% | USD 334,334-1.7% | USD 6.61-2.4% | |
| GLPG (Galapagos NV ADR) | 9,438 0.7% | USD 312,4921.1% | USD 33.110.4% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,541 0.7% | USD 289,8360.6% | USD 7.33001-0.1% | |
| RCKT (Rocket Pharmaceuticals Inc) | 76,856 0.7% | USD 286,673-3.2% | USD 3.73-3.9% | |
| ALLO (Allogene Therapeutics Inc) | 157,784 0.7% | USD 269,81115.6% | USD 1.7114.8% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,946 0.7% | USD 269,5953.5% | USD 7.52.7% | |
| AVXL (Anavex Life Sciences Corp) | 61,800 0.7% | USD 264,5040.9% | USD 4.280.2% | |
| TRDA (Entrada Therapeutics Inc) | 25,464 0.7% | USD 255,149-4.1% | USD 10.02-4.8% | |
| EOLS (Evolus Inc) | 43,828 0.7% | USD 247,628-0.9% | USD 5.65-1.6% | |
| ACIU (AC Immune Ltd) | 71,942 0.7% | USD 245,322-0.2% | USD 3.41-0.9% | |
| AUTL (Autolus Therapeutics Ltd) | 127,929 0.7% | USD 231,551-4.6% | USD 1.81-5.2% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,097 0.7% | USD 226,4040.9% | USD 6.640.2% | |
| AVIR (Atea Pharmaceuticals Inc) | 60,372 0.7% | USD 208,283-3.7% | USD 3.44999-4.4% | |
| ACRS (Aclaris Therapeutics Inc) | 73,235 0.7% | USD 193,340-0.8% | USD 2.63999-1.5% | |
| OABI (OmniAb Inc.) | 88,879 0.7% | USD 169,7591.8% | USD 1.911.1% | |
| VYGR (Voyager Therapeutics Inc) | 37,063 0.7% | USD 148,993-0.3% | USD 4.01999-1.0% | |
| EDIT (Editas Medicine Inc) | 69,081 0.7% | USD 142,998-2.6% | USD 2.07-3.3% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,532 0.7% | USD 139,2070.9% | USD 6.780.1% | |
| HUMA (Humacyte Inc) | 117,192 0.7% | USD 137,1150.7% | USD 1.17 | |
| CABA (Cabaletta Bio Inc) | 65,066 0.7% | USD 136,639-2.5% | USD 2.10001-3.2% | |
| CRBU (Caribou Biosciences Inc) | 63,181 0.7% | USD 104,880-1.1% | USD 1.65999-1.8% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 168,450 | USD 79,117,596-3.0% | USD 469.68-3.0% | |
| AMGN (Amgen Inc) | 211,429 | USD 69,794,827-3.4% | USD 330.11-3.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,367 | USD 55,563,661-1.4% | USD 801.01-1.4% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,743 | USD 35,443,954-5.5% | USD 399.4-5.5% | |
| INSM (Insmed Inc) | 143,244 | USD 24,390,156-3.3% | USD 170.27-3.3% | |
| BIIB (Biogen Inc) | 98,534 | USD 18,327,324-0.5% | USD 186-0.5% | |
| ARGX (argenx NV ADR) | 19,555 | USD 15,557,371-3.3% | USD 795.57-3.3% | |
| ILMN (Illumina Inc) | 102,626 | USD 14,965,950-2.9% | USD 145.83-2.9% | |
| UTHR (United Therapeutics Corporation) | 28,919 | USD 14,194,313-2.6% | USD 490.83-2.6% | |
| INCY (Incyte Corporation) | 131,864 | USD 13,967,035-4.2% | USD 105.92-4.2% | |
| RVMD (Revolution Medicines Inc) | 129,841 0.5% | USD 13,943,6255.0% | USD 107.394.6% | |
| RPRX (Royalty Pharma Plc) | 286,958 | USD 11,552,929-2.7% | USD 40.26-2.7% | |
| MEDP (Medpace Holdings Inc) | 18,918 | USD 11,351,178-2.1% | USD 600.02-2.1% | |
| ROIV (Roivant Sciences Ltd) | 467,127 | USD 10,174,026-0.9% | USD 21.78-0.9% | |
| VTRS (Viatris Inc) | 773,585 | USD 9,747,1711.1% | USD 12.61.1% | |
| BBIO (BridgeBio Pharma Inc) | 129,431 | USD 9,554,596-0.6% | USD 73.82-0.6% | |
| GH (Guardant Health Inc) | 86,897 | USD 9,449,180-1.1% | USD 108.74-1.1% | |
| SMMT (Summit Therapeutics PLC) | 500,006 | USD 9,415,113-0.9% | USD 18.83-0.9% | |
| NBIX (Neurocrine Biosciences Inc) | 66,968 | USD 9,078,852-3.6% | USD 135.57-3.6% | |
| MRNA (Moderna Inc) | 262,398 | USD 8,884,796-5.7% | USD 33.86-5.7% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,790 | USD 8,870,737-2.0% | USD 81.54-2.0% | |
| ASND (Ascendis Pharma AS) | 41,245 | USD 8,609,894-2.1% | USD 208.75-2.1% | |
| SNY (Sanofi ADR) | 177,732 | USD 8,554,241-0.5% | USD 48.13-0.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,257 | USD 8,486,249-0.9% | USD 556.22-0.9% | |
| EXEL (Exelixis Inc) | 180,078 | USD 7,950,444-4.4% | USD 44.15-4.4% | |
| BMRN (Biomarin Pharmaceutical Inc) | 129,033 | USD 7,787,142-1.6% | USD 60.35-1.6% | |
| RNA (Avidity Biosciences Inc) | 101,205 | USD 7,324,206 | USD 72.37 | |
| BNTX (BioNTech SE) | 67,908 | USD 6,712,706-1.2% | USD 98.85-1.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,809 | USD 6,539,642-5.4% | USD 160.25-5.4% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 91,219 | USD 5,929,235-1.1% | USD 65-1.1% | |
| HALO (Halozyme Therapeutics Inc) | 78,984 | USD 5,697,116-4.0% | USD 72.13-4.0% | |
| AXSM (Axsome Therapeutics Inc) | 33,863 | USD 5,673,746-1.8% | USD 167.55-1.8% | |
| CYTK (Cytokinetics Inc) | 82,121 | USD 5,199,902-3.2% | USD 63.32-3.2% | |
| NUVL (Nuvalent Inc) | 48,326 | USD 4,961,630-3.9% | USD 102.67-3.9% | |
| PRAX (Praxis Precision Medicines Inc) | 16,795 | USD 4,944,1120.6% | USD 294.380.6% | |
| KRYS (Krystal Biotech Inc) | 19,477 | USD 4,848,0201.0% | USD 248.911.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,822 | USD 4,368,352-4.1% | USD 97.46-4.1% | |
| PTCT (PTC Therapeutics Inc) | 53,925 | USD 4,144,136-0.5% | USD 76.85-0.5% | |
| PCVX (Vaxcyte Inc) | 87,920 | USD 3,984,534-1.6% | USD 45.32-1.6% | |
| COGT (Cogent Biosciences Inc) | 103,101 | USD 3,667,303-1.9% | USD 35.57-1.9% | |
| KYMR (Kymera Therapeutics Inc) | 48,324 | USD 3,623,334-2.2% | USD 74.98-2.2% | |
| CRSP (Crispr Therapeutics AG) | 64,011 | USD 3,610,220-2.7% | USD 56.4-2.7% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,731 | USD 3,393,038-0.2% | USD 53.24-0.2% | |
| PTGX (Protagonist Therapeutics Inc) | 41,991 | USD 3,367,678-2.6% | USD 80.2-2.6% | |
| ALKS (Alkermes Plc) | 110,900 | USD 3,282,6400.8% | USD 29.60.8% | |
| IMVT (Immunovant Inc) | 117,722 | USD 3,097,266-1.6% | USD 26.31-1.6% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 113,633 | USD 3,057,864-1.9% | USD 26.91-1.9% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,879 | USD 3,005,9951.1% | USD 66.981.1% | |
| FOLD (Amicus Therapeutics Inc) | 207,217 | USD 2,959,059-0.1% | USD 14.28-0.1% | |
| ADMA (ADMA Biologics Inc) | 159,845 | USD 2,888,399-4.0% | USD 18.07-4.0% | |
| SRRK (Scholar Rock Holding Corp) | 69,279 | USD 2,886,856-5.8% | USD 41.67-5.8% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,831 | USD 2,853,666-1.9% | USD 77.48-1.9% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,518 | USD 2,816,669-0.5% | USD 81.6-0.5% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 211,134 | USD 2,786,969-0.5% | USD 13.2-0.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,216 | USD 2,644,0590.1% | USD 200.0650.1% | |
| GRAL (GRAIL, LLC) | 26,072 | USD 2,556,099-5.4% | USD 98.04-5.4% | |
| ACLX (Arcellx Inc) | 38,836 | USD 2,497,543-1.1% | USD 64.31-1.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 82,268 | USD 2,458,1681.0% | USD 29.881.0% | |
| VCYT (Veracyte Inc) | 53,093 | USD 2,312,731-3.4% | USD 43.56-3.4% | |
| CGON (CG Oncology, Inc. Common stock) | 53,916 | USD 2,260,698-1.2% | USD 41.93-1.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,979 | USD 2,231,549-0.9% | USD 26.26-0.9% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,511 | USD 2,229,8450.2% | USD 78.210.2% | |
| IDYA (Ideaya Biosciences Inc) | 58,884 | USD 2,145,144-3.8% | USD 36.43-3.8% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,904 | USD 2,139,483-2.1% | USD 41.22-2.1% | |
| TVTX (Travere Therapeutics Inc) | 60,096 | USD 2,139,418-1.9% | USD 35.6-1.9% | |
| VERA (Vera Therapeutics Inc) | 42,941 | USD 2,047,856-2.0% | USD 47.69-2.0% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,514 | USD 1,970,761-0.1% | USD 51.17-0.1% | |
| BEAM (Beam Therapeutics Inc) | 68,155 | USD 1,908,340-3.2% | USD 28-3.2% | |
| EWTX (Edgewise Therapeutics Inc) | 71,104 | USD 1,775,4671.2% | USD 24.971.2% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 53,155 | USD 1,761,025-6.3% | USD 33.13-6.3% | |
| DYN (Dyne Therapeutics Inc) | 95,920 | USD 1,751,499-5.8% | USD 18.26-5.8% | |
| DNLI (Denali Therapeutics Inc) | 98,499 | USD 1,681,3780.7% | USD 17.070.7% | |
| WVE (Wave Life Sciences Ltd) | 112,278 | USD 1,665,083-3.9% | USD 14.83-3.9% | |
| SRPT (Sarepta Therapeutics Inc) | 71,478 | USD 1,654,716-1.3% | USD 23.15-1.3% | |
| ADPT (Adaptive Biotechnologies Corp) | 102,534 | USD 1,636,443-4.6% | USD 15.96-4.6% | |
| OCUL (Ocular Therapeutix Inc) | 143,077 | USD 1,628,216-1.0% | USD 11.38-1.0% | |
| RXRX (Recursion Pharmaceuticals Inc) | 345,320 | USD 1,623,004-3.3% | USD 4.7-3.3% | |
| SYRE (Spyre Therapeutics Inc.) | 52,112 | USD 1,570,656-2.9% | USD 30.14-2.9% | |
| TXG (10X Genomics Inc) | 78,222 | USD 1,508,902-3.5% | USD 19.29-3.5% | |
| RARE (Ultragenyx) | 64,800 | USD 1,504,008-4.1% | USD 23.21-4.1% | |
| IBRX (Immunitybio Inc) | 661,128 | USD 1,480,9271.8% | USD 2.241.8% | |
| HRMY (Harmony Biosciences Holdings) | 38,681 | USD 1,464,8490.9% | USD 37.870.9% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,800 | USD 1,428,840-2.8% | USD 22.05-2.8% | |
| TWST (Twist Bioscience Corp) | 41,071 | USD 1,426,807-5.0% | USD 34.74-5.0% | |
| VCEL (Vericel Corp Ord) | 33,965 | USD 1,383,3940.9% | USD 40.730.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 88,544 | USD 1,357,380-4.3% | USD 15.33-4.3% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,823 | USD 1,350,684-5.5% | USD 25.57-5.5% | |
| GMAB (Genmab AS) | 39,259 | USD 1,320,280-0.8% | USD 33.63-0.8% | |
| LEGN (Legend Biotech Corp) | 56,554 | USD 1,302,4391.4% | USD 23.031.4% | |
| STOK (Stoke Therapeutics Inc) | 38,362 | USD 1,292,032-4.2% | USD 33.68-4.2% | |
| HROW (Harrow Health Inc) | 24,873 | USD 1,269,5180.1% | USD 51.040.1% | |
| NRIX (Nurix Therapeutics Inc) | 68,082 | USD 1,268,3680.8% | USD 18.630.8% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,304 | USD 1,264,586-1.6% | USD 41.73-1.6% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,366 | USD 1,248,449-3.3% | USD 21.39-3.3% | |
| MNKD (MannKind Corp) | 206,214 | USD 1,239,3462.7% | USD 6.012.7% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,084 | USD 1,222,4072.0% | USD 81.042.0% | |
| DVAX (Dynavax Technologies Corporation) | 78,854 | USD 1,215,140 | USD 15.41 | |
| ZYME (Zymeworks Inc. Common Stock) | 50,259 | USD 1,160,983-7.0% | USD 23.1-7.0% | |
| ARDX (Ardelyx Inc) | 163,166 | USD 1,142,16220.1% | USD 720.1% | |
| NVCR (Novocure Ltd) | 75,206 | USD 1,118,3133.2% | USD 14.873.2% | |
| ERAS (Erasca Inc) | 190,503 0.5% | USD 1,106,82212.9% | USD 5.8112.4% | |
| AGIO (Agios Pharm) | 39,164 | USD 1,102,858-1.3% | USD 28.16-1.3% | |
| PGEN (Precigen Inc) | 237,604 | USD 1,095,354-4.9% | USD 4.61-4.9% | |
| FTRE (Fortrea Holdings Inc.) | 61,956 | USD 1,080,513-0.3% | USD 17.44-0.3% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 141,388 | USD 1,077,377-3.8% | USD 7.62-3.8% | |
| PHVS (Pharvaris BV) | 43,020 | USD 1,075,500-0.2% | USD 25-0.2% | |
| COLL (Collegium Pharmaceutical Inc) | 21,233 | USD 1,035,7463.2% | USD 48.783.2% | |
| TNGX (Tango Therapeutics Inc) | 90,432 0.5% | USD 999,726-5.8% | USD 11.055-6.2% | |
| INVA (Innoviva Inc) | 50,213 | USD 986,6850.6% | USD 19.650.6% | |
| MNMD (Mind Medicine Inc) | 66,158 | USD 972,5234.8% | USD 14.74.8% | |
| QURE (Uniqure NV) | 41,837 | USD 968,5270.3% | USD 23.150.3% | |
| IMCR (Immunocore Holdings Ltd) | 29,267 | USD 967,274-2.1% | USD 33.05-2.1% | |
| TSHA (Taysha Gene Therapies Inc) | 183,953 | USD 945,518-3.2% | USD 5.14-3.2% | |
| RLAY (Relay Therapeutics Inc) | 116,389 | USD 931,112-2.2% | USD 8-2.2% | |
| ELVN (Enliven Therapeutics Inc.) | 39,355 | USD 915,00450.3% | USD 23.2550.3% | |
| XERS (Xeris Pharmaceuticals Inc) | 111,416 | USD 905,81212.8% | USD 8.1312.8% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,751 | USD 872,474-1.3% | USD 11.83-1.3% | |
| AMPH (Amphastar P) | 30,860 | USD 856,0561.5% | USD 27.741.5% | |
| ABCL (Abcellera Biologics Inc) | 199,653 | USD 820,574-0.5% | USD 4.11-0.5% | |
| ANAB (AnaptysBio Inc) | 18,598 | USD 814,592-3.1% | USD 43.8-3.1% | |
| NTLA (Intellia Therapeutics Inc) | 77,408 | USD 814,3323.8% | USD 10.523.8% | |
| SANA (Sana Biotechnology Inc) | 177,891 | USD 804,067-4.4% | USD 4.52-4.4% | |
| NVAX (Novavax Inc) | 108,892 | USD 799,267-3.7% | USD 7.34-3.7% | |
| SVRA (Savara Inc) | 136,640 | USD 787,046-0.2% | USD 5.76-0.2% | |
| CSTL (Castle Biosciences Inc) | 19,595 | USD 781,645-1.8% | USD 39.89-1.8% | |
| GRFS (Grifols SA ADR) | 81,916 | USD 777,3830.1% | USD 9.490.1% | |
| PCRX (Pacira BioSciences, Inc.) | 28,895 | USD 751,8480.1% | USD 26.020.1% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,778 | USD 745,337-13.7% | USD 15.6-13.7% | |
| URGN (UroGen Pharma Ltd) | 31,438 | USD 737,8501.4% | USD 23.471.4% | |
| SPRY (Silverback Therapeutics Inc) | 66,382 | USD 726,883-1.4% | USD 10.95-1.4% | |
| XNCR (Xencor Inc) | 47,956 | USD 680,496-5.1% | USD 14.19-5.1% | |
| VTYX (Ventyx Biosciences Inc) | 47,908 0.5% | USD 663,0471.3% | USD 13.840.8% | |
| IOVA (Iovance Biotherapeutics Inc) | 252,859 | USD 659,962-5.8% | USD 2.61-5.8% | |
| TBPH (Theravance Biopharma Inc) | 33,424 | USD 635,7240.7% | USD 19.020.7% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,381 | USD 623,274-3.7% | USD 9.25-3.7% | |
| ABUS (Arbutus Biopharma Corp) | 129,140 | USD 600,501-4.7% | USD 4.65-4.7% | |
| RAPT (RAPT Therapeutics Inc) | 18,613 | USD 580,726-3.8% | USD 31.2-3.8% | |
| GERN (Geron Corporation) | 418,720 | USD 573,646 | USD 1.37 | |
| PAHC (Phibro Animal Health Corporation) | 14,311 | USD 568,4330.7% | USD 39.720.7% | |
| KURA (Kura Oncology Inc) | 58,428 | USD 557,987-4.2% | USD 9.54999-4.2% | |
| JANX (Janux Therapeutics Inc) | 39,596 | USD 550,780-0.5% | USD 13.91-0.5% | |
| VIR (Vir Biotechnology Inc) | 91,091 | USD 541,991-3.4% | USD 5.95-3.4% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,719 | USD 538,426-2.6% | USD 8.45001-2.6% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,947 | USD 537,042-3.2% | USD 15.82-3.2% | |
| ARVN (Arvinas Inc) | 43,128 | USD 525,299-1.9% | USD 12.18-1.9% | |
| RGNX (Regenxbio Inc) | 33,987 | USD 509,805-1.6% | USD 15-1.6% | |
| PRME (Prime Medicine, Inc. Common Stock) | 124,654 | USD 488,644-3.0% | USD 3.92-3.0% | |
| ZLAB (Zai Lab Ltd) | 26,285 | USD 486,273-2.8% | USD 18.5-2.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 109,207 | USD 434,644-2.5% | USD 3.98-2.5% | |
| CGEM (Cullinan Oncology LLC) | 38,977 | USD 434,2041.8% | USD 11.141.8% | |
| REPL (Replimune Group Inc) | 52,392 | USD 431,186-7.7% | USD 8.23-7.7% | |
| PACB (Pacific Biosciences of California) | 202,671 | USD 413,449-4.2% | USD 2.04-4.2% | |
| KROS (Keros Therapeutics Inc) | 20,458 | USD 380,1100.1% | USD 18.580.1% | |
| MGTX (MeiraGTx Holdings PLC) | 51,953 | USD 378,218-5.8% | USD 7.28-5.8% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 97,355 | USD 374,817-0.3% | USD 3.85-0.3% | |
| FULC (Fulcrum Therapeutics Inc) | 36,342 | USD 367,4181.3% | USD 10.111.3% | |
| PRTA (Prothena Corporation plc) | 39,174 | USD 354,525-0.9% | USD 9.05001-0.9% | |
| SIGA (SIGA Technologies Inc) | 50,226 | USD 340,030-1.2% | USD 6.77-1.2% | |
| LYEL (Lyell Immunopharma Inc) | 13,701 | USD 332,934-3.0% | USD 24.3-3.0% | |
| GLPG (Galapagos NV ADR) | 9,372 | USD 309,182-0.2% | USD 32.99-0.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 76,316 | USD 296,106-0.3% | USD 3.88-0.3% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,262 | USD 288,183-14.1% | USD 7.34-14.1% | |
| TRDA (Entrada Therapeutics Inc) | 25,284 | USD 265,988-2.1% | USD 10.52-2.1% | |
| AVXL (Anavex Life Sciences Corp) | 61,365 | USD 262,0294.1% | USD 4.270014.1% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,694 | USD 260,566-6.0% | USD 7.29999-6.0% | |
| EOLS (Evolus Inc) | 43,519 | USD 249,7991.4% | USD 5.741.4% | |
| ACIU (AC Immune Ltd) | 71,432 | USD 245,726-6.5% | USD 3.44-6.5% | |
| AUTL (Autolus Therapeutics Ltd) | 127,023 | USD 242,614-2.1% | USD 1.91-2.1% | |
| ALLO (Allogene Therapeutics Inc) | 156,665 | USD 233,431 | USD 1.49 | |
| BCYC (Bicycle Therapeutics Ltd) | 33,857 | USD 224,472-3.5% | USD 6.63-3.5% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,943 | USD 216,3943.7% | USD 3.613.7% | |
| ACRS (Aclaris Therapeutics Inc) | 72,713 | USD 194,871 | USD 2.68 | |
| OABI (OmniAb Inc.) | 88,243 | USD 166,779-0.5% | USD 1.89-0.5% | |
| VYGR (Voyager Therapeutics Inc) | 36,796 | USD 149,392-0.7% | USD 4.06001-0.7% | |
| EDIT (Editas Medicine Inc) | 68,583 | USD 146,768-0.9% | USD 2.14001-0.9% | |
| CABA (Cabaletta Bio Inc) | 64,598 | USD 140,1781.4% | USD 2.170011.4% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,385 | USD 138,006-1.0% | USD 6.76998-1.0% | |
| HUMA (Humacyte Inc) | 116,346 | USD 136,125-2.5% | USD 1.17-2.5% | |
| CRBU (Caribou Biosciences Inc) | 62,725 | USD 106,005-4.5% | USD 1.69-4.5% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 168,450 0.5% | USD 81,555,0683.8% | USD 484.153.4% | |
| AMGN (Amgen Inc) | 211,429 0.5% | USD 72,232,6044.0% | USD 341.643.5% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,367 0.5% | USD 56,344,7335.1% | USD 812.274.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,743 0.5% | USD 37,493,9184.4% | USD 422.54.0% | |
| INSM (Insmed Inc) | 143,244 0.5% | USD 25,210,9441.0% | USD 1760.5% | |
| BIIB (Biogen Inc) | 98,534 0.5% | USD 18,416,9902.8% | USD 186.912.4% | |
| ARGX (argenx NV ADR) | 19,555 0.5% | USD 16,092,5922.9% | USD 822.942.4% | |
| ILMN (Illumina Inc) | 102,626 0.5% | USD 15,408,2682.5% | USD 150.142.1% | |
| INCY (Incyte Corporation) | 131,864 0.5% | USD 14,580,2024.1% | USD 110.573.7% | |
| UTHR (United Therapeutics Corporation) | 28,919 0.5% | USD 14,566,2110.7% | USD 503.690.2% | |
| RVMD (Revolution Medicines Inc) | 129,239 | USD 13,274,13828.6% | USD 102.7128.6% | |
| RPRX (Royalty Pharma Plc) | 286,958 0.5% | USD 11,877,1922.3% | USD 41.391.8% | |
| MEDP (Medpace Holdings Inc) | 18,918 0.5% | USD 11,598,4371.2% | USD 613.090.7% | |
| ROIV (Roivant Sciences Ltd) | 467,127 0.5% | USD 10,267,4512.2% | USD 21.981.7% | |
| VTRS (Viatris Inc) | 773,585 0.5% | USD 9,638,8691.0% | USD 12.460.5% | |
| BBIO (BridgeBio Pharma Inc) | 129,431 0.5% | USD 9,612,8400.8% | USD 74.270.4% | |
| GH (Guardant Health Inc) | 86,897 0.5% | USD 9,552,587-1.7% | USD 109.93-2.1% | |
| SMMT (Summit Therapeutics PLC) | 500,006 0.5% | USD 9,505,1142.3% | USD 19.011.9% | |
| MRNA (Moderna Inc) | 262,398 0.5% | USD 9,417,4641.1% | USD 35.890.6% | |
| NBIX (Neurocrine Biosciences Inc) | 66,968 0.5% | USD 9,417,0402.9% | USD 140.622.4% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,790 0.5% | USD 9,048,0642.5% | USD 83.172.1% | |
| ASND (Ascendis Pharma AS) | 41,245 0.5% | USD 8,796,7342.4% | USD 213.281.9% | |
| SNY (Sanofi ADR) | 177,732 0.5% | USD 8,596,8970.9% | USD 48.370.4% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,257 0.5% | USD 8,561,1601.0% | USD 561.130.6% | |
| EXEL (Exelixis Inc) | 180,078 0.5% | USD 8,317,8036.2% | USD 46.195.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 129,033 0.5% | USD 7,911,0132.5% | USD 61.312.1% | |
| RNA (Avidity Biosciences Inc) | 101,205 0.5% | USD 7,324,2060.6% | USD 72.370.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,809 0.5% | USD 6,911,8201.9% | USD 169.371.4% | |
| BNTX (BioNTech SE) | 67,908 0.5% | USD 6,796,2332.5% | USD 100.082.0% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 91,219 0.5% | USD 5,992,176-6.8% | USD 65.69-7.2% | |
| HALO (Halozyme Therapeutics Inc) | 78,984 0.5% | USD 5,932,4883.2% | USD 75.112.7% | |
| AXSM (Axsome Therapeutics Inc) | 33,863 0.5% | USD 5,780,075-0.2% | USD 170.69-0.7% | |
| CYTK (Cytokinetics Inc) | 82,121 0.5% | USD 5,372,3561.7% | USD 65.421.3% | |
| NUVL (Nuvalent Inc) | 48,326 0.5% | USD 5,162,18310.4% | USD 106.829.9% | |
| PRAX (Praxis Precision Medicines Inc) | 16,795 0.5% | USD 4,914,7217.7% | USD 292.637.2% | |
| KRYS (Krystal Biotech Inc) | 19,477 0.5% | USD 4,798,548-0.8% | USD 246.37-1.2% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,822 0.5% | USD 4,553,4672.7% | USD 101.592.2% | |
| PTCT (PTC Therapeutics Inc) | 53,925 0.5% | USD 4,165,1671.2% | USD 77.240.7% | |
| PCVX (Vaxcyte Inc) | 87,920 0.5% | USD 4,049,5953.2% | USD 46.062.7% | |
| COGT (Cogent Biosciences Inc) | 103,101 0.5% | USD 3,739,4734.8% | USD 36.274.3% | |
| CRSP (Crispr Therapeutics AG) | 64,011 0.5% | USD 3,711,9980.1% | USD 57.99-0.3% | |
| KYMR (Kymera Therapeutics Inc) | 48,324 0.5% | USD 3,705,9684.9% | USD 76.694.4% | |
| PTGX (Protagonist Therapeutics Inc) | 41,991 0.5% | USD 3,457,5390.5% | USD 82.340.1% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,731 0.5% | USD 3,399,41216.6% | USD 53.3416.1% | |
| ALKS (Alkermes Plc) | 110,900 0.5% | USD 3,256,0242.5% | USD 29.362.0% | |
| IMVT (Immunovant Inc) | 117,722 0.5% | USD 3,146,7093.7% | USD 26.733.2% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 113,633 0.5% | USD 3,115,8172.3% | USD 27.421.8% | |
| SRRK (Scholar Rock Holding Corp) | 69,279 0.5% | USD 3,064,2107.6% | USD 44.237.1% | |
| ADMA (ADMA Biologics Inc) | 159,845 0.5% | USD 3,008,2833.1% | USD 18.822.6% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,879 0.5% | USD 2,973,2345.2% | USD 66.254.8% | |
| FOLD (Amicus Therapeutics Inc) | 207,217 0.5% | USD 2,963,2030.6% | USD 14.30.1% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,831 0.5% | USD 2,907,8071.4% | USD 78.950.9% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,518 0.5% | USD 2,829,7867.7% | USD 81.987.2% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 211,134 0.5% | USD 2,799,6372.6% | USD 13.262.1% | |
| GRAL (GRAIL, LLC) | 26,072 0.5% | USD 2,700,7980.1% | USD 103.59-0.4% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,216 0.5% | USD 2,642,6712.5% | USD 199.962.0% | |
| ACLX (Arcellx Inc) | 38,836 0.5% | USD 2,524,7285.2% | USD 65.014.8% | |
| ARQT (Arcutis Biotherapeutics Inc) | 82,268 0.5% | USD 2,433,4871.7% | USD 29.581.2% | |
| VCYT (Veracyte Inc) | 53,093 0.5% | USD 2,395,025-0.7% | USD 45.11-1.2% | |
| CGON (CG Oncology, Inc. Common stock) | 53,916 0.5% | USD 2,288,7345.6% | USD 42.455.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,979 0.5% | USD 2,251,09411.2% | USD 26.4910.7% | |
| IDYA (Ideaya Biosciences Inc) | 58,884 0.5% | USD 2,229,3484.8% | USD 37.864.3% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,511 0.5% | USD 2,226,139-1.8% | USD 78.08-2.3% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,904 0.5% | USD 2,186,1963.2% | USD 42.122.7% | |
| TVTX (Travere Therapeutics Inc) | 60,096 0.5% | USD 2,180,2831.8% | USD 36.281.3% | |
| VERA (Vera Therapeutics Inc) | 42,941 0.5% | USD 2,090,3685.1% | USD 48.684.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,514 0.5% | USD 1,973,4574.5% | USD 51.244.0% | |
| BEAM (Beam Therapeutics Inc) | 68,155 0.5% | USD 1,971,7242.6% | USD 28.932.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 53,155 0.5% | USD 1,879,029-0.5% | USD 35.35-1.0% | |
| DYN (Dyne Therapeutics Inc) | 95,920 0.5% | USD 1,859,8897.5% | USD 19.397.0% | |
| EWTX (Edgewise Therapeutics Inc) | 71,104 0.5% | USD 1,754,1368.0% | USD 24.677.5% | |
| WVE (Wave Life Sciences Ltd) | 112,278 0.5% | USD 1,732,4502.3% | USD 15.431.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 102,534 0.5% | USD 1,715,3944.3% | USD 16.733.8% | |
| RXRX (Recursion Pharmaceuticals Inc) | 345,320 0.5% | USD 1,678,2557.3% | USD 4.866.8% | |
| SRPT (Sarepta Therapeutics Inc) | 71,478 0.5% | USD 1,676,8745.5% | USD 23.465.0% | |
| DNLI (Denali Therapeutics Inc) | 98,499 0.5% | USD 1,669,558-1.1% | USD 16.95-1.5% | |
| OCUL (Ocular Therapeutix Inc) | 143,077 0.5% | USD 1,645,3862.7% | USD 11.52.2% | |
| SYRE (Spyre Therapeutics Inc.) | 52,112 0.5% | USD 1,618,0782.9% | USD 31.052.4% | |
| RARE (Ultragenyx) | 64,800 0.5% | USD 1,568,1607.9% | USD 24.27.4% | |
| TXG (10X Genomics Inc) | 78,222 0.5% | USD 1,563,6584.0% | USD 19.993.5% | |
| TWST (Twist Bioscience Corp) | 41,071 0.5% | USD 1,501,145-0.4% | USD 36.55-0.9% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,800 0.5% | USD 1,470,3120.5% | USD 22.690.0% | |
| IBRX (Immunitybio Inc) | 661,128 0.5% | USD 1,454,4823.3% | USD 2.22.8% | |
| HRMY (Harmony Biosciences Holdings) | 38,681 0.5% | USD 1,452,4722.7% | USD 37.552.2% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,823 0.5% | USD 1,429,9198.6% | USD 27.078.1% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 88,544 0.5% | USD 1,418,4754.2% | USD 16.023.8% | |
| VCEL (Vericel Corp Ord) | 33,965 0.5% | USD 1,370,4883.0% | USD 40.352.6% | |
| STOK (Stoke Therapeutics Inc) | 38,362 0.5% | USD 1,349,1920.3% | USD 35.17-0.1% | |
| GMAB (Genmab AS) | 39,259 0.5% | USD 1,330,8802.9% | USD 33.92.4% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,366 0.5% | USD 1,290,4729.2% | USD 22.118.7% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,304 0.5% | USD 1,285,496-0.1% | USD 42.42-0.6% | |
| LEGN (Legend Biotech Corp) | 56,554 0.5% | USD 1,284,9078.8% | USD 22.728.3% | |
| HROW (Harrow Health Inc) | 24,873 0.5% | USD 1,268,523-4.2% | USD 51-4.7% | |
| NRIX (Nurix Therapeutics Inc) | 68,082 0.5% | USD 1,258,8366.6% | USD 18.496.1% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,259 0.5% | USD 1,248,9363.3% | USD 24.852.8% | |
| DVAX (Dynavax Technologies Corporation) | 78,854 0.5% | USD 1,215,1400.3% | USD 15.41-0.1% | |
| MNKD (MannKind Corp) | 206,214 0.5% | USD 1,206,3524.6% | USD 5.854.1% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,084 0.5% | USD 1,198,7253.0% | USD 79.472.6% | |
| PGEN (Precigen Inc) | 237,604 0.5% | USD 1,152,3797.1% | USD 4.856.6% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 141,388 0.5% | USD 1,119,7935.0% | USD 7.924.5% | |
| AGIO (Agios Pharm) | 39,164 0.5% | USD 1,117,7414.4% | USD 28.543.9% | |
| NVCR (Novocure Ltd) | 75,206 0.5% | USD 1,083,7181.3% | USD 14.410.8% | |
| FTRE (Fortrea Holdings Inc.) | 61,956 0.5% | USD 1,083,6100.2% | USD 17.49-0.3% | |
| PHVS (Pharvaris BV) | 43,020 0.5% | USD 1,077,2214.6% | USD 25.044.1% | |
| TNGX (Tango Therapeutics Inc) | 90,010 | USD 1,061,21821.9% | USD 11.7921.9% | |
| COLL (Collegium Pharmaceutical Inc) | 21,233 0.5% | USD 1,003,4722.7% | USD 47.262.3% | |
| IMCR (Immunocore Holdings Ltd) | 29,267 0.5% | USD 988,0543.3% | USD 33.762.8% | |
| INVA (Innoviva Inc) | 50,213 0.5% | USD 981,1621.7% | USD 19.541.2% | |
| ERAS (Erasca Inc) | 189,613 | USD 980,29942.4% | USD 5.1742.4% | |
| TSHA (Taysha Gene Therapies Inc) | 183,953 0.5% | USD 976,7901.4% | USD 5.311.0% | |
| QURE (Uniqure NV) | 41,837 0.5% | USD 965,5983.9% | USD 23.083.5% | |
| RLAY (Relay Therapeutics Inc) | 116,389 0.5% | USD 952,0620.6% | USD 8.180.1% | |
| ARDX (Ardelyx Inc) | 163,166 0.5% | USD 951,2585.3% | USD 5.834.9% | |
| MNMD (Mind Medicine Inc) | 66,158 0.5% | USD 928,1974.3% | USD 14.033.8% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,751 0.5% | USD 884,2745.9% | USD 11.995.4% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,778 0.5% | USD 863,82611.0% | USD 18.0810.4% | |
| AMPH (Amphastar P) | 30,860 0.5% | USD 843,404-0.6% | USD 27.33-1.0% | |
| SANA (Sana Biotechnology Inc) | 177,891 0.5% | USD 841,4249.0% | USD 4.738.5% | |
| ANAB (AnaptysBio Inc) | 18,598 0.5% | USD 840,8163.4% | USD 45.213.0% | |
| NVAX (Novavax Inc) | 108,892 0.5% | USD 829,7572.9% | USD 7.622.4% | |
| ABCL (Abcellera Biologics Inc) | 199,653 0.5% | USD 824,5676.4% | USD 4.135.9% | |
| XERS (Xeris Pharmaceuticals Inc) | 111,416 0.5% | USD 803,3094.1% | USD 7.213.6% | |
| CSTL (Castle Biosciences Inc) | 19,595 0.5% | USD 795,7531.8% | USD 40.611.3% | |
| SVRA (Savara Inc) | 136,640 0.5% | USD 788,4134.6% | USD 5.774.2% | |
| NTLA (Intellia Therapeutics Inc) | 77,408 0.5% | USD 784,1434.6% | USD 10.134.1% | |
| GRFS (Grifols SA ADR) | 81,916 0.5% | USD 776,5643.6% | USD 9.483.2% | |
| PCRX (Pacira BioSciences, Inc.) | 28,895 0.5% | USD 751,2703.2% | USD 262.7% | |
| SPRY (Silverback Therapeutics Inc) | 66,382 0.5% | USD 736,8400.0% | USD 11.1-0.4% | |
| URGN (UroGen Pharma Ltd) | 31,438 0.5% | USD 727,4756.2% | USD 23.145.7% | |
| XNCR (Xencor Inc) | 47,956 0.5% | USD 716,9426.8% | USD 14.956.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 252,859 0.5% | USD 700,4199.1% | USD 2.778.6% | |
| VTYX (Ventyx Biosciences Inc) | 47,684 | USD 654,70136.6% | USD 13.7336.6% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,381 0.5% | USD 647,53111.7% | USD 9.6099911.2% | |
| TBPH (Theravance Biopharma Inc) | 33,424 0.5% | USD 631,0453.7% | USD 18.883.2% | |
| ABUS (Arbutus Biopharma Corp) | 129,140 0.5% | USD 630,2032.4% | USD 4.881.9% | |
| ELVN (Enliven Therapeutics Inc.) | 39,355 0.5% | USD 608,8222.7% | USD 15.472.2% | |
| RAPT (RAPT Therapeutics Inc) | 18,613 0.5% | USD 603,4335.6% | USD 32.425.2% | |
| KURA (Kura Oncology Inc) | 58,428 0.5% | USD 582,5275.0% | USD 9.974.5% | |
| GERN (Geron Corporation) | 418,720 0.5% | USD 573,6464.3% | USD 1.373.8% | |
| PAHC (Phibro Animal Health Corporation) | 14,311 0.5% | USD 564,2830.2% | USD 39.43-0.3% | |
| VIR (Vir Biotechnology Inc) | 91,091 0.5% | USD 561,1213.8% | USD 6.163.4% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,947 0.5% | USD 554,6944.2% | USD 16.343.7% | |
| JANX (Janux Therapeutics Inc) | 39,596 0.5% | USD 553,5524.5% | USD 13.984.0% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,719 0.5% | USD 553,0817.1% | USD 8.686.6% | |
| ARVN (Arvinas Inc) | 43,128 0.5% | USD 535,2185.4% | USD 12.414.9% | |
| RGNX (Regenxbio Inc) | 33,987 0.5% | USD 517,9628.0% | USD 15.247.5% | |
| PRME (Prime Medicine, Inc. Common Stock) | 124,654 0.5% | USD 503,6029.7% | USD 4.049.2% | |
| ZLAB (Zai Lab Ltd) | 26,285 0.5% | USD 500,2045.0% | USD 19.034.6% | |
| REPL (Replimune Group Inc) | 52,392 0.5% | USD 467,3376.1% | USD 8.920015.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 109,207 0.5% | USD 445,565-4.7% | USD 4.08-5.1% | |
| PACB (Pacific Biosciences of California) | 202,671 0.5% | USD 431,6892.9% | USD 2.132.4% | |
| CGEM (Cullinan Oncology LLC) | 38,977 0.5% | USD 426,4088.2% | USD 10.947.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,953 0.5% | USD 401,5973.4% | USD 7.730012.9% | |
| KROS (Keros Therapeutics Inc) | 20,458 0.5% | USD 379,7004.8% | USD 18.564.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 97,355 0.5% | USD 375,7900.0% | USD 3.86-0.5% | |
| FULC (Fulcrum Therapeutics Inc) | 36,342 0.5% | USD 362,6930.4% | USD 9.98-0.1% | |
| PRTA (Prothena Corporation plc) | 39,174 0.5% | USD 357,6592.3% | USD 9.130011.8% | |
| SIGA (SIGA Technologies Inc) | 50,226 0.5% | USD 344,0483.3% | USD 6.852.9% | |
| LYEL (Lyell Immunopharma Inc) | 13,701 0.5% | USD 343,210-2.2% | USD 25.05-2.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,262 0.5% | USD 335,2975.5% | USD 8.539995.0% | |
| GLPG (Galapagos NV ADR) | 9,372 0.5% | USD 309,6512.1% | USD 33.041.6% | |
| RCKT (Rocket Pharmaceuticals Inc) | 76,316 0.5% | USD 296,86910.4% | USD 3.899.9% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,694 0.5% | USD 277,3428.6% | USD 7.769998.1% | |
| TRDA (Entrada Therapeutics Inc) | 25,284 0.5% | USD 271,8037.2% | USD 10.756.6% | |
| ACIU (AC Immune Ltd) | 71,432 0.5% | USD 262,8707.8% | USD 3.687.3% | |
| AVXL (Anavex Life Sciences Corp) | 61,365 0.5% | USD 251,5972.7% | USD 4.100012.2% | |
| AUTL (Autolus Therapeutics Ltd) | 127,023 0.5% | USD 247,695-2.0% | USD 1.95-2.5% | |
| EOLS (Evolus Inc) | 43,519 0.5% | USD 246,318-3.8% | USD 5.66001-4.2% | |
| ALLO (Allogene Therapeutics Inc) | 156,665 0.5% | USD 233,4316.2% | USD 1.495.7% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,857 0.5% | USD 232,5985.1% | USD 6.870014.6% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,943 0.5% | USD 208,6022.5% | USD 3.480012.1% | |
| ACRS (Aclaris Therapeutics Inc) | 72,713 0.5% | USD 194,8711.6% | USD 2.681.1% | |
| OABI (OmniAb Inc.) | 88,243 0.5% | USD 167,6623.8% | USD 1.93.3% | |
| VYGR (Voyager Therapeutics Inc) | 36,796 0.5% | USD 150,4962.2% | USD 4.090011.7% | |
| EDIT (Editas Medicine Inc) | 68,583 0.5% | USD 148,1391.4% | USD 2.160.9% | |
| HUMA (Humacyte Inc) | 116,346 0.5% | USD 139,61511.7% | USD 1.211.1% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,385 0.5% | USD 139,4334.0% | USD 6.839983.5% | |
| CABA (Cabaletta Bio Inc) | 64,598 0.5% | USD 138,2405.4% | USD 2.144.9% | |
| CRBU (Caribou Biosciences Inc) | 62,725 0.5% | USD 111,0233.4% | USD 1.772.9% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 167,670 | USD 78,533,2754.4% | USD 468.384.4% | |
| AMGN (Amgen Inc) | 210,449 | USD 69,483,9462.9% | USD 330.172.9% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,045 | USD 53,616,2041.7% | USD 776.541.7% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,331 | USD 35,897,7182.2% | USD 406.42.2% | |
| INSM (Insmed Inc) | 142,580 | USD 24,961,481-0.1% | USD 175.07-0.1% | |
| BIIB (Biogen Inc) | 98,078 | USD 17,910,0244.6% | USD 182.614.6% | |
| ARGX (argenx NV ADR) | 19,465 | USD 15,644,7990.4% | USD 803.740.4% | |
| ILMN (Illumina Inc) | 102,150 | USD 15,027,2874.1% | USD 147.114.1% | |
| UTHR (United Therapeutics Corporation) | 28,785 | USD 14,470,5072.7% | USD 502.712.7% | |
| INCY (Incyte Corporation) | 131,254 | USD 13,999,5524.8% | USD 106.664.8% | |
| RPRX (Royalty Pharma Plc) | 285,628 | USD 11,610,7782.5% | USD 40.652.5% | |
| MEDP (Medpace Holdings Inc) | 18,830 | USD 11,465,3993.8% | USD 608.893.8% | |
| RVMD (Revolution Medicines Inc) | 129,239 | USD 10,319,7341.9% | USD 79.851.9% | |
| ROIV (Roivant Sciences Ltd) | 464,963 | USD 10,047,8501.5% | USD 21.611.5% | |
| GH (Guardant Health Inc) | 86,495 | USD 9,715,98310.3% | USD 112.3310.3% | |
| VTRS (Viatris Inc) | 770,001 | USD 9,548,0120.2% | USD 12.40.2% | |
| BBIO (BridgeBio Pharma Inc) | 128,831 | USD 9,532,2060.8% | USD 73.990.8% | |
| MRNA (Moderna Inc) | 261,182 | USD 9,313,75010.8% | USD 35.6610.8% | |
| SMMT (Summit Therapeutics PLC) | 497,690 | USD 9,286,8957.0% | USD 18.667.0% | |
| NBIX (Neurocrine Biosciences Inc) | 66,658 | USD 9,155,4761.0% | USD 137.351.0% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,286 | USD 8,824,2263.8% | USD 81.493.8% | |
| ASND (Ascendis Pharma AS) | 41,053 | USD 8,591,982-1.8% | USD 209.29-1.8% | |
| SNY (Sanofi ADR) | 176,908 | USD 8,521,6581.4% | USD 48.171.4% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,187 | USD 8,474,498-5.2% | USD 558.01-5.2% | |
| EXEL (Exelixis Inc) | 179,244 | USD 7,829,3783.0% | USD 43.683.0% | |
| BMRN (Biomarin Pharmaceutical Inc) | 128,435 | USD 7,715,0902.0% | USD 60.072.0% | |
| RNA (Avidity Biosciences Inc) | 100,737 | USD 7,278,2480.2% | USD 72.250.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,619 | USD 6,782,967-4.2% | USD 166.99-4.2% | |
| BNTX (BioNTech SE) | 67,594 | USD 6,630,2951.3% | USD 98.091.3% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,797 | USD 6,429,33610.8% | USD 70.8110.8% | |
| AXSM (Axsome Therapeutics Inc) | 33,707 | USD 5,793,5590.2% | USD 171.880.2% | |
| HALO (Halozyme Therapeutics Inc) | 78,618 | USD 5,749,3342.7% | USD 73.132.7% | |
| CYTK (Cytokinetics Inc) | 81,741 | USD 5,280,4695.5% | USD 64.65.5% | |
| KRYS (Krystal Biotech Inc) | 19,387 | USD 4,834,9241.9% | USD 249.391.9% | |
| NUVL (Nuvalent Inc) | 48,102 | USD 4,675,514-0.8% | USD 97.2-0.8% | |
| PRAX (Praxis Precision Medicines Inc) | 16,717 | USD 4,562,069-1.5% | USD 272.9-1.5% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,614 | USD 4,435,524-2.4% | USD 99.42-2.4% | |
| PTCT (PTC Therapeutics Inc) | 53,675 | USD 4,116,873-0.1% | USD 76.7-0.1% | |
| PCVX (Vaxcyte Inc) | 87,512 | USD 3,924,913-2.6% | USD 44.85-2.6% | |
| CRSP (Crispr Therapeutics AG) | 63,715 | USD 3,707,5765.5% | USD 58.195.5% | |
| COGT (Cogent Biosciences Inc) | 102,623 | USD 3,569,2281.5% | USD 34.781.5% | |
| KYMR (Kymera Therapeutics Inc) | 48,100 | USD 3,533,4261.5% | USD 73.461.5% | |
| PTGX (Protagonist Therapeutics Inc) | 41,797 | USD 3,438,639-2.3% | USD 82.27-2.3% | |
| ALKS (Alkermes Plc) | 110,386 | USD 3,176,9092.8% | USD 28.782.8% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 113,107 | USD 3,047,1033.0% | USD 26.943.0% | |
| IMVT (Immunovant Inc) | 117,176 | USD 3,034,8583.7% | USD 25.93.7% | |
| FOLD (Amicus Therapeutics Inc) | 206,257 | USD 2,945,3500.2% | USD 14.280.2% | |
| ADMA (ADMA Biologics Inc) | 159,103 | USD 2,917,9491.7% | USD 18.341.7% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,435 | USD 2,914,838-4.6% | USD 45.95-4.6% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,661 | USD 2,868,7231.0% | USD 78.251.0% | |
| SRRK (Scholar Rock Holding Corp) | 68,959 | USD 2,848,696-3.4% | USD 41.31-3.4% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,671 | USD 2,824,9940.7% | USD 63.240.7% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 210,154 | USD 2,729,9002.2% | USD 12.992.2% | |
| GRAL (GRAIL, LLC) | 25,952 | USD 2,698,4898.6% | USD 103.988.6% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,358 | USD 2,627,0131.2% | USD 76.461.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,154 | USD 2,578,4472.1% | USD 196.022.1% | |
| VCYT (Veracyte Inc) | 52,847 | USD 2,411,9374.6% | USD 45.644.6% | |
| ACLX (Arcellx Inc) | 38,656 | USD 2,398,9910.4% | USD 62.060.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,886 | USD 2,392,709-3.2% | USD 29.22-3.2% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,379 | USD 2,266,9150.2% | USD 79.880.2% | |
| CGON (CG Oncology, Inc. Common stock) | 53,666 | USD 2,166,4960.8% | USD 40.370.8% | |
| TVTX (Travere Therapeutics Inc) | 59,818 | USD 2,141,484-6.1% | USD 35.8-6.1% | |
| IDYA (Ideaya Biosciences Inc) | 58,612 | USD 2,128,2023.9% | USD 36.313.9% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,664 | USD 2,118,224-1.9% | USD 41-1.9% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,585 | USD 2,024,965-3.7% | USD 23.94-3.7% | |
| VERA (Vera Therapeutics Inc) | 42,743 | USD 1,988,404-1.2% | USD 46.52-1.2% | |
| BEAM (Beam Therapeutics Inc) | 67,839 | USD 1,922,5575.6% | USD 28.345.6% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,909 | USD 1,889,3800.1% | USD 35.710.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,336 | USD 1,888,431-0.3% | USD 49.26-0.3% | |
| DYN (Dyne Therapeutics Inc) | 95,474 | USD 1,729,989-0.6% | USD 18.12-0.6% | |
| WVE (Wave Life Sciences Ltd) | 111,756 | USD 1,693,1031.0% | USD 15.151.0% | |
| DNLI (Denali Therapeutics Inc) | 98,041 | USD 1,687,2867.4% | USD 17.217.4% | |
| ADPT (Adaptive Biotechnologies Corp) | 102,058 | USD 1,644,154-0.4% | USD 16.11-0.4% | |
| EWTX (Edgewise Therapeutics Inc) | 70,774 | USD 1,623,556-2.7% | USD 22.94-2.7% | |
| OCUL (Ocular Therapeutix Inc) | 142,413 | USD 1,602,146-2.6% | USD 11.25-2.6% | |
| SRPT (Sarepta Therapeutics Inc) | 71,146 | USD 1,590,1136.1% | USD 22.356.1% | |
| SYRE (Spyre Therapeutics Inc.) | 51,870 | USD 1,573,2171.2% | USD 30.331.2% | |
| RXRX (Recursion Pharmaceuticals Inc) | 343,714 | USD 1,563,8994.1% | USD 4.554.1% | |
| TWST (Twist Bioscience Corp) | 40,881 | USD 1,507,2827.4% | USD 36.877.4% | |
| TXG (10X Genomics Inc) | 77,860 | USD 1,503,4775.4% | USD 19.315.4% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,500 | USD 1,462,860-1.5% | USD 22.68-1.5% | |
| RARE (Ultragenyx) | 64,500 | USD 1,453,830-2.5% | USD 22.54-2.5% | |
| HRMY (Harmony Biosciences Holdings) | 38,501 | USD 1,414,912 | USD 36.75 | |
| IBRX (Immunitybio Inc) | 658,054 | USD 1,408,2362.9% | USD 2.142.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 88,132 | USD 1,360,7580.9% | USD 15.440.9% | |
| STOK (Stoke Therapeutics Inc) | 38,184 | USD 1,344,8408.2% | USD 35.228.2% | |
| VCEL (Vericel Corp Ord) | 33,807 | USD 1,329,9676.1% | USD 39.346.1% | |
| HROW (Harrow Health Inc) | 24,757 | USD 1,324,500-2.4% | USD 53.5-2.4% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,579 | USD 1,316,578-0.2% | USD 25.04-0.2% | |
| GMAB (Genmab AS) | 39,077 | USD 1,293,4494.1% | USD 33.14.1% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,164 | USD 1,287,4003.9% | USD 42.683.9% | |
| DVAX (Dynavax Technologies Corporation) | 78,488 | USD 1,211,0700.1% | USD 15.430.1% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,025 | USD 1,209,605-5.1% | USD 24.18-5.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,096 | USD 1,181,6730.6% | USD 20.340.6% | |
| NRIX (Nurix Therapeutics Inc) | 67,766 | USD 1,181,161-0.3% | USD 17.43-0.3% | |
| LEGN (Legend Biotech Corp) | 56,292 | USD 1,181,0063.3% | USD 20.983.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,014 | USD 1,163,285-1.5% | USD 77.48-1.5% | |
| MNKD (MannKind Corp) | 205,254 | USD 1,153,527 | USD 5.62 | |
| FTRE (Fortrea Holdings Inc.) | 61,668 | USD 1,081,6575.5% | USD 17.545.5% | |
| PGEN (Precigen Inc) | 236,498 | USD 1,076,0668.9% | USD 4.558.9% | |
| AGIO (Agios Pharm) | 38,982 | USD 1,070,8360.1% | USD 27.470.1% | |
| NVCR (Novocure Ltd) | 74,856 | USD 1,069,6923.8% | USD 14.293.8% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,730 | USD 1,066,7332.3% | USD 7.582.3% | |
| PHVS (Pharvaris BV) | 42,820 | USD 1,029,821-3.3% | USD 24.05-3.3% | |
| COLL (Collegium Pharmaceutical Inc) | 21,135 | USD 976,6481.2% | USD 46.211.2% | |
| INVA (Innoviva Inc) | 49,979 | USD 965,094-3.6% | USD 19.31-3.6% | |
| TSHA (Taysha Gene Therapies Inc) | 183,095 | USD 963,0807.6% | USD 5.267.6% | |
| IMCR (Immunocore Holdings Ltd) | 29,131 | USD 956,9530.3% | USD 32.850.3% | |
| RLAY (Relay Therapeutics Inc) | 115,847 | USD 946,4703.9% | USD 8.173.9% | |
| QURE (Uniqure NV) | 41,643 | USD 929,055-1.4% | USD 22.31-1.4% | |
| ARDX (Ardelyx Inc) | 162,406 | USD 902,977-8.7% | USD 5.56-8.7% | |
| MNMD (Mind Medicine Inc) | 65,850 | USD 889,634-0.5% | USD 13.51-0.5% | |
| TNGX (Tango Therapeutics Inc) | 90,010 | USD 870,3978.5% | USD 9.678.5% | |
| AMPH (Amphastar P) | 30,716 | USD 848,3763.4% | USD 27.623.4% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,407 | USD 835,372-0.1% | USD 11.38-0.1% | |
| ANAB (AnaptysBio Inc) | 18,512 | USD 812,8621.6% | USD 43.911.6% | |
| NVAX (Novavax Inc) | 108,384 | USD 806,3772.6% | USD 7.442.6% | |
| CSTL (Castle Biosciences Inc) | 19,505 | USD 781,5652.7% | USD 40.072.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,556 | USD 778,4923.4% | USD 16.373.4% | |
| ABCL (Abcellera Biologics Inc) | 198,721 | USD 775,01213.7% | USD 3.913.7% | |
| SANA (Sana Biotechnology Inc) | 177,061 | USD 771,9867.4% | USD 4.367.4% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,896 | USD 771,836-1.8% | USD 6.96-1.8% | |
| SVRA (Savara Inc) | 136,002 | USD 753,451-4.5% | USD 5.54-4.5% | |
| NTLA (Intellia Therapeutics Inc) | 77,048 | USD 749,6773.8% | USD 9.733.8% | |
| GRFS (Grifols SA ADR) | 81,534 | USD 749,297-1.4% | USD 9.18999-1.4% | |
| SPRY (Silverback Therapeutics Inc) | 66,072 | USD 736,7031.6% | USD 11.151.6% | |
| PCRX (Pacira BioSciences, Inc.) | 28,761 | USD 727,9410.8% | USD 25.310.8% | |
| ERAS (Erasca Inc) | 189,613 | USD 688,2954.0% | USD 3.634.0% | |
| URGN (UroGen Pharma Ltd) | 31,292 | USD 684,982-1.1% | USD 21.89-1.1% | |
| XNCR (Xencor Inc) | 47,732 | USD 671,112-1.5% | USD 14.06-1.5% | |
| IOVA (Iovance Biotherapeutics Inc) | 251,677 | USD 641,7764.1% | USD 2.554.1% | |
| ABUS (Arbutus Biopharma Corp) | 128,536 | USD 615,6871.7% | USD 4.791.7% | |
| TBPH (Theravance Biopharma Inc) | 33,268 | USD 608,804-0.7% | USD 18.3-0.7% | |
| ELVN (Enliven Therapeutics Inc.) | 39,171 | USD 593,049-0.5% | USD 15.14-0.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,067 | USD 579,4591.1% | USD 8.641.1% | |
| RAPT (RAPT Therapeutics Inc) | 18,527 | USD 571,1873.4% | USD 30.833.4% | |
| PAHC (Phibro Animal Health Corporation) | 14,245 | USD 563,2473.0% | USD 39.543.0% | |
| KURA (Kura Oncology Inc) | 58,156 | USD 554,808 | USD 9.54 | |
| GERN (Geron Corporation) | 416,758 | USD 550,121 | USD 1.32 | |
| VIR (Vir Biotechnology Inc) | 90,665 | USD 540,3632.9% | USD 5.962.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,789 | USD 532,1770.6% | USD 15.750.6% | |
| JANX (Janux Therapeutics Inc) | 39,412 | USD 529,697-2.3% | USD 13.44-2.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,421 | USD 516,247-0.1% | USD 8.14-0.1% | |
| ARVN (Arvinas Inc) | 42,926 | USD 507,8155.9% | USD 11.835.9% | |
| RGNX (Regenxbio Inc) | 33,829 | USD 479,6955.8% | USD 14.185.8% | |
| VTYX (Ventyx Biosciences Inc) | 47,684 | USD 479,22428.5% | USD 10.0528.5% | |
| ZLAB (Zai Lab Ltd) | 26,163 | USD 476,1670.6% | USD 18.20.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,695 | USD 467,389-6.3% | USD 4.3-6.3% | |
| PRME (Prime Medicine, Inc. Common Stock) | 124,070 | USD 459,0593.6% | USD 3.73.6% | |
| REPL (Replimune Group Inc) | 52,146 | USD 440,6340.4% | USD 8.450010.4% | |
| PACB (Pacific Biosciences of California) | 201,719 | USD 419,5765.1% | USD 2.085.1% | |
| CGEM (Cullinan Oncology LLC) | 38,795 | USD 394,1571.7% | USD 10.161.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,709 | USD 388,335-0.5% | USD 7.51001-0.5% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,897 | USD 375,9602.4% | USD 3.882.4% | |
| KROS (Keros Therapeutics Inc) | 20,362 | USD 362,240-0.7% | USD 17.79-0.7% | |
| FULC (Fulcrum Therapeutics Inc) | 36,172 | USD 361,358-7.8% | USD 9.98999-7.8% | |
| LYEL (Lyell Immunopharma Inc) | 13,637 | USD 350,880-8.1% | USD 25.73-8.1% | |
| PRTA (Prothena Corporation plc) | 38,990 | USD 349,740-1.4% | USD 8.96999-1.4% | |
| SIGA (SIGA Technologies Inc) | 49,990 | USD 332,9334.2% | USD 6.659994.2% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,078 | USD 317,7043.3% | USD 8.133.3% | |
| GLPG (Galapagos NV ADR) | 9,328 | USD 303,347-0.7% | USD 32.52-0.7% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,954 | USD 268,877-0.3% | USD 3.54-0.3% | |
| EOLS (Evolus Inc) | 43,313 | USD 255,980-2.3% | USD 5.91-2.3% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,526 | USD 255,432-1.5% | USD 7.19-1.5% | |
| TRDA (Entrada Therapeutics Inc) | 25,164 | USD 253,653-4.0% | USD 10.08-4.0% | |
| AUTL (Autolus Therapeutics Ltd) | 126,419 | USD 252,8387.5% | USD 27.5% | |
| AVXL (Anavex Life Sciences Corp) | 61,073 | USD 244,9031.5% | USD 4.011.5% | |
| ACIU (AC Immune Ltd) | 71,092 | USD 243,846-2.6% | USD 3.43001-2.6% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,697 | USD 221,389-0.6% | USD 6.56999-0.6% | |
| ALLO (Allogene Therapeutics Inc) | 155,919 | USD 219,8464.4% | USD 1.414.4% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,657 | USD 203,430 | USD 3.40999 | |
| ACRS (Aclaris Therapeutics Inc) | 72,365 | USD 191,767 | USD 2.65 | |
| OABI (OmniAb Inc.) | 87,819 | USD 161,587-0.5% | USD 1.84-0.5% | |
| VYGR (Voyager Therapeutics Inc) | 36,618 | USD 147,204-1.5% | USD 4.01999-1.5% | |
| EDIT (Editas Medicine Inc) | 68,251 | USD 146,0577.5% | USD 2.147.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,287 | USD 134,0973.8% | USD 6.613.8% | |
| CABA (Cabaletta Bio Inc) | 64,284 | USD 131,139-7.3% | USD 2.03999-7.3% | |
| HUMA (Humacyte Inc) | 115,782 | USD 125,0451.9% | USD 1.081.9% | |
| CRBU (Caribou Biosciences Inc) | 62,421 | USD 107,3646.8% | USD 1.726.8% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 167,670 | USD 75,250,296-0.7% | USD 448.8-0.7% | |
| AMGN (Amgen Inc) | 210,449 | USD 67,495,203-2.1% | USD 320.72-2.1% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,045 | USD 52,697,215-1.7% | USD 763.23-1.7% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,331 | USD 35,140,722-0.6% | USD 397.83-0.6% | |
| INSM (Insmed Inc) | 142,580 | USD 24,980,016-1.1% | USD 175.2-1.1% | |
| BIIB (Biogen Inc) | 98,078 | USD 17,127,361-1.8% | USD 174.63-1.8% | |
| ARGX (argenx NV ADR) | 19,465 | USD 15,589,129-4.7% | USD 800.88-4.7% | |
| ILMN (Illumina Inc) | 102,150 | USD 14,436,8605.2% | USD 141.335.2% | |
| UTHR (United Therapeutics Corporation) | 28,785 | USD 14,095,727-1.4% | USD 489.69-1.4% | |
| INCY (Incyte Corporation) | 131,254 | USD 13,360,3450.4% | USD 101.790.4% | |
| RPRX (Royalty Pharma Plc) | 285,628 | USD 11,325,1502.0% | USD 39.652.0% | |
| MEDP (Medpace Holdings Inc) | 18,830 | USD 11,050,0092.8% | USD 586.832.8% | |
| RVMD (Revolution Medicines Inc) | 129,239 | USD 10,123,291-0.9% | USD 78.33-0.9% | |
| ROIV (Roivant Sciences Ltd) | 464,963 | USD 9,903,712-2.9% | USD 21.3-2.9% | |
| VTRS (Viatris Inc) | 770,001 | USD 9,524,912-0.7% | USD 12.37-0.7% | |
| BBIO (BridgeBio Pharma Inc) | 128,831 | USD 9,458,772-6.2% | USD 73.42-6.2% | |
| NBIX (Neurocrine Biosciences Inc) | 66,658 | USD 9,064,821-3.3% | USD 135.99-3.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,187 | USD 8,936,031-0.9% | USD 588.4-0.9% | |
| GH (Guardant Health Inc) | 86,495 | USD 8,811,2460.1% | USD 101.870.1% | |
| ASND (Ascendis Pharma AS) | 41,053 | USD 8,750,447-0.1% | USD 213.15-0.1% | |
| SMMT (Summit Therapeutics PLC) | 497,690 | USD 8,679,714-0.5% | USD 17.44-0.5% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,286 | USD 8,503,700-1.4% | USD 78.53-1.4% | |
| SNY (Sanofi ADR) | 176,908 | USD 8,404,899-1.5% | USD 47.51-1.5% | |
| MRNA (Moderna Inc) | 261,182 | USD 8,402,2254.2% | USD 32.174.2% | |
| EXEL (Exelixis Inc) | 179,244 | USD 7,599,946-2.7% | USD 42.4-2.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 128,435 | USD 7,560,968-1.0% | USD 58.87-1.0% | |
| RNA (Avidity Biosciences Inc) | 100,737 | USD 7,260,1160.0% | USD 72.070.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,619 | USD 7,083,5470.7% | USD 174.390.7% | |
| BNTX (BioNTech SE) | 67,594 | USD 6,546,4790.2% | USD 96.850.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,797 | USD 5,800,112-5.8% | USD 63.88-5.8% | |
| AXSM (Axsome Therapeutics Inc) | 33,707 | USD 5,780,413-4.0% | USD 171.49-4.0% | |
| HALO (Halozyme Therapeutics Inc) | 78,618 | USD 5,597,6021.3% | USD 71.21.3% | |
| CYTK (Cytokinetics Inc) | 81,741 | USD 5,007,454-0.8% | USD 61.26-0.8% | |
| KRYS (Krystal Biotech Inc) | 19,387 | USD 4,744,193-0.9% | USD 244.71-0.9% | |
| NUVL (Nuvalent Inc) | 48,102 | USD 4,711,110-2.9% | USD 97.94-2.9% | |
| PRAX (Praxis Precision Medicines Inc) | 16,717 | USD 4,629,272-3.3% | USD 276.92-3.3% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,614 | USD 4,544,382-3.0% | USD 101.86-3.0% | |
| PTCT (PTC Therapeutics Inc) | 53,675 | USD 4,120,0930.0% | USD 76.760.0% | |
| PCVX (Vaxcyte Inc) | 87,512 | USD 4,028,177-0.9% | USD 46.03-0.9% | |
| PTGX (Protagonist Therapeutics Inc) | 41,797 | USD 3,518,471-3.4% | USD 84.18-3.4% | |
| COGT (Cogent Biosciences Inc) | 102,623 | USD 3,515,864-1.4% | USD 34.26-1.4% | |
| CRSP (Crispr Therapeutics AG) | 63,715 | USD 3,513,8822.6% | USD 55.152.6% | |
| KYMR (Kymera Therapeutics Inc) | 48,100 | USD 3,482,921-0.5% | USD 72.41-0.5% | |
| ALKS (Alkermes Plc) | 110,386 | USD 3,090,808-0.9% | USD 28-0.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,435 | USD 3,056,2983.1% | USD 48.183.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 113,107 | USD 2,957,748-0.5% | USD 26.15-0.5% | |
| SRRK (Scholar Rock Holding Corp) | 68,959 | USD 2,948,687-0.1% | USD 42.76-0.1% | |
| FOLD (Amicus Therapeutics Inc) | 206,257 | USD 2,939,162-0.1% | USD 14.25-0.1% | |
| IMVT (Immunovant Inc) | 117,176 | USD 2,925,885-3.6% | USD 24.97-3.6% | |
| ADMA (ADMA Biologics Inc) | 159,103 | USD 2,868,6270.8% | USD 18.030.8% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,661 | USD 2,841,5942.3% | USD 77.512.3% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,671 | USD 2,803,999-7.9% | USD 62.77-7.9% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 210,154 | USD 2,671,0570.4% | USD 12.710.4% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,358 | USD 2,596,090-3.2% | USD 75.56-3.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,154 | USD 2,525,9631.0% | USD 192.031.0% | |
| GRAL (GRAIL, LLC) | 25,952 | USD 2,484,9047.7% | USD 95.757.7% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,886 | USD 2,472,9574.1% | USD 30.24.1% | |
| ACLX (Arcellx Inc) | 38,656 | USD 2,390,100-2.4% | USD 61.83-2.4% | |
| VCYT (Veracyte Inc) | 52,847 | USD 2,305,7152.9% | USD 43.632.9% | |
| TVTX (Travere Therapeutics Inc) | 59,818 | USD 2,279,664-3.6% | USD 38.11-3.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,379 | USD 2,263,225-1.3% | USD 79.75-1.3% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,664 | USD 2,159,039-6.1% | USD 41.79-6.1% | |
| CGON (CG Oncology, Inc. Common stock) | 53,666 | USD 2,148,787-4.2% | USD 40.04-4.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,585 | USD 2,103,629-3.8% | USD 24.87-3.8% | |
| IDYA (Ideaya Biosciences Inc) | 58,612 | USD 2,047,9033.2% | USD 34.943.2% | |
| VERA (Vera Therapeutics Inc) | 42,743 | USD 2,011,913-3.2% | USD 47.07-3.2% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,336 | USD 1,893,798-0.1% | USD 49.4-0.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,909 | USD 1,886,735-0.1% | USD 35.66-0.1% | |
| BEAM (Beam Therapeutics Inc) | 67,839 | USD 1,820,799-1.1% | USD 26.84-1.1% | |
| DYN (Dyne Therapeutics Inc) | 95,474 | USD 1,740,491-1.5% | USD 18.23-1.5% | |
| WVE (Wave Life Sciences Ltd) | 111,756 | USD 1,676,340-6.0% | USD 15-6.0% | |
| EWTX (Edgewise Therapeutics Inc) | 70,774 | USD 1,668,143-0.8% | USD 23.57-0.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 102,058 | USD 1,650,2781.6% | USD 16.171.6% | |
| OCUL (Ocular Therapeutix Inc) | 142,413 | USD 1,644,870-2.3% | USD 11.55-2.3% | |
| DNLI (Denali Therapeutics Inc) | 98,041 | USD 1,570,617-1.5% | USD 16.02-1.5% | |
| SYRE (Spyre Therapeutics Inc.) | 51,870 | USD 1,554,025-2.0% | USD 29.96-2.0% | |
| RXRX (Recursion Pharmaceuticals Inc) | 343,714 | USD 1,502,0304.0% | USD 4.374.0% | |
| SRPT (Sarepta Therapeutics Inc) | 71,146 | USD 1,499,046-1.1% | USD 21.07-1.1% | |
| RARE (Ultragenyx) | 64,500 | USD 1,490,595-2.1% | USD 23.11-2.1% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,500 | USD 1,484,790-2.8% | USD 23.02-2.8% | |
| TXG (10X Genomics Inc) | 77,860 | USD 1,426,39510.2% | USD 18.3210.2% | |
| HRMY (Harmony Biosciences Holdings) | 38,501 | USD 1,414,912-1.7% | USD 36.75-1.7% | |
| TWST (Twist Bioscience Corp) | 40,881 | USD 1,403,8546.0% | USD 34.346.0% | |
| IBRX (Immunitybio Inc) | 658,054 | USD 1,368,7523.0% | USD 2.083.0% | |
| HROW (Harrow Health Inc) | 24,757 | USD 1,356,6849.8% | USD 54.89.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 88,132 | USD 1,348,420-0.3% | USD 15.3-0.3% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,579 | USD 1,319,733-0.7% | USD 25.1-0.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,025 | USD 1,274,637-4.3% | USD 25.48-4.3% | |
| VCEL (Vericel Corp Ord) | 33,807 | USD 1,253,5644.1% | USD 37.084.1% | |
| STOK (Stoke Therapeutics Inc) | 38,184 | USD 1,242,8895.3% | USD 32.555.3% | |
| GMAB (Genmab AS) | 39,077 | USD 1,242,649-0.1% | USD 31.8-0.1% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,164 | USD 1,238,534-2.2% | USD 41.06-2.2% | |
| DVAX (Dynavax Technologies Corporation) | 78,488 | USD 1,209,5000.2% | USD 15.410.2% | |
| NRIX (Nurix Therapeutics Inc) | 67,766 | USD 1,185,227-3.2% | USD 17.49-3.2% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,014 | USD 1,181,0010.3% | USD 78.660.3% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,096 | USD 1,174,701-5.1% | USD 20.22-5.1% | |
| MNKD (MannKind Corp) | 205,254 | USD 1,153,5270.4% | USD 5.620.4% | |
| LEGN (Legend Biotech Corp) | 56,292 | USD 1,143,291-5.6% | USD 20.31-5.6% | |
| AGIO (Agios Pharm) | 38,982 | USD 1,070,0561.0% | USD 27.451.0% | |
| PHVS (Pharvaris BV) | 42,820 | USD 1,065,362-6.0% | USD 24.88-6.0% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,730 | USD 1,042,809-1.2% | USD 7.41-1.2% | |
| NVCR (Novocure Ltd) | 74,856 | USD 1,030,7675.0% | USD 13.775.0% | |
| FTRE (Fortrea Holdings Inc.) | 61,668 | USD 1,024,922-1.1% | USD 16.62-1.1% | |
| INVA (Innoviva Inc) | 49,979 | USD 1,001,0790.8% | USD 20.030.8% | |
| ARDX (Ardelyx Inc) | 162,406 | USD 989,053-1.0% | USD 6.09-1.0% | |
| PGEN (Precigen Inc) | 236,498 | USD 988,562-2.3% | USD 4.18-2.3% | |
| COLL (Collegium Pharmaceutical Inc) | 21,135 | USD 965,4470.3% | USD 45.680.3% | |
| IMCR (Immunocore Holdings Ltd) | 29,131 | USD 954,040-3.0% | USD 32.75-3.0% | |
| QURE (Uniqure NV) | 41,643 | USD 942,381-3.2% | USD 22.63-3.2% | |
| RLAY (Relay Therapeutics Inc) | 115,847 | USD 910,557-3.9% | USD 7.86-3.9% | |
| TSHA (Taysha Gene Therapies Inc) | 183,095 | USD 895,335-6.9% | USD 4.89-6.9% | |
| MNMD (Mind Medicine Inc) | 65,850 | USD 894,243-0.4% | USD 13.58-0.4% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,407 | USD 836,106-0.3% | USD 11.39-0.3% | |
| AMPH (Amphastar P) | 30,716 | USD 820,7321.0% | USD 26.721.0% | |
| TNGX (Tango Therapeutics Inc) | 90,010 | USD 801,989-0.2% | USD 8.91-0.2% | |
| ANAB (AnaptysBio Inc) | 18,512 | USD 799,718-3.9% | USD 43.2-3.9% | |
| SVRA (Savara Inc) | 136,002 | USD 788,8122.8% | USD 5.82.8% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,896 | USD 786,253-3.5% | USD 7.09-3.5% | |
| NVAX (Novavax Inc) | 108,384 | USD 785,7841.7% | USD 7.251.7% | |
| CSTL (Castle Biosciences Inc) | 19,505 | USD 760,6951.2% | USD 391.2% | |
| GRFS (Grifols SA ADR) | 81,534 | USD 759,8970.9% | USD 9.320.9% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,556 | USD 752,8110.8% | USD 15.830.8% | |
| SPRY (Silverback Therapeutics Inc) | 66,072 | USD 724,810-4.5% | USD 10.97-4.5% | |
| NTLA (Intellia Therapeutics Inc) | 77,048 | USD 721,9401.7% | USD 9.371.7% | |
| PCRX (Pacira BioSciences, Inc.) | 28,761 | USD 721,9012.6% | USD 25.12.6% | |
| SANA (Sana Biotechnology Inc) | 177,061 | USD 718,868-3.1% | USD 4.06-3.1% | |
| URGN (UroGen Pharma Ltd) | 31,292 | USD 692,492-2.6% | USD 22.13-2.6% | |
| ABCL (Abcellera Biologics Inc) | 198,721 | USD 681,613 | USD 3.43 | |
| XNCR (Xencor Inc) | 47,732 | USD 681,136-4.4% | USD 14.27-4.4% | |
| ERAS (Erasca Inc) | 189,613 | USD 661,749-2.8% | USD 3.49-2.8% | |
| IOVA (Iovance Biotherapeutics Inc) | 251,677 | USD 616,609-2.8% | USD 2.45-2.8% | |
| TBPH (Theravance Biopharma Inc) | 33,268 | USD 612,7971.5% | USD 18.421.5% | |
| ABUS (Arbutus Biopharma Corp) | 128,536 | USD 605,405-1.3% | USD 4.71-1.3% | |
| ELVN (Enliven Therapeutics Inc.) | 39,171 | USD 595,791-2.1% | USD 15.21-2.1% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,067 | USD 573,423-3.4% | USD 8.55-3.4% | |
| KURA (Kura Oncology Inc) | 58,156 | USD 554,808-7.7% | USD 9.54-7.7% | |
| RAPT (RAPT Therapeutics Inc) | 18,527 | USD 552,475-6.4% | USD 29.82-6.4% | |
| GERN (Geron Corporation) | 416,758 | USD 550,121 | USD 1.32 | |
| PAHC (Phibro Animal Health Corporation) | 14,245 | USD 546,5812.9% | USD 38.372.9% | |
| JANX (Janux Therapeutics Inc) | 39,412 | USD 541,9150.7% | USD 13.750.7% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,789 | USD 529,1361.3% | USD 15.661.3% | |
| VIR (Vir Biotechnology Inc) | 90,665 | USD 524,950-2.5% | USD 5.79-2.5% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,421 | USD 516,881-0.2% | USD 8.15-0.2% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,695 0.2% | USD 498,9107.7% | USD 4.597.5% | |
| ARVN (Arvinas Inc) | 42,926 | USD 479,483-2.6% | USD 11.17-2.6% | |
| ZLAB (Zai Lab Ltd) | 26,163 | USD 473,2894.4% | USD 18.094.4% | |
| RGNX (Regenxbio Inc) | 33,829 | USD 453,309-1.3% | USD 13.4-1.3% | |
| PRME (Prime Medicine, Inc. Common Stock) | 124,070 | USD 442,9301.1% | USD 3.571.1% | |
| REPL (Replimune Group Inc) | 52,146 | USD 439,069-5.4% | USD 8.41999-5.4% | |
| PACB (Pacific Biosciences of California) | 201,719 | USD 399,4047.6% | USD 1.987.6% | |
| FULC (Fulcrum Therapeutics Inc) | 36,172 | USD 392,104-0.7% | USD 10.84-0.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,709 | USD 390,403-3.3% | USD 7.55-3.3% | |
| CGEM (Cullinan Oncology LLC) | 38,795 | USD 387,562-1.3% | USD 9.99-1.3% | |
| LYEL (Lyell Immunopharma Inc) | 13,637 | USD 381,972-3.3% | USD 28.01-3.3% | |
| VTYX (Ventyx Biosciences Inc) | 47,684 | USD 372,889-6.9% | USD 7.82-6.9% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,897 | USD 367,24011.5% | USD 3.7911.5% | |
| KROS (Keros Therapeutics Inc) | 20,362 | USD 364,887-3.3% | USD 17.92-3.3% | |
| PRTA (Prothena Corporation plc) | 38,990 | USD 354,809-1.1% | USD 9.1-1.1% | |
| SIGA (SIGA Technologies Inc) | 49,990 | USD 319,4361.9% | USD 6.391.9% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,078 | USD 307,544-4.6% | USD 7.87-4.6% | |
| GLPG (Galapagos NV ADR) | 9,328 | USD 305,399-0.7% | USD 32.74-0.7% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,954 | USD 269,6372.6% | USD 3.552.6% | |
| TRDA (Entrada Therapeutics Inc) | 25,164 | USD 264,2224.5% | USD 10.54.5% | |
| EOLS (Evolus Inc) | 43,313 | USD 262,044-10.0% | USD 6.05001-10.0% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,526 | USD 259,340-0.3% | USD 7.30001-0.3% | |
| ACIU (AC Immune Ltd) | 71,092 | USD 250,2444.8% | USD 3.524.8% | |
| AVXL (Anavex Life Sciences Corp) | 61,073 | USD 241,2387.3% | USD 3.949997.3% | |
| AUTL (Autolus Therapeutics Ltd) | 126,419 | USD 235,139-0.5% | USD 1.86-0.5% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,697 | USD 222,737-1.0% | USD 6.60999-1.0% | |
| ALLO (Allogene Therapeutics Inc) | 155,919 | USD 210,491 | USD 1.35 | |
| AVIR (Atea Pharmaceuticals Inc) | 59,657 | USD 203,430-2.0% | USD 3.40999-2.0% | |
| ACRS (Aclaris Therapeutics Inc) | 72,365 | USD 191,767-8.0% | USD 2.65-8.0% | |
| OABI (OmniAb Inc.) | 87,819 | USD 162,465-1.6% | USD 1.85-1.6% | |
| VYGR (Voyager Therapeutics Inc) | 36,618 | USD 149,4011.2% | USD 4.079991.2% | |
| CABA (Cabaletta Bio Inc) | 64,284 | USD 141,425-0.5% | USD 2.2-0.5% | |
| EDIT (Editas Medicine Inc) | 68,251 | USD 135,819-2.9% | USD 1.98999-2.9% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,287 | USD 129,2281.9% | USD 6.369991.9% | |
| HUMA (Humacyte Inc) | 115,782 | USD 122,7298.7% | USD 1.068.7% | |
| CRBU (Caribou Biosciences Inc) | 62,421 | USD 100,4981.3% | USD 1.611.3% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 167,670 0.2% | USD 75,808,6370.0% | USD 452.13-0.3% | |
| AMGN (Amgen Inc) | 210,449 0.2% | USD 68,951,5100.3% | USD 327.640.1% | |
| REGN (Regeneron Pharmaceuticals Inc) | 69,045 0.2% | USD 53,600,3240.8% | USD 776.310.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,331 0.2% | USD 35,347,4160.9% | USD 400.170.6% | |
| INSM (Insmed Inc) | 142,580 0.2% | USD 25,253,7702.0% | USD 177.121.8% | |
| BIIB (Biogen Inc) | 98,078 0.2% | USD 17,440,2301.3% | USD 177.821.0% | |
| ARGX (argenx NV ADR) | 19,465 0.2% | USD 16,350,4050.1% | USD 839.99-0.1% | |
| UTHR (United Therapeutics Corporation) | 28,785 0.2% | USD 14,298,0852.2% | USD 496.721.9% | |
| ILMN (Illumina Inc) | 102,150 0.2% | USD 13,723,8532.7% | USD 134.352.4% | |
| INCY (Incyte Corporation) | 131,254 0.2% | USD 13,311,7812.9% | USD 101.422.7% | |
| RPRX (Royalty Pharma Plc) | 285,628 0.2% | USD 11,099,5040.8% | USD 38.860.6% | |
| MEDP (Medpace Holdings Inc) | 18,830 0.2% | USD 10,752,3071.9% | USD 571.021.7% | |
| RVMD (Revolution Medicines Inc) | 129,239 0.2% | USD 10,212,466-0.6% | USD 79.02-0.8% | |
| ROIV (Roivant Sciences Ltd) | 464,963 0.2% | USD 10,196,6391.3% | USD 21.931.1% | |
| BBIO (BridgeBio Pharma Inc) | 128,831 0.2% | USD 10,079,0932.5% | USD 78.2352.3% | |
| VTRS (Viatris Inc) | 770,001 0.2% | USD 9,594,2120.3% | USD 12.460.1% | |
| NBIX (Neurocrine Biosciences Inc) | 66,658 0.2% | USD 9,372,115-0.6% | USD 140.6-0.9% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,187 0.2% | USD 9,019,1042.2% | USD 593.872.0% | |
| GH (Guardant Health Inc) | 86,495 0.2% | USD 8,800,001-0.2% | USD 101.74-0.4% | |
| ASND (Ascendis Pharma AS) | 41,053 0.2% | USD 8,756,1940.3% | USD 213.290.0% | |
| SMMT (Summit Therapeutics PLC) | 497,690 0.2% | USD 8,719,5290.4% | USD 17.520.2% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,286 0.2% | USD 8,627,1460.9% | USD 79.670.7% | |
| SNY (Sanofi ADR) | 176,908 0.2% | USD 8,532,273-0.2% | USD 48.23-0.5% | |
| MRNA (Moderna Inc) | 261,182 0.2% | USD 8,060,0774.9% | USD 30.864.6% | |
| EXEL (Exelixis Inc) | 179,244 0.2% | USD 7,811,454-0.3% | USD 43.58-0.6% | |
| BMRN (Biomarin Pharmaceutical Inc) | 128,435 0.2% | USD 7,635,4610.3% | USD 59.450.0% | |
| RNA (Avidity Biosciences Inc) | 100,737 0.2% | USD 7,263,1380.2% | USD 72.10.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,619 0.2% | USD 7,033,1802.1% | USD 173.151.9% | |
| BNTX (BioNTech SE) | 67,594 0.2% | USD 6,535,6641.8% | USD 96.691.6% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,797 0.2% | USD 6,155,1292.3% | USD 67.792.1% | |
| AXSM (Axsome Therapeutics Inc) | 33,707 0.2% | USD 6,023,104-1.9% | USD 178.69-2.2% | |
| HALO (Halozyme Therapeutics Inc) | 78,618 0.2% | USD 5,527,6324.7% | USD 70.314.5% | |
| CYTK (Cytokinetics Inc) | 81,741 0.2% | USD 5,045,872-2.6% | USD 61.73-2.8% | |
| NUVL (Nuvalent Inc) | 48,102 0.2% | USD 4,850,6060.5% | USD 100.840.2% | |
| PRAX (Praxis Precision Medicines Inc) | 16,717 0.2% | USD 4,787,749-2.6% | USD 286.4-2.8% | |
| KRYS (Krystal Biotech Inc) | 19,387 0.2% | USD 4,786,8440.4% | USD 246.910.2% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,614 0.2% | USD 4,684,916-1.7% | USD 105.01-1.9% | |
| PTCT (PTC Therapeutics Inc) | 53,675 0.2% | USD 4,119,0201.3% | USD 76.741.0% | |
| PCVX (Vaxcyte Inc) | 87,512 0.2% | USD 4,065,8080.9% | USD 46.460.7% | |
| PTGX (Protagonist Therapeutics Inc) | 41,797 0.2% | USD 3,643,8620.0% | USD 87.18-0.2% | |
| COGT (Cogent Biosciences Inc) | 102,623 0.2% | USD 3,565,123-2.0% | USD 34.74-2.2% | |
| KYMR (Kymera Therapeutics Inc) | 48,100 0.2% | USD 3,499,756-6.3% | USD 72.76-6.5% | |
| CRSP (Crispr Therapeutics AG) | 63,715 0.2% | USD 3,425,9562.8% | USD 53.772.5% | |
| ALKS (Alkermes Plc) | 110,386 0.2% | USD 3,119,5081.2% | USD 28.261.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,671 0.2% | USD 3,042,989-1.8% | USD 68.12-2.1% | |
| IMVT (Immunovant Inc) | 117,176 0.2% | USD 3,036,0302.2% | USD 25.911.9% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 113,107 0.2% | USD 2,973,583-1.3% | USD 26.29-1.6% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,435 0.2% | USD 2,964,3180.6% | USD 46.730.4% | |
| SRRK (Scholar Rock Holding Corp) | 68,959 0.2% | USD 2,951,445-2.6% | USD 42.8-2.8% | |
| FOLD (Amicus Therapeutics Inc) | 206,257 0.2% | USD 2,943,2870.4% | USD 14.270.2% | |
| ADMA (ADMA Biologics Inc) | 159,103 0.2% | USD 2,844,762-1.7% | USD 17.88-2.0% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,661 0.2% | USD 2,778,1710.6% | USD 75.780.4% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,358 0.2% | USD 2,682,329-0.9% | USD 78.07-1.2% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 210,154 0.2% | USD 2,660,5500.7% | USD 12.660.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,154 0.2% | USD 2,500,7070.8% | USD 190.110.6% | |
| ACLX (Arcellx Inc) | 38,656 0.2% | USD 2,448,471-2.6% | USD 63.34-2.9% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,886 0.2% | USD 2,374,6940.1% | USD 29-0.1% | |
| TVTX (Travere Therapeutics Inc) | 59,818 0.2% | USD 2,364,0073.7% | USD 39.523.4% | |
| GRAL (GRAIL, LLC) | 25,952 0.2% | USD 2,306,3544.1% | USD 88.873.8% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,664 0.2% | USD 2,298,531-0.5% | USD 44.49-0.7% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,379 0.2% | USD 2,292,172-1.1% | USD 80.77-1.4% | |
| CGON (CG Oncology, Inc. Common stock) | 53,666 0.2% | USD 2,242,7020.9% | USD 41.790.7% | |
| VCYT (Veracyte Inc) | 52,847 0.2% | USD 2,240,1840.9% | USD 42.390.7% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,585 0.2% | USD 2,187,3683.2% | USD 25.862.9% | |
| VERA (Vera Therapeutics Inc) | 42,743 0.2% | USD 2,078,165-3.8% | USD 48.62-4.0% | |
| IDYA (Ideaya Biosciences Inc) | 58,612 0.2% | USD 1,984,016-1.9% | USD 33.85-2.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,336 0.2% | USD 1,896,482-0.2% | USD 49.47-0.5% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,909 0.2% | USD 1,889,380-1.4% | USD 35.71-1.6% | |
| BEAM (Beam Therapeutics Inc) | 67,839 0.2% | USD 1,841,150-1.9% | USD 27.14-2.1% | |
| WVE (Wave Life Sciences Ltd) | 111,756 0.2% | USD 1,782,508-6.0% | USD 15.95-6.2% | |
| DYN (Dyne Therapeutics Inc) | 95,474 0.2% | USD 1,766,269-5.2% | USD 18.5-5.4% | |
| OCUL (Ocular Therapeutix Inc) | 142,413 0.2% | USD 1,683,322-2.4% | USD 11.82-2.6% | |
| EWTX (Edgewise Therapeutics Inc) | 70,774 0.2% | USD 1,680,883-4.1% | USD 23.75-4.3% | |
| ADPT (Adaptive Biotechnologies Corp) | 102,058 0.2% | USD 1,623,743-1.8% | USD 15.91-2.0% | |
| DNLI (Denali Therapeutics Inc) | 98,041 0.2% | USD 1,595,127-1.2% | USD 16.27-1.5% | |
| SYRE (Spyre Therapeutics Inc.) | 51,870 0.2% | USD 1,586,185-6.4% | USD 30.58-6.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,500 0.2% | USD 1,528,005-5.1% | USD 23.69-5.3% | |
| RARE (Ultragenyx) | 64,500 0.2% | USD 1,522,2002.8% | USD 23.62.6% | |
| SRPT (Sarepta Therapeutics Inc) | 71,146 0.2% | USD 1,516,121-0.7% | USD 21.31-1.0% | |
| RXRX (Recursion Pharmaceuticals Inc) | 343,714 0.2% | USD 1,443,5992.9% | USD 4.22.7% | |
| HRMY (Harmony Biosciences Holdings) | 38,501 0.2% | USD 1,439,1670.1% | USD 37.38-0.1% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 88,132 0.2% | USD 1,352,826-3.5% | USD 15.35-3.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 50,025 0.2% | USD 1,331,6661.3% | USD 26.621.1% | |
| IBRX (Immunitybio Inc) | 658,054 0.2% | USD 1,329,2692.3% | USD 2.022.0% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,579 0.2% | USD 1,329,1971.4% | USD 25.281.1% | |
| TWST (Twist Bioscience Corp) | 40,881 0.2% | USD 1,324,1362.4% | USD 32.392.1% | |
| TXG (10X Genomics Inc) | 77,860 0.2% | USD 1,294,0332.1% | USD 16.621.9% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,164 0.2% | USD 1,267,0392.1% | USD 42.0051.8% | |
| GMAB (Genmab AS) | 39,077 0.2% | USD 1,243,4303.6% | USD 31.823.3% | |
| SNDX (Syndax Pharmaceuticals Inc) | 58,096 0.2% | USD 1,237,4451.6% | USD 21.31.4% | |
| HROW (Harrow Health Inc) | 24,757 0.2% | USD 1,235,6222.1% | USD 49.911.9% | |
| NRIX (Nurix Therapeutics Inc) | 67,766 0.2% | USD 1,223,854-4.6% | USD 18.06-4.8% | |
| LEGN (Legend Biotech Corp) | 56,292 0.2% | USD 1,210,841-0.8% | USD 21.51-1.1% | |
| DVAX (Dynavax Technologies Corporation) | 78,488 0.2% | USD 1,207,1450.2% | USD 15.38 | |
| VCEL (Vericel Corp Ord) | 33,807 0.2% | USD 1,203,867-0.9% | USD 35.61-1.1% | |
| STOK (Stoke Therapeutics Inc) | 38,184 0.2% | USD 1,179,886-2.4% | USD 30.9-2.6% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,014 0.2% | USD 1,177,548-0.4% | USD 78.43-0.6% | |
| MNKD (MannKind Corp) | 205,254 0.2% | USD 1,149,422-1.0% | USD 5.6-1.2% | |
| PHVS (Pharvaris BV) | 42,820 0.2% | USD 1,133,874-4.4% | USD 26.48-4.6% | |
| AGIO (Agios Pharm) | 38,982 0.2% | USD 1,059,5310.1% | USD 27.18-0.1% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,730 0.2% | USD 1,055,475-3.6% | USD 7.5-3.8% | |
| FTRE (Fortrea Holdings Inc.) | 61,668 0.2% | USD 1,036,639-2.3% | USD 16.81-2.6% | |
| PGEN (Precigen Inc) | 236,498 0.2% | USD 1,012,2112.6% | USD 4.282.4% | |
| ARDX (Ardelyx Inc) | 162,406 0.2% | USD 998,7975.7% | USD 6.155.5% | |
| INVA (Innoviva Inc) | 49,979 0.2% | USD 993,083-0.4% | USD 19.87-0.6% | |
| IMCR (Immunocore Holdings Ltd) | 29,131 0.2% | USD 984,045-2.5% | USD 33.78-2.7% | |
| NVCR (Novocure Ltd) | 74,856 0.2% | USD 982,1111.7% | USD 13.121.5% | |
| QURE (Uniqure NV) | 41,643 0.2% | USD 974,030-2.0% | USD 23.39-2.3% | |
| COLL (Collegium Pharmaceutical Inc) | 21,135 0.2% | USD 962,277-1.4% | USD 45.53-1.7% | |
| TSHA (Taysha Gene Therapies Inc) | 183,095 0.2% | USD 961,249-4.3% | USD 5.25-4.5% | |
| RLAY (Relay Therapeutics Inc) | 115,847 0.2% | USD 947,628-3.1% | USD 8.18-3.3% | |
| MNMD (Mind Medicine Inc) | 65,850 0.2% | USD 898,1942.1% | USD 13.641.9% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,407 0.2% | USD 838,308-5.2% | USD 11.42-5.5% | |
| ANAB (AnaptysBio Inc) | 18,512 0.2% | USD 832,114-7.1% | USD 44.95-7.3% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,896 0.2% | USD 815,086-6.1% | USD 7.35-6.4% | |
| AMPH (Amphastar P) | 30,716 0.2% | USD 812,745-1.0% | USD 26.46-1.2% | |
| TNGX (Tango Therapeutics Inc) | 90,010 0.2% | USD 803,7891.0% | USD 8.930.8% | |
| NVAX (Novavax Inc) | 108,384 0.2% | USD 772,7786.4% | USD 7.136.1% | |
| SVRA (Savara Inc) | 136,002 0.2% | USD 767,051-6.2% | USD 5.64-6.5% | |
| SPRY (Silverback Therapeutics Inc) | 66,072 0.2% | USD 759,167-1.1% | USD 11.49-1.4% | |
| GRFS (Grifols SA ADR) | 81,534 0.2% | USD 753,374-0.9% | USD 9.24-1.2% | |
| CSTL (Castle Biosciences Inc) | 19,505 0.2% | USD 751,723-0.7% | USD 38.54-0.9% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,556 0.2% | USD 747,105-5.1% | USD 15.71-5.3% | |
| SANA (Sana Biotechnology Inc) | 177,061 0.2% | USD 741,8863.2% | USD 4.192.9% | |
| XNCR (Xencor Inc) | 47,732 0.2% | USD 712,161-2.3% | USD 14.92-2.5% | |
| URGN (UroGen Pharma Ltd) | 31,292 0.2% | USD 710,641-2.8% | USD 22.71-3.0% | |
| NTLA (Intellia Therapeutics Inc) | 77,048 0.2% | USD 709,6122.7% | USD 9.212.4% | |
| PCRX (Pacira BioSciences, Inc.) | 28,761 0.2% | USD 703,494-5.3% | USD 24.46-5.5% | |
| ABCL (Abcellera Biologics Inc) | 198,721 0.2% | USD 681,6130.5% | USD 3.430.3% | |
| ERAS (Erasca Inc) | 189,613 0.2% | USD 680,711-3.3% | USD 3.59-3.5% | |
| IOVA (Iovance Biotherapeutics Inc) | 251,677 0.2% | USD 634,226-7.5% | USD 2.52-7.7% | |
| ABUS (Arbutus Biopharma Corp) | 128,536 0.2% | USD 613,117-0.6% | USD 4.77-0.8% | |
| ELVN (Enliven Therapeutics Inc.) | 39,171 0.2% | USD 608,7171.1% | USD 15.540.9% | |
| TBPH (Theravance Biopharma Inc) | 33,268 0.2% | USD 603,814-2.8% | USD 18.15-3.0% | |
| KURA (Kura Oncology Inc) | 58,156 0.2% | USD 601,042-0.3% | USD 10.335-0.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 67,067 0.2% | USD 593,543-4.8% | USD 8.85-5.0% | |
| RAPT (RAPT Therapeutics Inc) | 18,527 0.2% | USD 590,085-5.7% | USD 31.85-6.0% | |
| GERN (Geron Corporation) | 416,758 0.2% | USD 550,1210.2% | USD 1.32 | |
| VIR (Vir Biotechnology Inc) | 90,665 0.2% | USD 538,550-1.3% | USD 5.94-1.5% | |
| JANX (Janux Therapeutics Inc) | 39,412 0.2% | USD 537,974-0.9% | USD 13.65-1.1% | |
| PAHC (Phibro Animal Health Corporation) | 14,245 0.2% | USD 531,3390.1% | USD 37.3-0.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,789 0.2% | USD 522,378-4.0% | USD 15.46-4.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,421 0.2% | USD 518,1500.1% | USD 8.17001-0.1% | |
| ARVN (Arvinas Inc) | 42,926 0.2% | USD 492,361-3.1% | USD 11.47-3.3% | |
| REPL (Replimune Group Inc) | 52,146 0.2% | USD 464,099-8.2% | USD 8.89999-8.4% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,438 | USD 463,03026.7% | USD 4.2726.7% | |
| RGNX (Regenxbio Inc) | 33,829 0.2% | USD 459,060-5.5% | USD 13.57-5.8% | |
| ZLAB (Zai Lab Ltd) | 26,163 0.2% | USD 453,405-1.5% | USD 17.33-1.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 124,070 0.2% | USD 437,9672.0% | USD 3.531.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,709 0.2% | USD 403,847-1.5% | USD 7.80999-1.8% | |
| VTYX (Ventyx Biosciences Inc) | 47,684 0.2% | USD 400,546-6.8% | USD 8.40001-7.0% | |
| LYEL (Lyell Immunopharma Inc) | 13,637 0.2% | USD 395,200-5.6% | USD 28.98-5.8% | |
| FULC (Fulcrum Therapeutics Inc) | 36,172 0.2% | USD 394,998-3.2% | USD 10.92-3.4% | |
| CGEM (Cullinan Oncology LLC) | 38,795 0.2% | USD 392,605-2.0% | USD 10.12-2.2% | |
| KROS (Keros Therapeutics Inc) | 20,362 0.2% | USD 377,511-8.7% | USD 18.54-8.9% | |
| PACB (Pacific Biosciences of California) | 201,719 0.2% | USD 371,163-1.4% | USD 1.84-1.6% | |
| PRTA (Prothena Corporation plc) | 38,990 0.2% | USD 358,708-3.4% | USD 9.2-3.7% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,897 0.2% | USD 329,4504.9% | USD 3.44.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 39,078 0.2% | USD 322,394-6.2% | USD 8.25001-6.5% | |
| SIGA (SIGA Technologies Inc) | 49,990 0.2% | USD 313,4372.9% | USD 6.269992.6% | |
| GLPG (Galapagos NV ADR) | 9,328 0.2% | USD 307,5441.1% | USD 32.970.8% | |
| EOLS (Evolus Inc) | 43,313 0.2% | USD 291,0631.3% | USD 6.719991.1% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,954 0.2% | USD 262,801-1.2% | USD 3.46-1.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,526 0.2% | USD 260,050-2.2% | USD 7.31999-2.4% | |
| TRDA (Entrada Therapeutics Inc) | 25,164 0.2% | USD 252,898-2.0% | USD 10.05-2.2% | |
| ACIU (AC Immune Ltd) | 71,092 0.2% | USD 238,8697.3% | USD 3.367.0% | |
| AUTL (Autolus Therapeutics Ltd) | 126,419 0.2% | USD 236,404-5.8% | USD 1.87-6.0% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,697 0.2% | USD 225,096-5.4% | USD 6.68-5.6% | |
| AVXL (Anavex Life Sciences Corp) | 61,073 0.2% | USD 224,7493.6% | USD 3.680013.4% | |
| ALLO (Allogene Therapeutics Inc) | 155,919 0.2% | USD 210,491-1.2% | USD 1.35-1.5% | |
| ACRS (Aclaris Therapeutics Inc) | 72,365 0.2% | USD 208,411-4.1% | USD 2.88-4.3% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,657 0.2% | USD 207,606-2.3% | USD 3.47999-2.5% | |
| OABI (OmniAb Inc.) | 87,819 0.2% | USD 165,1001.9% | USD 1.881.6% | |
| VYGR (Voyager Therapeutics Inc) | 36,618 0.2% | USD 147,5712.8% | USD 4.030012.5% | |
| CABA (Cabaletta Bio Inc) | 64,284 0.2% | USD 142,0681.2% | USD 2.210010.9% | |
| EDIT (Editas Medicine Inc) | 68,251 0.2% | USD 139,9150.2% | USD 2.050010.0% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,287 0.2% | USD 126,7942.2% | USD 6.250012.0% | |
| HUMA (Humacyte Inc) | 115,782 0.2% | USD 112,8871.8% | USD 0.9749961.5% | |
| CRBU (Caribou Biosciences Inc) | 62,421 0.2% | USD 99,2490.2% | USD 1.589990.0% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 167,280 | USD 75,838,061-0.1% | USD 453.36-0.1% | |
| AMGN (Amgen Inc) | 209,959 | USD 68,721,680-0.4% | USD 327.31-0.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,884 | USD 53,169,493-0.3% | USD 771.87-0.3% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,125 | USD 35,042,9060.1% | USD 397.650.1% | |
| INSM (Insmed Inc) | 142,248 | USD 24,756,8420.0% | USD 174.040.0% | |
| BIIB (Biogen Inc) | 97,850 | USD 17,220,622-0.2% | USD 175.99-0.2% | |
| ARGX (argenx NV ADR) | 19,420 | USD 16,331,2490.4% | USD 840.950.4% | |
| UTHR (United Therapeutics Corporation) | 28,718 | USD 13,992,846-1.8% | USD 487.25-1.8% | |
| ILMN (Illumina Inc) | 101,912 | USD 13,366,778-1.2% | USD 131.16-1.2% | |
| INCY (Incyte Corporation) | 130,949 | USD 12,933,833-0.1% | USD 98.77-0.1% | |
| RPRX (Royalty Pharma Plc) | 284,963 | USD 11,010,970-0.9% | USD 38.64-0.9% | |
| MEDP (Medpace Holdings Inc) | 18,786 | USD 10,551,157-1.3% | USD 561.65-1.3% | |
| RVMD (Revolution Medicines Inc) | 128,938 | USD 10,269,9120.0% | USD 79.650.0% | |
| ROIV (Roivant Sciences Ltd) | 463,881 | USD 10,066,2180.3% | USD 21.70.3% | |
| BBIO (BridgeBio Pharma Inc) | 128,531 | USD 9,831,3361.3% | USD 76.491.3% | |
| VTRS (Viatris Inc) | 768,209 | USD 9,564,202-0.7% | USD 12.45-0.7% | |
| NBIX (Neurocrine Biosciences Inc) | 66,503 | USD 9,432,1200.6% | USD 141.830.6% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,152 | USD 8,823,616-0.2% | USD 582.34-0.2% | |
| GH (Guardant Health Inc) | 86,294 | USD 8,814,0691.5% | USD 102.141.5% | |
| ASND (Ascendis Pharma AS) | 40,957 | USD 8,733,6711.9% | USD 213.241.9% | |
| SMMT (Summit Therapeutics PLC) | 496,532 | USD 8,684,345 | USD 17.49 | |
| SNY (Sanofi ADR) | 176,496 | USD 8,552,996-0.6% | USD 48.46-0.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,034 | USD 8,546,5700.2% | USD 79.110.2% | |
| EXEL (Exelixis Inc) | 178,827 | USD 7,837,987-0.5% | USD 43.83-0.5% | |
| MRNA (Moderna Inc) | 260,574 | USD 7,684,327-3.0% | USD 29.49-3.0% | |
| BMRN (Biomarin Pharmaceutical Inc) | 128,136 | USD 7,615,1220.7% | USD 59.430.7% | |
| RNA (Avidity Biosciences Inc) | 100,503 | USD 7,249,2810.0% | USD 72.130.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,524 | USD 6,889,080-0.5% | USD 170-0.5% | |
| BNTX (BioNTech SE) | 67,437 | USD 6,420,002-0.1% | USD 95.2-0.1% | |
| AXSM (Axsome Therapeutics Inc) | 33,629 | USD 6,142,00122.8% | USD 182.6422.8% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,586 | USD 6,014,005-1.3% | USD 66.39-1.3% | |
| HALO (Halozyme Therapeutics Inc) | 78,435 | USD 5,278,676-0.6% | USD 67.3-0.6% | |
| CYTK (Cytokinetics Inc) | 81,551 | USD 5,181,7513.5% | USD 63.543.5% | |
| PRAX (Praxis Precision Medicines Inc) | 16,678 | USD 4,915,674-0.8% | USD 294.74-0.8% | |
| NUVL (Nuvalent Inc) | 47,990 | USD 4,827,3140.2% | USD 100.590.2% | |
| KRYS (Krystal Biotech Inc) | 19,342 | USD 4,768,577-0.5% | USD 246.54-0.5% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,510 | USD 4,764,3500.3% | USD 107.040.3% | |
| PTCT (PTC Therapeutics Inc) | 53,550 | USD 4,067,658-0.3% | USD 75.96-0.3% | |
| PCVX (Vaxcyte Inc) | 87,308 | USD 4,028,3911.6% | USD 46.141.6% | |
| KYMR (Kymera Therapeutics Inc) | 47,988 | USD 3,733,946-0.4% | USD 77.81-0.4% | |
| PTGX (Protagonist Therapeutics Inc) | 41,700 | USD 3,642,0780.1% | USD 87.340.1% | |
| COGT (Cogent Biosciences Inc) | 102,384 | USD 3,636,680-4.3% | USD 35.52-4.3% | |
| CRSP (Crispr Therapeutics AG) | 63,567 | USD 3,333,453-1.4% | USD 52.44-1.4% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,567 | USD 3,099,6352.6% | USD 69.552.6% | |
| ALKS (Alkermes Plc) | 110,129 | USD 3,081,4090.6% | USD 27.980.6% | |
| SRRK (Scholar Rock Holding Corp) | 68,799 | USD 3,030,5961.0% | USD 44.051.0% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,844 | USD 3,014,0630.0% | USD 26.710.0% | |
| IMVT (Immunovant Inc) | 116,903 | USD 2,971,6740.3% | USD 25.420.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,287 | USD 2,946,010-1.8% | USD 46.55-1.8% | |
| FOLD (Amicus Therapeutics Inc) | 205,776 | USD 2,930,250-0.1% | USD 14.24-0.1% | |
| ADMA (ADMA Biologics Inc) | 158,732 | USD 2,895,272-0.7% | USD 18.24-0.7% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,576 | USD 2,760,756-0.4% | USD 75.48-0.4% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,278 | USD 2,707,6190.2% | USD 78.990.2% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,664 | USD 2,641,766-2.2% | USD 12.6-2.2% | |
| ACLX (Arcellx Inc) | 38,566 | USD 2,514,5032.5% | USD 65.22.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,123 | USD 2,481,166-0.6% | USD 189.07-0.6% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,695 | USD 2,372,4233.4% | USD 29.043.4% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,313 | USD 2,318,268-0.5% | USD 81.88-0.5% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,544 | USD 2,310,2021.6% | USD 44.821.6% | |
| TVTX (Travere Therapeutics Inc) | 59,679 | USD 2,280,3351.4% | USD 38.211.4% | |
| CGON (CG Oncology, Inc. Common stock) | 53,541 | USD 2,223,0223.4% | USD 41.523.4% | |
| VCYT (Veracyte Inc) | 52,724 | USD 2,219,680-0.4% | USD 42.1-0.4% | |
| GRAL (GRAIL, LLC) | 25,892 | USD 2,216,0960.3% | USD 85.590.3% | |
| VERA (Vera Therapeutics Inc) | 42,644 | USD 2,159,492-1.0% | USD 50.64-1.0% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,388 | USD 2,119,827-0.5% | USD 25.12-0.5% | |
| IDYA (Ideaya Biosciences Inc) | 58,476 | USD 2,021,5150.2% | USD 34.570.2% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,786 | USD 1,915,6042.2% | USD 36.292.2% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,247 | USD 1,900,876-0.4% | USD 49.7-0.4% | |
| WVE (Wave Life Sciences Ltd) | 111,496 | USD 1,895,432-0.9% | USD 17-0.9% | |
| BEAM (Beam Therapeutics Inc) | 67,681 | USD 1,876,117-0.4% | USD 27.72-0.4% | |
| DYN (Dyne Therapeutics Inc) | 95,252 | USD 1,863,1291.9% | USD 19.561.9% | |
| EWTX (Edgewise Therapeutics Inc) | 70,609 | USD 1,752,1621.1% | USD 24.8151.1% | |
| OCUL (Ocular Therapeutix Inc) | 142,081 | USD 1,724,863-0.5% | USD 12.14-0.5% | |
| SYRE (Spyre Therapeutics Inc.) | 51,749 | USD 1,695,2972.8% | USD 32.762.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,820 | USD 1,653,557-1.1% | USD 16.24-1.1% | |
| DNLI (Denali Therapeutics Inc) | 97,812 | USD 1,614,8760.6% | USD 16.510.6% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,350 | USD 1,609,3941.1% | USD 25.011.1% | |
| SRPT (Sarepta Therapeutics Inc) | 70,980 | USD 1,527,4900.1% | USD 21.520.1% | |
| RARE (Ultragenyx) | 64,350 | USD 1,480,0501.0% | USD 231.0% | |
| HRMY (Harmony Biosciences Holdings) | 38,411 | USD 1,437,340-0.6% | USD 37.42-0.6% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,911 | USD 1,402,506-0.5% | USD 4.09-0.5% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,926 | USD 1,402,4200.8% | USD 15.950.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,908 | USD 1,314,078-0.8% | USD 26.33-0.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,457 | USD 1,311,425-0.3% | USD 25-0.3% | |
| IBRX (Immunitybio Inc) | 656,515 | USD 1,299,900 | USD 1.98 | |
| TWST (Twist Bioscience Corp) | 40,786 | USD 1,293,732-1.3% | USD 31.72-1.3% | |
| NRIX (Nurix Therapeutics Inc) | 67,608 | USD 1,282,524-0.3% | USD 18.97-0.3% | |
| TXG (10X Genomics Inc) | 77,678 | USD 1,266,9280.1% | USD 16.310.1% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,094 | USD 1,241,3780.6% | USD 41.250.6% | |
| LEGN (Legend Biotech Corp) | 56,161 | USD 1,220,9401.0% | USD 21.741.0% | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,961 | USD 1,217,7611.3% | USD 21.011.3% | |
| VCEL (Vericel Corp Ord) | 33,728 | USD 1,214,545-2.0% | USD 36.01-2.0% | |
| HROW (Harrow Health Inc) | 24,699 | USD 1,210,251-2.0% | USD 49-2.0% | |
| STOK (Stoke Therapeutics Inc) | 38,095 | USD 1,209,135-0.3% | USD 31.74-0.3% | |
| DVAX (Dynavax Technologies Corporation) | 78,305 | USD 1,204,3310.1% | USD 15.380.1% | |
| GMAB (Genmab AS) | 38,986 | USD 1,200,769-2.2% | USD 30.8-2.2% | |
| PHVS (Pharvaris BV) | 42,720 | USD 1,185,4805.7% | USD 27.755.7% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,979 | USD 1,182,442-0.6% | USD 78.94-0.6% | |
| MNKD (MannKind Corp) | 204,774 | USD 1,161,0690.2% | USD 5.670.2% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,401 | USD 1,095,1281.8% | USD 7.81.8% | |
| FTRE (Fortrea Holdings Inc.) | 61,524 | USD 1,061,289-0.7% | USD 17.25-0.7% | |
| AGIO (Agios Pharm) | 38,891 | USD 1,058,613-0.4% | USD 27.22-0.4% | |
| IMCR (Immunocore Holdings Ltd) | 29,063 | USD 1,008,7771.8% | USD 34.711.8% | |
| TSHA (Taysha Gene Therapies Inc) | 182,667 | USD 1,004,669-2.8% | USD 5.5-2.8% | |
| INVA (Innoviva Inc) | 49,862 | USD 996,7410.5% | USD 19.990.5% | |
| QURE (Uniqure NV) | 41,546 | USD 994,1960.6% | USD 23.930.6% | |
| PGEN (Precigen Inc) | 235,944 | USD 986,246-1.9% | USD 4.18-1.9% | |
| RLAY (Relay Therapeutics Inc) | 115,576 | USD 977,7731.3% | USD 8.461.3% | |
| COLL (Collegium Pharmaceutical Inc) | 21,086 | USD 976,282-1.8% | USD 46.3-1.8% | |
| NVCR (Novocure Ltd) | 74,681 | USD 965,625-2.2% | USD 12.93-2.2% | |
| ARDX (Ardelyx Inc) | 162,026 | USD 944,6120.5% | USD 5.830.5% | |
| ANAB (AnaptysBio Inc) | 18,469 | USD 895,3770.5% | USD 48.480.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,235 | USD 884,6790.7% | USD 12.080.7% | |
| MNMD (Mind Medicine Inc) | 65,696 | USD 879,6693.4% | USD 13.393.4% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,636 | USD 868,4937.4% | USD 7.857.4% | |
| AMPH (Amphastar P) | 30,644 | USD 820,646-0.8% | USD 26.78-0.8% | |
| SVRA (Savara Inc) | 135,683 | USD 818,168-1.3% | USD 6.03-1.3% | |
| TNGX (Tango Therapeutics Inc) | 89,799 | USD 795,6192.7% | USD 8.862.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,445 | USD 787,113-2.0% | USD 16.59-2.0% | |
| SPRY (Silverback Therapeutics Inc) | 65,917 | USD 767,9330.1% | USD 11.650.1% | |
| GRFS (Grifols SA ADR) | 81,343 | USD 760,5571.6% | USD 9.351.6% | |
| CSTL (Castle Biosciences Inc) | 19,460 | USD 756,994-1.0% | USD 38.9-1.0% | |
| PCRX (Pacira BioSciences, Inc.) | 28,694 | USD 742,601-0.7% | USD 25.88-0.7% | |
| URGN (UroGen Pharma Ltd) | 31,219 | USD 731,1491.1% | USD 23.421.1% | |
| XNCR (Xencor Inc) | 47,620 | USD 729,0621.9% | USD 15.311.9% | |
| NVAX (Novavax Inc) | 108,130 | USD 726,634 | USD 6.72 | |
| SANA (Sana Biotechnology Inc) | 176,645 | USD 718,945-0.2% | USD 4.07-0.2% | |
| ERAS (Erasca Inc) | 189,168 | USD 703,7055.1% | USD 3.725.1% | |
| NTLA (Intellia Therapeutics Inc) | 76,867 | USD 691,034-0.8% | USD 8.99-0.8% | |
| IOVA (Iovance Biotherapeutics Inc) | 251,086 | USD 685,465-1.4% | USD 2.73-1.4% | |
| ABCL (Abcellera Biologics Inc) | 198,254 | USD 678,029-0.9% | USD 3.42-0.9% | |
| RAPT (RAPT Therapeutics Inc) | 18,484 | USD 626,0531.5% | USD 33.871.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,910 | USD 623,6011.5% | USD 9.321.5% | |
| TBPH (Theravance Biopharma Inc) | 33,190 | USD 620,985-1.1% | USD 18.71-1.1% | |
| ABUS (Arbutus Biopharma Corp) | 128,234 | USD 616,8064.1% | USD 4.814.1% | |
| KURA (Kura Oncology Inc) | 58,020 | USD 602,8281.7% | USD 10.391.7% | |
| ELVN (Enliven Therapeutics Inc.) | 39,079 | USD 601,817-1.0% | USD 15.4-1.0% | |
| GERN (Geron Corporation) | 415,776 | USD 548,824-1.5% | USD 1.32-1.5% | |
| VIR (Vir Biotechnology Inc) | 90,452 | USD 545,4263.3% | USD 6.033.3% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,710 | USD 544,4173.0% | USD 16.153.0% | |
| JANX (Janux Therapeutics Inc) | 39,320 | USD 542,616-0.2% | USD 13.8-0.2% | |
| PAHC (Phibro Animal Health Corporation) | 14,212 | USD 530,960-0.4% | USD 37.36-0.4% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,272 | USD 517,5651.2% | USD 8.181.2% | |
| ARVN (Arvinas Inc) | 42,825 | USD 507,9051.1% | USD 11.861.1% | |
| REPL (Replimune Group Inc) | 52,023 | USD 505,664-1.0% | USD 9.72001-1.0% | |
| RGNX (Regenxbio Inc) | 33,750 | USD 486,0002.2% | USD 14.42.2% | |
| ZLAB (Zai Lab Ltd) | 26,102 | USD 460,4390.1% | USD 17.640.1% | |
| VTYX (Ventyx Biosciences Inc) | 47,572 | USD 429,5753.2% | USD 9.033.2% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,777 | USD 429,5060.9% | USD 3.470.9% | |
| LYEL (Lyell Immunopharma Inc) | 13,605 | USD 418,762-2.6% | USD 30.78-2.6% | |
| KROS (Keros Therapeutics Inc) | 20,314 | USD 413,5930.4% | USD 20.360.4% | |
| MGTX (MeiraGTx Holdings PLC) | 51,587 | USD 410,1171.0% | USD 7.950011.0% | |
| FULC (Fulcrum Therapeutics Inc) | 36,087 | USD 408,144-0.3% | USD 11.31-0.3% | |
| CGEM (Cullinan Oncology LLC) | 38,704 | USD 400,5864.3% | USD 10.354.3% | |
| PACB (Pacific Biosciences of California) | 201,241 | USD 376,3218.1% | USD 1.878.1% | |
| PRTA (Prothena Corporation plc) | 38,898 | USD 371,4762.6% | USD 9.552.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,438 | USD 365,4361.2% | USD 3.371.2% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,986 | USD 343,85725.5% | USD 8.8200125.5% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,667 | USD 314,168-0.6% | USD 3.25-0.6% | |
| SIGA (SIGA Technologies Inc) | 49,871 | USD 304,712-1.0% | USD 6.11-1.0% | |
| GLPG (Galapagos NV ADR) | 9,306 | USD 304,3060.3% | USD 32.70.3% | |
| EOLS (Evolus Inc) | 43,210 | USD 287,347-0.3% | USD 6.65001-0.3% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,773 | USD 265,9632.6% | USD 3.512.6% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,442 | USD 265,815-1.1% | USD 7.5-1.1% | |
| TRDA (Entrada Therapeutics Inc) | 25,104 | USD 258,0691.9% | USD 10.281.9% | |
| AUTL (Autolus Therapeutics Ltd) | 126,117 | USD 250,9731.0% | USD 1.991.0% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,617 | USD 238,0084.1% | USD 7.079994.1% | |
| ACIU (AC Immune Ltd) | 70,922 | USD 222,695-0.3% | USD 3.14-0.3% | |
| ACRS (Aclaris Therapeutics Inc) | 72,192 | USD 217,2983.8% | USD 3.013.8% | |
| AVXL (Anavex Life Sciences Corp) | 60,927 | USD 216,900-6.3% | USD 3.56-6.3% | |
| ALLO (Allogene Therapeutics Inc) | 155,545 | USD 213,0974.6% | USD 1.374.6% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,514 | USD 212,4650.6% | USD 3.570.6% | |
| OABI (OmniAb Inc.) | 87,606 | USD 162,071-0.5% | USD 1.85-0.5% | |
| VYGR (Voyager Therapeutics Inc) | 36,529 | USD 143,559-0.3% | USD 3.93-0.3% | |
| CABA (Cabaletta Bio Inc) | 64,127 | USD 140,4381.9% | USD 2.191.9% | |
| EDIT (Editas Medicine Inc) | 68,085 | USD 139,5740.5% | USD 2.050.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,238 | USD 124,059-1.0% | USD 6.13-1.0% | |
| HUMA (Humacyte Inc) | 115,500 | USD 110,938-4.9% | USD 0.960502-4.9% | |
| CRBU (Caribou Biosciences Inc) | 62,269 | USD 99,008 | USD 1.59 | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 167,280 0.2% | USD 75,901,627-1.1% | USD 453.74-1.3% | |
| AMGN (Amgen Inc) | 209,959 0.2% | USD 69,011,424-0.1% | USD 328.69-0.3% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,884 0.2% | USD 53,312,083-0.6% | USD 773.94-0.8% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 88,125 0.2% | USD 35,007,656-0.2% | USD 397.25-0.4% | |
| INSM (Insmed Inc) | 142,248 0.2% | USD 24,763,954-1.0% | USD 174.09-1.3% | |
| BIIB (Biogen Inc) | 97,850 0.2% | USD 17,260,7400.0% | USD 176.4-0.2% | |
| ARGX (argenx NV ADR) | 19,420 0.2% | USD 16,272,0180.3% | USD 837.90.1% | |
| UTHR (United Therapeutics Corporation) | 28,718 0.2% | USD 14,249,584-1.1% | USD 496.19-1.3% | |
| ILMN (Illumina Inc) | 101,912 0.2% | USD 13,528,818-1.1% | USD 132.75-1.3% | |
| INCY (Incyte Corporation) | 130,949 0.2% | USD 12,952,166-0.2% | USD 98.91-0.4% | |
| RPRX (Royalty Pharma Plc) | 284,963 0.2% | USD 11,110,7070.0% | USD 38.99-0.2% | |
| MEDP (Medpace Holdings Inc) | 18,786 0.2% | USD 10,686,4160.0% | USD 568.85-0.2% | |
| RVMD (Revolution Medicines Inc) | 128,938 0.2% | USD 10,272,490-0.8% | USD 79.67-1.1% | |
| ROIV (Roivant Sciences Ltd) | 463,881 0.2% | USD 10,033,746-0.1% | USD 21.63-0.3% | |
| BBIO (BridgeBio Pharma Inc) | 128,531 0.2% | USD 9,701,5200.1% | USD 75.48-0.2% | |
| VTRS (Viatris Inc) | 768,209 0.2% | USD 9,633,3411.6% | USD 12.541.4% | |
| NBIX (Neurocrine Biosciences Inc) | 66,503 0.2% | USD 9,373,598-1.6% | USD 140.95-1.9% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,152 0.2% | USD 8,844,677-0.7% | USD 583.73-1.0% | |
| SMMT (Summit Therapeutics PLC) | 496,532 0.2% | USD 8,684,345-1.4% | USD 17.49-1.6% | |
| GH (Guardant Health Inc) | 86,294 0.2% | USD 8,681,176-0.5% | USD 100.6-0.8% | |
| SNY (Sanofi ADR) | 176,496 0.2% | USD 8,602,4151.0% | USD 48.740.8% | |
| ASND (Ascendis Pharma AS) | 40,957 0.2% | USD 8,573,938-0.6% | USD 209.34-0.8% | |
| IONS (Ionis Pharmaceuticals Inc) | 108,034 0.2% | USD 8,531,445-1.0% | USD 78.97-1.3% | |
| MRNA (Moderna Inc) | 260,574 0.2% | USD 7,924,055-2.1% | USD 30.41-2.4% | |
| EXEL (Exelixis Inc) | 178,827 0.2% | USD 7,875,541-2.7% | USD 44.04-2.9% | |
| BMRN (Biomarin Pharmaceutical Inc) | 128,136 0.2% | USD 7,558,743-1.5% | USD 58.99-1.7% | |
| RNA (Avidity Biosciences Inc) | 100,503 0.2% | USD 7,251,2910.2% | USD 72.150.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,524 0.2% | USD 6,922,3100.4% | USD 170.820.2% | |
| BNTX (BioNTech SE) | 67,437 0.2% | USD 6,425,3970.3% | USD 95.280.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,586 0.2% | USD 6,091,909-3.2% | USD 67.25-3.4% | |
| HALO (Halozyme Therapeutics Inc) | 78,435 0.2% | USD 5,310,050-1.6% | USD 67.7-1.8% | |
| CYTK (Cytokinetics Inc) | 81,551 0.2% | USD 5,004,785-0.4% | USD 61.37-0.6% | |
| AXSM (Axsome Therapeutics Inc) | 33,629 0.2% | USD 5,003,659-1.0% | USD 148.79-1.3% | |
| PRAX (Praxis Precision Medicines Inc) | 16,678 0.2% | USD 4,953,700-2.3% | USD 297.02-2.5% | |
| NUVL (Nuvalent Inc) | 47,990 0.2% | USD 4,817,236-1.1% | USD 100.38-1.4% | |
| KRYS (Krystal Biotech Inc) | 19,342 0.2% | USD 4,794,495-2.1% | USD 247.88-2.3% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,510 0.2% | USD 4,751,888-4.9% | USD 106.76-5.1% | |
| PTCT (PTC Therapeutics Inc) | 53,550 0.2% | USD 4,079,975-1.6% | USD 76.19-1.9% | |
| PCVX (Vaxcyte Inc) | 87,308 0.2% | USD 3,964,656-2.3% | USD 45.41-2.5% | |
| COGT (Cogent Biosciences Inc) | 102,384 0.2% | USD 3,800,494-1.9% | USD 37.12-2.1% | |
| KYMR (Kymera Therapeutics Inc) | 47,988 0.2% | USD 3,748,823-2.5% | USD 78.12-2.8% | |
| PTGX (Protagonist Therapeutics Inc) | 41,700 0.2% | USD 3,638,742-0.5% | USD 87.26-0.8% | |
| CRSP (Crispr Therapeutics AG) | 63,567 0.2% | USD 3,381,129-1.2% | USD 53.19-1.4% | |
| ALKS (Alkermes Plc) | 110,129 0.2% | USD 3,062,687-0.5% | USD 27.81-0.7% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,567 0.2% | USD 3,020,7510.8% | USD 67.780.6% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,844 0.2% | USD 3,012,935-1.8% | USD 26.7-2.1% | |
| SRRK (Scholar Rock Holding Corp) | 68,799 0.2% | USD 3,001,012-3.2% | USD 43.62-3.5% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,287 0.2% | USD 2,999,1710.0% | USD 47.39-0.3% | |
| IMVT (Immunovant Inc) | 116,903 0.2% | USD 2,963,491-0.8% | USD 25.35-1.0% | |
| FOLD (Amicus Therapeutics Inc) | 205,776 0.2% | USD 2,932,3080.2% | USD 14.25 | |
| ADMA (ADMA Biologics Inc) | 158,732 0.2% | USD 2,914,320-3.7% | USD 18.36-3.9% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,576 0.2% | USD 2,770,998-0.6% | USD 75.76-0.8% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,278 0.2% | USD 2,702,820-1.5% | USD 78.85-1.7% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,664 0.2% | USD 2,700,4720.0% | USD 12.88-0.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,123 0.2% | USD 2,495,995-2.3% | USD 190.2-2.5% | |
| ACLX (Arcellx Inc) | 38,566 0.2% | USD 2,452,798-2.1% | USD 63.6-2.3% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,313 0.2% | USD 2,331,0090.7% | USD 82.330.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,695 0.2% | USD 2,293,996-1.5% | USD 28.08-1.7% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,544 0.2% | USD 2,274,121-0.2% | USD 44.12-0.5% | |
| TVTX (Travere Therapeutics Inc) | 59,679 0.2% | USD 2,248,705-2.9% | USD 37.68-3.1% | |
| VCYT (Veracyte Inc) | 52,724 0.2% | USD 2,229,171-1.2% | USD 42.28-1.4% | |
| GRAL (GRAIL, LLC) | 25,892 0.2% | USD 2,208,588-2.7% | USD 85.3-2.9% | |
| VERA (Vera Therapeutics Inc) | 42,644 0.2% | USD 2,182,093-1.8% | USD 51.17-2.1% | |
| CGON (CG Oncology, Inc. Common stock) | 53,541 0.2% | USD 2,150,7421.0% | USD 40.170.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,388 0.2% | USD 2,129,9530.5% | USD 25.240.3% | |
| IDYA (Ideaya Biosciences Inc) | 58,476 0.2% | USD 2,018,007-0.7% | USD 34.51-0.9% | |
| WVE (Wave Life Sciences Ltd) | 111,496 0.2% | USD 1,912,156-3.8% | USD 17.15-4.0% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,247 0.2% | USD 1,908,143-2.4% | USD 49.89-2.7% | |
| BEAM (Beam Therapeutics Inc) | 67,681 0.2% | USD 1,882,8850.2% | USD 27.82-0.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,786 0.2% | USD 1,873,903-3.4% | USD 35.5-3.6% | |
| DYN (Dyne Therapeutics Inc) | 95,252 0.2% | USD 1,828,838-1.8% | USD 19.2-2.0% | |
| OCUL (Ocular Therapeutix Inc) | 142,081 0.2% | USD 1,733,388-0.6% | USD 12.2-0.8% | |
| EWTX (Edgewise Therapeutics Inc) | 70,609 0.2% | USD 1,732,745-0.1% | USD 24.54-0.3% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,820 0.2% | USD 1,671,884-1.2% | USD 16.42-1.4% | |
| SYRE (Spyre Therapeutics Inc.) | 51,749 0.2% | USD 1,649,758-1.9% | USD 31.88-2.1% | |
| DNLI (Denali Therapeutics Inc) | 97,812 0.2% | USD 1,605,095-0.8% | USD 16.41-1.0% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,350 0.2% | USD 1,592,0190.0% | USD 24.74-0.2% | |
| SRPT (Sarepta Therapeutics Inc) | 70,980 0.2% | USD 1,525,360-1.3% | USD 21.49-1.5% | |
| RARE (Ultragenyx) | 64,350 0.2% | USD 1,465,89315.8% | USD 22.7815.5% | |
| HRMY (Harmony Biosciences Holdings) | 38,411 0.2% | USD 1,445,790-0.5% | USD 37.64-0.7% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,911 0.2% | USD 1,409,364-0.3% | USD 4.11-0.5% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,926 0.2% | USD 1,390,989-0.2% | USD 15.82-0.4% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,908 0.2% | USD 1,324,558-0.5% | USD 26.54-0.7% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,457 0.2% | USD 1,315,097-2.0% | USD 25.07-2.2% | |
| TWST (Twist Bioscience Corp) | 40,786 0.2% | USD 1,311,270-1.9% | USD 32.15-2.1% | |
| IBRX (Immunitybio Inc) | 656,515 0.2% | USD 1,299,900-2.7% | USD 1.98-2.9% | |
| NRIX (Nurix Therapeutics Inc) | 67,608 0.2% | USD 1,285,904-1.5% | USD 19.02-1.8% | |
| TXG (10X Genomics Inc) | 77,678 0.2% | USD 1,265,3751.1% | USD 16.290.9% | |
| VCEL (Vericel Corp Ord) | 33,728 0.2% | USD 1,238,829-2.1% | USD 36.73-2.3% | |
| HROW (Harrow Health Inc) | 24,699 0.2% | USD 1,235,444-1.2% | USD 50.02-1.5% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,094 0.2% | USD 1,233,5530.2% | USD 40.990.0% | |
| GMAB (Genmab AS) | 38,986 0.2% | USD 1,227,669-2.9% | USD 31.49-3.2% | |
| STOK (Stoke Therapeutics Inc) | 38,095 0.2% | USD 1,212,183-0.9% | USD 31.82-1.1% | |
| LEGN (Legend Biotech Corp) | 56,161 0.2% | USD 1,209,146-1.5% | USD 21.53-1.8% | |
| DVAX (Dynavax Technologies Corporation) | 78,305 0.2% | USD 1,203,5480.2% | USD 15.37 | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,961 0.2% | USD 1,202,111-1.3% | USD 20.74-1.6% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,979 0.2% | USD 1,189,632-2.2% | USD 79.42-2.4% | |
| MNKD (MannKind Corp) | 204,774 0.2% | USD 1,159,021-1.7% | USD 5.66-1.9% | |
| PHVS (Pharvaris BV) | 42,720 0.2% | USD 1,121,4002.2% | USD 26.252.0% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,401 0.2% | USD 1,075,472-0.4% | USD 7.66-0.6% | |
| FTRE (Fortrea Holdings Inc.) | 61,524 0.2% | USD 1,069,2871.0% | USD 17.380.8% | |
| AGIO (Agios Pharm) | 38,891 0.2% | USD 1,062,8910.9% | USD 27.330.6% | |
| TSHA (Taysha Gene Therapies Inc) | 182,667 0.2% | USD 1,033,8950.4% | USD 5.660.2% | |
| PGEN (Precigen Inc) | 235,944 0.2% | USD 1,005,121-4.0% | USD 4.26-4.3% | |
| COLL (Collegium Pharmaceutical Inc) | 21,086 0.2% | USD 993,783-4.5% | USD 47.13-4.7% | |
| INVA (Innoviva Inc) | 49,862 0.2% | USD 991,7551.1% | USD 19.890.9% | |
| IMCR (Immunocore Holdings Ltd) | 29,063 0.2% | USD 991,048-3.3% | USD 34.1-3.6% | |
| QURE (Uniqure NV) | 41,546 0.2% | USD 987,964-2.9% | USD 23.78-3.2% | |
| NVCR (Novocure Ltd) | 74,681 0.2% | USD 987,283-0.1% | USD 13.22-0.4% | |
| RLAY (Relay Therapeutics Inc) | 115,576 0.2% | USD 965,060-0.5% | USD 8.35-0.7% | |
| ARDX (Ardelyx Inc) | 162,026 0.2% | USD 939,7510.6% | USD 5.80.3% | |
| ANAB (AnaptysBio Inc) | 18,469 0.2% | USD 890,760-5.0% | USD 48.23-5.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,235 0.2% | USD 878,820-1.3% | USD 12-1.6% | |
| MNMD (Mind Medicine Inc) | 65,696 0.2% | USD 850,763-3.6% | USD 12.95-3.8% | |
| SVRA (Savara Inc) | 135,683 0.2% | USD 829,023-3.2% | USD 6.11-3.5% | |
| AMPH (Amphastar P) | 30,644 0.2% | USD 827,3881.0% | USD 270.8% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,636 0.2% | USD 808,749-1.4% | USD 7.31-1.6% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,445 0.2% | USD 802,769-1.5% | USD 16.92-1.7% | |
| TNGX (Tango Therapeutics Inc) | 89,799 0.2% | USD 774,965-1.1% | USD 8.63-1.4% | |
| SPRY (Silverback Therapeutics Inc) | 65,917 0.2% | USD 767,274-0.4% | USD 11.64-0.7% | |
| CSTL (Castle Biosciences Inc) | 19,460 0.2% | USD 764,9730.3% | USD 39.310.1% | |
| GRFS (Grifols SA ADR) | 81,343 0.2% | USD 748,3561.1% | USD 9.20.9% | |
| PCRX (Pacira BioSciences, Inc.) | 28,694 0.2% | USD 748,0530.3% | USD 26.070.0% | |
| NVAX (Novavax Inc) | 108,130 0.2% | USD 726,634-1.2% | USD 6.72-1.5% | |
| URGN (UroGen Pharma Ltd) | 31,219 0.2% | USD 723,344-0.5% | USD 23.17-0.7% | |
| SANA (Sana Biotechnology Inc) | 176,645 0.2% | USD 720,712-0.7% | USD 4.08-1.0% | |
| XNCR (Xencor Inc) | 47,620 0.2% | USD 715,729-0.7% | USD 15.03-0.9% | |
| NTLA (Intellia Therapeutics Inc) | 76,867 0.2% | USD 696,415-0.6% | USD 9.06-0.9% | |
| IOVA (Iovance Biotherapeutics Inc) | 251,086 0.2% | USD 695,508-0.5% | USD 2.77-0.7% | |
| ABCL (Abcellera Biologics Inc) | 198,254 0.2% | USD 683,976-0.1% | USD 3.45-0.3% | |
| ERAS (Erasca Inc) | 189,168 0.2% | USD 669,6552.6% | USD 3.542.3% | |
| TBPH (Theravance Biopharma Inc) | 33,190 0.2% | USD 627,6231.3% | USD 18.911.1% | |
| RAPT (RAPT Therapeutics Inc) | 18,484 0.2% | USD 616,996-6.6% | USD 33.38-6.9% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,910 0.2% | USD 614,234-1.8% | USD 9.18-2.0% | |
| ELVN (Enliven Therapeutics Inc.) | 39,079 0.2% | USD 607,678-2.2% | USD 15.55-2.4% | |
| KURA (Kura Oncology Inc) | 58,020 0.2% | USD 592,964-2.0% | USD 10.22-2.2% | |
| ABUS (Arbutus Biopharma Corp) | 128,234 0.2% | USD 592,441-1.9% | USD 4.62-2.1% | |
| GERN (Geron Corporation) | 415,776 0.2% | USD 557,140-2.0% | USD 1.34-2.2% | |
| JANX (Janux Therapeutics Inc) | 39,320 0.2% | USD 543,796-1.5% | USD 13.83-1.7% | |
| PAHC (Phibro Animal Health Corporation) | 14,212 0.2% | USD 533,092-0.4% | USD 37.51-0.6% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,710 0.2% | USD 528,5733.6% | USD 15.683.4% | |
| VIR (Vir Biotechnology Inc) | 90,452 0.2% | USD 528,240-2.1% | USD 5.84-2.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,272 0.2% | USD 511,238-1.8% | USD 8.08-2.1% | |
| REPL (Replimune Group Inc) | 52,023 0.2% | USD 510,8660.9% | USD 9.820.6% | |
| ARVN (Arvinas Inc) | 42,825 0.2% | USD 502,337-1.2% | USD 11.73-1.4% | |
| RGNX (Regenxbio Inc) | 33,750 0.2% | USD 475,538-1.2% | USD 14.09-1.5% | |
| ZLAB (Zai Lab Ltd) | 26,102 0.2% | USD 460,178-0.8% | USD 17.63-1.1% | |
| LYEL (Lyell Immunopharma Inc) | 13,605 0.2% | USD 429,782-12.2% | USD 31.59-12.4% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,777 0.2% | USD 425,7932.3% | USD 3.442.1% | |
| VTYX (Ventyx Biosciences Inc) | 47,572 0.2% | USD 416,255-3.4% | USD 8.75-3.6% | |
| KROS (Keros Therapeutics Inc) | 20,314 0.2% | USD 411,765-1.5% | USD 20.27-1.7% | |
| FULC (Fulcrum Therapeutics Inc) | 36,087 0.2% | USD 409,227-5.2% | USD 11.34-5.4% | |
| MGTX (MeiraGTx Holdings PLC) | 51,587 0.2% | USD 405,9900.9% | USD 7.870010.6% | |
| CGEM (Cullinan Oncology LLC) | 38,704 0.2% | USD 383,944-1.9% | USD 9.92001-2.2% | |
| PRTA (Prothena Corporation plc) | 38,898 0.2% | USD 362,140-1.6% | USD 9.30999-1.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,438 0.2% | USD 361,0994.0% | USD 3.333.7% | |
| PACB (Pacific Biosciences of California) | 201,241 0.2% | USD 348,1471.4% | USD 1.731.2% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,667 0.2% | USD 316,101-1.6% | USD 3.27-1.8% | |
| SIGA (SIGA Technologies Inc) | 49,871 0.2% | USD 307,704-1.0% | USD 6.17-1.3% | |
| GLPG (Galapagos NV ADR) | 9,306 0.2% | USD 303,469-1.3% | USD 32.61-1.5% | |
| EOLS (Evolus Inc) | 43,210 0.2% | USD 288,2110.4% | USD 6.670010.2% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,986 0.2% | USD 274,072-2.1% | USD 7.03001-2.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,442 0.2% | USD 268,650-1.1% | USD 7.57999-1.3% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,773 0.2% | USD 259,144-1.5% | USD 3.42-1.7% | |
| TRDA (Entrada Therapeutics Inc) | 25,104 0.2% | USD 253,299-1.1% | USD 10.09-1.4% | |
| AUTL (Autolus Therapeutics Ltd) | 126,117 0.2% | USD 248,4505.6% | USD 1.975.3% | |
| AVXL (Anavex Life Sciences Corp) | 60,927 0.2% | USD 231,5234.4% | USD 3.800014.1% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,617 0.2% | USD 228,5960.5% | USD 6.800010.3% | |
| ACIU (AC Immune Ltd) | 70,922 0.2% | USD 223,404-2.8% | USD 3.15-3.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,514 0.2% | USD 211,275-1.2% | USD 3.55-1.4% | |
| ACRS (Aclaris Therapeutics Inc) | 72,192 0.2% | USD 209,357-3.4% | USD 2.9-3.7% | |
| ALLO (Allogene Therapeutics Inc) | 155,545 0.2% | USD 203,764-4.8% | USD 1.31-5.1% | |
| OABI (OmniAb Inc.) | 87,606 0.2% | USD 162,947-1.9% | USD 1.86-2.1% | |
| VYGR (Voyager Therapeutics Inc) | 36,529 0.2% | USD 143,924-2.2% | USD 3.93999-2.5% | |
| EDIT (Editas Medicine Inc) | 68,085 0.2% | USD 138,893-2.6% | USD 2.03999-2.9% | |
| CABA (Cabaletta Bio Inc) | 64,127 0.2% | USD 137,873-5.5% | USD 2.15-5.7% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,238 0.2% | USD 125,2730.7% | USD 6.189990.5% | |
| HUMA (Humacyte Inc) | 115,500 0.2% | USD 116,655-0.7% | USD 1.01-1.0% | |
| CRBU (Caribou Biosciences Inc) | 62,269 0.2% | USD 99,008-3.4% | USD 1.59-3.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 166,890 | USD 76,732,684-0.7% | USD 459.78-0.7% | |
| AMGN (Amgen Inc) | 209,469 | USD 69,047,266-1.0% | USD 329.63-1.0% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,723 | USD 53,638,302-0.6% | USD 780.5-0.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 87,919 | USD 35,063,856-0.4% | USD 398.82-0.4% | |
| INSM (Insmed Inc) | 141,916 | USD 25,025,467-0.9% | USD 176.34-0.9% | |
| BIIB (Biogen Inc) | 97,622 | USD 17,262,498-0.1% | USD 176.83-0.1% | |
| ARGX (argenx NV ADR) | 19,375 | USD 16,225,594-0.9% | USD 837.45-0.9% | |
| UTHR (United Therapeutics Corporation) | 28,651 | USD 14,408,588-0.8% | USD 502.9-0.8% | |
| ILMN (Illumina Inc) | 101,674 | USD 13,673,120-0.3% | USD 134.48-0.3% | |
| INCY (Incyte Corporation) | 130,644 | USD 12,971,643-0.8% | USD 99.29-0.8% | |
| RPRX (Royalty Pharma Plc) | 284,298 | USD 11,110,366-0.4% | USD 39.08-0.4% | |
| MEDP (Medpace Holdings Inc) | 18,742 | USD 10,682,5650.4% | USD 569.980.4% | |
| RVMD (Revolution Medicines Inc) | 128,637 | USD 10,357,851-0.3% | USD 80.52-0.3% | |
| ROIV (Roivant Sciences Ltd) | 462,799 | USD 10,042,738-2.4% | USD 21.7-2.4% | |
| BBIO (BridgeBio Pharma Inc) | 128,231 | USD 9,695,546-0.3% | USD 75.61-0.3% | |
| NBIX (Neurocrine Biosciences Inc) | 66,348 | USD 9,530,227-1.1% | USD 143.64-1.1% | |
| VTRS (Viatris Inc) | 766,417 | USD 9,480,5780.4% | USD 12.370.4% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,117 | USD 8,911,018-1.6% | USD 589.47-1.6% | |
| SMMT (Summit Therapeutics PLC) | 495,374 | USD 8,807,750-2.0% | USD 17.78-2.0% | |
| GH (Guardant Health Inc) | 86,093 | USD 8,728,969-1.5% | USD 101.39-1.5% | |
| ASND (Ascendis Pharma AS) | 40,861 | USD 8,622,4881.0% | USD 211.021.0% | |
| IONS (Ionis Pharmaceuticals Inc) | 107,782 | USD 8,620,4040.1% | USD 79.980.1% | |
| SNY (Sanofi ADR) | 176,084 | USD 8,513,661-0.2% | USD 48.35-0.2% | |
| MRNA (Moderna Inc) | 259,966 | USD 8,097,941-0.2% | USD 31.15-0.2% | |
| EXEL (Exelixis Inc) | 178,410 | USD 8,094,462-1.9% | USD 45.37-1.9% | |
| BMRN (Biomarin Pharmaceutical Inc) | 127,837 | USD 7,675,3330.2% | USD 60.040.2% | |
| RNA (Avidity Biosciences Inc) | 100,269 | USD 7,236,4140.1% | USD 72.170.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,429 | USD 6,893,1450.0% | USD 170.50.0% | |
| BNTX (BioNTech SE) | 67,280 | USD 6,405,0560.7% | USD 95.20.7% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,375 | USD 6,291,908-0.8% | USD 69.62-0.8% | |
| HALO (Halozyme Therapeutics Inc) | 78,252 | USD 5,395,4750.1% | USD 68.950.1% | |
| PRAX (Praxis Precision Medicines Inc) | 16,639 | USD 5,067,90713.2% | USD 304.5813.2% | |
| AXSM (Axsome Therapeutics Inc) | 33,551 | USD 5,055,465-0.9% | USD 150.68-0.9% | |
| CYTK (Cytokinetics Inc) | 81,361 | USD 5,024,042-2.2% | USD 61.75-2.2% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,406 | USD 4,997,8952.3% | USD 112.552.3% | |
| KRYS (Krystal Biotech Inc) | 19,297 | USD 4,895,2630.6% | USD 253.680.6% | |
| NUVL (Nuvalent Inc) | 47,878 | USD 4,872,065-2.2% | USD 101.76-2.2% | |
| PTCT (PTC Therapeutics Inc) | 53,425 | USD 4,147,917-1.2% | USD 77.64-1.2% | |
| PCVX (Vaxcyte Inc) | 87,104 | USD 4,056,433-0.9% | USD 46.57-0.9% | |
| COGT (Cogent Biosciences Inc) | 102,145 | USD 3,873,338-2.5% | USD 37.92-2.5% | |
| KYMR (Kymera Therapeutics Inc) | 47,876 | USD 3,846,837-1.2% | USD 80.35-1.2% | |
| PTGX (Protagonist Therapeutics Inc) | 41,603 | USD 3,658,152-1.0% | USD 87.93-1.0% | |
| CRSP (Crispr Therapeutics AG) | 63,419 | USD 3,422,723-2.0% | USD 53.97-2.0% | |
| SRRK (Scholar Rock Holding Corp) | 68,639 | USD 3,101,796-1.1% | USD 45.19-1.1% | |
| ALKS (Alkermes Plc) | 109,872 | USD 3,077,515-1.7% | USD 28.01-1.7% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,581 | USD 3,068,958-1.3% | USD 27.26-1.3% | |
| ADMA (ADMA Biologics Inc) | 158,361 | USD 3,026,279-0.9% | USD 19.11-0.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,139 | USD 3,000,365-0.9% | USD 47.52-0.9% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,463 | USD 2,995,917-1.4% | USD 67.38-1.4% | |
| IMVT (Immunovant Inc) | 116,630 | USD 2,986,894-2.1% | USD 25.61-2.1% | |
| FOLD (Amicus Therapeutics Inc) | 205,295 | USD 2,925,454 | USD 14.25 | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,491 | USD 2,787,183-1.2% | USD 76.38-1.2% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,198 | USD 2,743,0221.2% | USD 80.211.2% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,174 | USD 2,700,436-0.3% | USD 12.91-0.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,092 | USD 2,555,035-0.3% | USD 195.16-0.3% | |
| ACLX (Arcellx Inc) | 38,476 | USD 2,505,942-0.9% | USD 65.13-0.9% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,504 | USD 2,327,754-1.4% | USD 28.56-1.4% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,247 | USD 2,315,4070.2% | USD 81.970.2% | |
| TVTX (Travere Therapeutics Inc) | 59,540 | USD 2,314,915-1.9% | USD 38.88-1.9% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,424 | USD 2,279,626-1.1% | USD 44.33-1.1% | |
| GRAL (GRAIL, LLC) | 25,832 | USD 2,270,116-4.1% | USD 87.88-4.1% | |
| VCYT (Veracyte Inc) | 52,601 | USD 2,255,5310.9% | USD 42.880.9% | |
| VERA (Vera Therapeutics Inc) | 42,545 | USD 2,222,976-2.5% | USD 52.25-2.5% | |
| CGON (CG Oncology, Inc. Common stock) | 53,416 | USD 2,129,1620.1% | USD 39.860.1% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,191 | USD 2,119,0870.8% | USD 25.170.8% | |
| IDYA (Ideaya Biosciences Inc) | 58,340 | USD 2,032,566-1.0% | USD 34.84-1.0% | |
| WVE (Wave Life Sciences Ltd) | 111,236 | USD 1,986,6750.5% | USD 17.860.5% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,158 | USD 1,955,598-0.6% | USD 51.25-0.6% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,663 | USD 1,939,578-0.8% | USD 36.83-0.8% | |
| BEAM (Beam Therapeutics Inc) | 67,523 | USD 1,879,840-0.5% | USD 27.84-0.5% | |
| DYN (Dyne Therapeutics Inc) | 95,030 | USD 1,861,638-2.2% | USD 19.59-2.2% | |
| OCUL (Ocular Therapeutix Inc) | 141,749 | USD 1,743,513-2.1% | USD 12.3-2.1% | |
| EWTX (Edgewise Therapeutics Inc) | 70,444 | USD 1,734,331-6.6% | USD 24.62-6.6% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,582 | USD 1,691,340-0.3% | USD 16.65-0.3% | |
| SYRE (Spyre Therapeutics Inc.) | 51,628 | USD 1,681,008-1.2% | USD 32.56-1.2% | |
| DNLI (Denali Therapeutics Inc) | 97,583 | USD 1,617,926-1.7% | USD 16.58-1.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,200 | USD 1,591,518-2.1% | USD 24.79-2.1% | |
| SRPT (Sarepta Therapeutics Inc) | 70,814 | USD 1,545,161-1.4% | USD 21.82-1.4% | |
| HRMY (Harmony Biosciences Holdings) | 38,321 | USD 1,452,749-0.6% | USD 37.91-0.6% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,108 | USD 1,412,906-2.8% | USD 4.13-2.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,720 | USD 1,393,871-2.2% | USD 15.89-2.2% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,335 | USD 1,341,869-2.2% | USD 25.64-2.2% | |
| TWST (Twist Bioscience Corp) | 40,691 | USD 1,336,699-0.6% | USD 32.85-0.6% | |
| IBRX (Immunitybio Inc) | 654,976 | USD 1,336,151-4.7% | USD 2.04-4.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,791 | USD 1,331,411-0.5% | USD 26.74-0.5% | |
| NRIX (Nurix Therapeutics Inc) | 67,450 | USD 1,305,8320.3% | USD 19.360.3% | |
| RARE (Ultragenyx) | 64,200 | USD 1,266,024-42.3% | USD 19.72-42.3% | |
| VCEL (Vericel Corp Ord) | 33,649 | USD 1,264,866-0.2% | USD 37.59-0.2% | |
| GMAB (Genmab AS) | 38,895 | USD 1,264,865-2.7% | USD 32.52-2.7% | |
| TXG (10X Genomics Inc) | 77,496 | USD 1,251,560-2.1% | USD 16.15-2.1% | |
| HROW (Harrow Health Inc) | 24,641 | USD 1,250,7771.3% | USD 50.761.3% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,024 | USD 1,230,834-2.4% | USD 40.995-2.4% | |
| LEGN (Legend Biotech Corp) | 56,030 | USD 1,228,178-2.7% | USD 21.92-2.7% | |
| STOK (Stoke Therapeutics Inc) | 38,006 | USD 1,223,0330.8% | USD 32.180.8% | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,826 | USD 1,218,394-1.1% | USD 21.07-1.1% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,944 | USD 1,216,143-1.2% | USD 81.38-1.2% | |
| DVAX (Dynavax Technologies Corporation) | 78,122 | USD 1,200,735-0.1% | USD 15.37-0.1% | |
| MNKD (MannKind Corp) | 204,294 | USD 1,178,776-0.3% | USD 5.77-0.3% | |
| PHVS (Pharvaris BV) | 42,620 | USD 1,097,039-0.1% | USD 25.74-0.1% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,072 | USD 1,079,9551.0% | USD 7.711.0% | |
| FTRE (Fortrea Holdings Inc.) | 61,380 | USD 1,058,805-0.9% | USD 17.25-0.9% | |
| AGIO (Agios Pharm) | 38,800 | USD 1,053,808-3.1% | USD 27.16-3.1% | |
| PGEN (Precigen Inc) | 235,390 | USD 1,047,4867.0% | USD 4.457.0% | |
| COLL (Collegium Pharmaceutical Inc) | 21,037 | USD 1,040,911-0.7% | USD 49.48-0.7% | |
| TSHA (Taysha Gene Therapies Inc) | 182,239 | USD 1,029,650-3.1% | USD 5.65-3.1% | |
| IMCR (Immunocore Holdings Ltd) | 28,995 | USD 1,025,263-2.1% | USD 35.36-2.1% | |
| QURE (Uniqure NV) | 41,449 | USD 1,017,987-1.0% | USD 24.56-1.0% | |
| NVCR (Novocure Ltd) | 74,506 | USD 988,695-1.6% | USD 13.27-1.6% | |
| INVA (Innoviva Inc) | 49,745 | USD 980,971-0.4% | USD 19.72-0.4% | |
| RLAY (Relay Therapeutics Inc) | 115,305 | USD 969,715-1.8% | USD 8.41-1.8% | |
| ANAB (AnaptysBio Inc) | 18,426 | USD 938,0681.6% | USD 50.911.6% | |
| ARDX (Ardelyx Inc) | 161,646 | USD 934,3140.7% | USD 5.780.7% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,063 | USD 890,638-1.1% | USD 12.19-1.1% | |
| MNMD (Mind Medicine Inc) | 65,542 | USD 882,1953.1% | USD 13.463.1% | |
| SVRA (Savara Inc) | 135,364 | USD 856,854-1.9% | USD 6.33-1.9% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,376 | USD 820,0940.8% | USD 7.430.8% | |
| AMPH (Amphastar P) | 30,572 | USD 819,024-1.2% | USD 26.79-1.2% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,334 | USD 815,091-1.9% | USD 17.22-1.9% | |
| TNGX (Tango Therapeutics Inc) | 89,588 | USD 783,8950.9% | USD 8.750.9% | |
| SPRY (Silverback Therapeutics Inc) | 65,762 | USD 770,7313.0% | USD 11.723.0% | |
| CSTL (Castle Biosciences Inc) | 19,415 | USD 762,427-0.3% | USD 39.27-0.3% | |
| PCRX (Pacira BioSciences, Inc.) | 28,627 | USD 746,020-1.7% | USD 26.06-1.7% | |
| GRFS (Grifols SA ADR) | 81,152 | USD 740,1060.2% | USD 9.120.2% | |
| NVAX (Novavax Inc) | 107,876 | USD 735,714-0.1% | USD 6.82-0.1% | |
| URGN (UroGen Pharma Ltd) | 31,146 | USD 726,6361.3% | USD 23.331.3% | |
| SANA (Sana Biotechnology Inc) | 176,229 | USD 726,063-6.6% | USD 4.12-6.6% | |
| XNCR (Xencor Inc) | 47,508 | USD 720,696-0.3% | USD 15.17-0.3% | |
| NTLA (Intellia Therapeutics Inc) | 76,686 | USD 700,910-3.2% | USD 9.14-3.2% | |
| IOVA (Iovance Biotherapeutics Inc) | 250,495 | USD 698,881-2.1% | USD 2.79-2.1% | |
| ABCL (Abcellera Biologics Inc) | 197,787 | USD 684,343-3.4% | USD 3.46-3.4% | |
| RAPT (RAPT Therapeutics Inc) | 18,441 | USD 660,9251.2% | USD 35.841.2% | |
| ERAS (Erasca Inc) | 188,722 | USD 652,978-0.6% | USD 3.46-0.6% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,753 | USD 625,476-0.8% | USD 9.37001-0.8% | |
| ELVN (Enliven Therapeutics Inc.) | 38,987 | USD 621,453-2.2% | USD 15.94-2.2% | |
| TBPH (Theravance Biopharma Inc) | 33,112 | USD 619,526-0.7% | USD 18.71-0.7% | |
| KURA (Kura Oncology Inc) | 57,884 | USD 604,888-1.7% | USD 10.45-1.7% | |
| ABUS (Arbutus Biopharma Corp) | 127,932 | USD 603,839-1.3% | USD 4.72-1.3% | |
| GERN (Geron Corporation) | 414,795 | USD 568,269 | USD 1.37 | |
| JANX (Janux Therapeutics Inc) | 39,228 | USD 551,938-1.3% | USD 14.07-1.3% | |
| VIR (Vir Biotechnology Inc) | 90,239 | USD 539,629-0.3% | USD 5.98-0.3% | |
| PAHC (Phibro Animal Health Corporation) | 14,179 | USD 534,974-1.2% | USD 37.73-1.2% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,123 | USD 520,765 | USD 8.25 | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,631 | USD 510,182 | USD 15.17 | |
| ARVN (Arvinas Inc) | 42,724 | USD 508,416-2.1% | USD 11.9-2.1% | |
| REPL (Replimune Group Inc) | 51,900 | USD 506,544-2.0% | USD 9.76-2.0% | |
| LYEL (Lyell Immunopharma Inc) | 13,573 | USD 489,3072.7% | USD 36.052.7% | |
| RGNX (Regenxbio Inc) | 33,671 | USD 481,4951.0% | USD 14.31.0% | |
| ZLAB (Zai Lab Ltd) | 26,041 | USD 464,051-2.8% | USD 17.82-2.8% | |
| FULC (Fulcrum Therapeutics Inc) | 36,002 | USD 431,6643.5% | USD 11.993.5% | |
| VTYX (Ventyx Biosciences Inc) | 47,460 | USD 430,937-1.9% | USD 9.08-1.9% | |
| KROS (Keros Therapeutics Inc) | 20,266 | USD 418,088-1.9% | USD 20.63-1.9% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,484 | USD 416,141-3.7% | USD 3.37-3.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,465 | USD 402,456-1.9% | USD 7.81999-1.9% | |
| CGEM (Cullinan Oncology LLC) | 38,613 | USD 391,536-2.2% | USD 10.14-2.2% | |
| PRTA (Prothena Corporation plc) | 38,806 | USD 367,881-0.6% | USD 9.48-0.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,180 | USD 347,2580.3% | USD 3.210.3% | |
| PACB (Pacific Biosciences of California) | 200,762 | USD 343,303-3.4% | USD 1.71-3.4% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,437 | USD 321,1351.8% | USD 3.331.8% | |
| SIGA (SIGA Technologies Inc) | 49,753 | USD 310,956-0.3% | USD 6.24999-0.3% | |
| GLPG (Galapagos NV ADR) | 9,284 | USD 307,4860.3% | USD 33.120.3% | |
| EOLS (Evolus Inc) | 43,107 | USD 287,093-3.5% | USD 6.66001-3.5% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,893 | USD 280,0302.3% | USD 7.200012.3% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,358 | USD 271,549-3.6% | USD 7.67999-3.6% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,592 | USD 263,060 | USD 3.48 | |
| TRDA (Entrada Therapeutics Inc) | 25,044 | USD 256,200-1.7% | USD 10.23-1.7% | |
| AUTL (Autolus Therapeutics Ltd) | 125,814 | USD 235,27212.0% | USD 1.8712.0% | |
| ACIU (AC Immune Ltd) | 70,752 | USD 229,9443.8% | USD 3.253.8% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,537 | USD 227,381-0.6% | USD 6.78-0.6% | |
| AVXL (Anavex Life Sciences Corp) | 60,781 | USD 221,8510.3% | USD 3.650010.3% | |
| ACRS (Aclaris Therapeutics Inc) | 72,019 | USD 216,777-0.7% | USD 3.01-0.7% | |
| ALLO (Allogene Therapeutics Inc) | 155,171 | USD 214,136 | USD 1.38 | |
| AVIR (Atea Pharmaceuticals Inc) | 59,371 | USD 213,736-1.4% | USD 3.60001-1.4% | |
| OABI (OmniAb Inc.) | 87,393 | USD 166,047-1.6% | USD 1.9-1.6% | |
| VYGR (Voyager Therapeutics Inc) | 36,440 | USD 147,218-1.0% | USD 4.04001-1.0% | |
| CABA (Cabaletta Bio Inc) | 63,971 | USD 145,8544.1% | USD 2.284.1% | |
| EDIT (Editas Medicine Inc) | 67,919 | USD 142,630-3.2% | USD 2.1-3.2% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,189 | USD 124,364 | USD 6.15999 | |
| HUMA (Humacyte Inc) | 115,218 | USD 117,522-4.7% | USD 1.02-4.7% | |
| CRBU (Caribou Biosciences Inc) | 62,117 | USD 102,493-2.9% | USD 1.65-2.9% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 166,890 | USD 77,253,3810.0% | USD 462.90.0% | |
| AMGN (Amgen Inc) | 209,469 | USD 69,738,514-0.3% | USD 332.93-0.3% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,723 | USD 53,945,4930.2% | USD 784.970.2% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 87,919 | USD 35,219,4720.0% | USD 400.590.0% | |
| INSM (Insmed Inc) | 141,916 | USD 25,244,0180.3% | USD 177.880.3% | |
| BIIB (Biogen Inc) | 97,622 | USD 17,286,9040.4% | USD 177.080.4% | |
| ARGX (argenx NV ADR) | 19,375 | USD 16,370,325-0.6% | USD 844.92-0.6% | |
| UTHR (United Therapeutics Corporation) | 28,651 | USD 14,530,641-1.5% | USD 507.16-1.5% | |
| ILMN (Illumina Inc) | 101,674 | USD 13,720,906-0.3% | USD 134.95-0.3% | |
| INCY (Incyte Corporation) | 130,644 | USD 13,078,771-0.3% | USD 100.11-0.3% | |
| RPRX (Royalty Pharma Plc) | 284,298 | USD 11,150,168-0.1% | USD 39.22-0.1% | |
| MEDP (Medpace Holdings Inc) | 18,742 | USD 10,637,210-0.8% | USD 567.56-0.8% | |
| RVMD (Revolution Medicines Inc) | 128,637 | USD 10,387,438-0.5% | USD 80.75-0.5% | |
| ROIV (Roivant Sciences Ltd) | 462,799 | USD 10,288,022-1.2% | USD 22.23-1.2% | |
| BBIO (BridgeBio Pharma Inc) | 128,231 | USD 9,719,910-1.0% | USD 75.8-1.0% | |
| NBIX (Neurocrine Biosciences Inc) | 66,348 | USD 9,637,710-1.1% | USD 145.26-1.1% | |
| VTRS (Viatris Inc) | 766,417 | USD 9,442,2570.7% | USD 12.320.7% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,117 | USD 9,053,722-0.6% | USD 598.91-0.6% | |
| SMMT (Summit Therapeutics PLC) | 495,374 | USD 8,986,084-1.3% | USD 18.14-1.3% | |
| GH (Guardant Health Inc) | 86,093 | USD 8,865,8570.6% | USD 102.980.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 107,782 | USD 8,615,015-0.9% | USD 79.93-0.9% | |
| ASND (Ascendis Pharma AS) | 40,861 | USD 8,539,132-1.8% | USD 208.98-1.8% | |
| SNY (Sanofi ADR) | 176,084 | USD 8,534,7910.2% | USD 48.470.2% | |
| EXEL (Exelixis Inc) | 178,410 | USD 8,249,678-0.6% | USD 46.24-0.6% | |
| MRNA (Moderna Inc) | 259,966 | USD 8,110,939-4.7% | USD 31.2-4.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 127,837 | USD 7,663,828-0.3% | USD 59.95-0.3% | |
| RNA (Avidity Biosciences Inc) | 100,269 | USD 7,232,403-0.1% | USD 72.13-0.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,429 | USD 6,892,336-0.2% | USD 170.48-0.2% | |
| BNTX (BioNTech SE) | 67,280 | USD 6,359,306-0.5% | USD 94.52-0.5% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,375 | USD 6,340,7100.1% | USD 70.160.1% | |
| HALO (Halozyme Therapeutics Inc) | 78,252 | USD 5,389,2150.7% | USD 68.870.7% | |
| CYTK (Cytokinetics Inc) | 81,361 | USD 5,134,693-1.7% | USD 63.11-1.7% | |
| AXSM (Axsome Therapeutics Inc) | 33,551 | USD 5,101,430-1.0% | USD 152.05-1.0% | |
| NUVL (Nuvalent Inc) | 47,878 | USD 4,983,860-1.6% | USD 104.095-1.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,406 | USD 4,884,660-2.0% | USD 110-2.0% | |
| KRYS (Krystal Biotech Inc) | 19,297 | USD 4,866,1240.4% | USD 252.170.4% | |
| PRAX (Praxis Precision Medicines Inc) | 16,639 | USD 4,475,059-2.1% | USD 268.95-2.1% | |
| PTCT (PTC Therapeutics Inc) | 53,425 | USD 4,197,0680.2% | USD 78.560.2% | |
| PCVX (Vaxcyte Inc) | 87,104 | USD 4,091,275-1.4% | USD 46.97-1.4% | |
| COGT (Cogent Biosciences Inc) | 102,145 | USD 3,971,398-2.1% | USD 38.88-2.1% | |
| KYMR (Kymera Therapeutics Inc) | 47,876 | USD 3,893,276-2.2% | USD 81.32-2.2% | |
| PTGX (Protagonist Therapeutics Inc) | 41,603 | USD 3,693,514-0.1% | USD 88.78-0.1% | |
| CRSP (Crispr Therapeutics AG) | 63,419 | USD 3,493,119-2.9% | USD 55.08-2.9% | |
| SRRK (Scholar Rock Holding Corp) | 68,639 | USD 3,134,743-0.4% | USD 45.67-0.4% | |
| ALKS (Alkermes Plc) | 109,872 | USD 3,130,253-0.1% | USD 28.49-0.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,581 | USD 3,109,487-0.9% | USD 27.62-0.9% | |
| ADMA (ADMA Biologics Inc) | 158,361 | USD 3,053,200-1.3% | USD 19.28-1.3% | |
| IMVT (Immunovant Inc) | 116,630 | USD 3,051,041-2.7% | USD 26.16-2.7% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,463 | USD 3,038,601-1.9% | USD 68.34-1.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,139 | USD 3,028,146-1.5% | USD 47.96-1.5% | |
| FOLD (Amicus Therapeutics Inc) | 205,295 | USD 2,925,454 | USD 14.25 | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,491 | USD 2,821,484-1.0% | USD 77.32-1.0% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,198 | USD 2,710,533-1.8% | USD 79.26-1.8% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,174 | USD 2,708,8030.6% | USD 12.950.6% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,092 | USD 2,563,806-0.7% | USD 195.83-0.7% | |
| ACLX (Arcellx Inc) | 38,476 | USD 2,528,258-0.4% | USD 65.71-0.4% | |
| GRAL (GRAIL, LLC) | 25,832 | USD 2,365,953-0.3% | USD 91.59-0.3% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,504 | USD 2,361,171-1.6% | USD 28.97-1.6% | |
| TVTX (Travere Therapeutics Inc) | 59,540 | USD 2,360,166-1.6% | USD 39.64-1.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,247 | USD 2,310,040-0.9% | USD 81.78-0.9% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,424 | USD 2,305,852-0.4% | USD 44.84-0.4% | |
| VERA (Vera Therapeutics Inc) | 42,545 | USD 2,279,561-3.8% | USD 53.58-3.8% | |
| VCYT (Veracyte Inc) | 52,601 | USD 2,235,016-0.7% | USD 42.49-0.7% | |
| RARE (Ultragenyx) | 64,200 | USD 2,194,998-1.1% | USD 34.19-1.1% | |
| CGON (CG Oncology, Inc. Common stock) | 53,416 | USD 2,128,093-0.7% | USD 39.84-0.7% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,191 | USD 2,102,249-0.8% | USD 24.97-0.8% | |
| IDYA (Ideaya Biosciences Inc) | 58,340 | USD 2,053,568-1.3% | USD 35.2-1.3% | |
| WVE (Wave Life Sciences Ltd) | 111,236 | USD 1,976,664-2.6% | USD 17.77-2.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,158 | USD 1,967,808-0.4% | USD 51.57-0.4% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,663 | USD 1,955,904-0.8% | USD 37.14-0.8% | |
| DYN (Dyne Therapeutics Inc) | 95,030 | USD 1,904,401-1.5% | USD 20.04-1.5% | |
| BEAM (Beam Therapeutics Inc) | 67,523 | USD 1,889,294-0.6% | USD 27.98-0.6% | |
| EWTX (Edgewise Therapeutics Inc) | 70,444 | USD 1,856,199-3.4% | USD 26.35-3.4% | |
| OCUL (Ocular Therapeutix Inc) | 141,749 | USD 1,780,367-1.2% | USD 12.56-1.2% | |
| SYRE (Spyre Therapeutics Inc.) | 51,628 | USD 1,700,626-0.3% | USD 32.94-0.3% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,582 | USD 1,696,4190.1% | USD 16.70.1% | |
| DNLI (Denali Therapeutics Inc) | 97,583 | USD 1,646,225-0.7% | USD 16.87-0.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,200 | USD 1,626,186-1.4% | USD 25.33-1.4% | |
| SRPT (Sarepta Therapeutics Inc) | 70,814 | USD 1,566,406-0.9% | USD 22.12-0.9% | |
| HRMY (Harmony Biosciences Holdings) | 38,321 | USD 1,461,180-0.9% | USD 38.13-0.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,108 | USD 1,453,959-3.4% | USD 4.25-3.4% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,720 | USD 1,425,450-0.2% | USD 16.25-0.2% | |
| IBRX (Immunitybio Inc) | 654,976 | USD 1,401,649 | USD 2.14 | |
| OLMA (Olema Pharmaceuticals Inc) | 52,335 | USD 1,372,747-4.4% | USD 26.23-4.4% | |
| TWST (Twist Bioscience Corp) | 40,691 | USD 1,344,838-1.6% | USD 33.05-1.6% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,791 | USD 1,337,8840.0% | USD 26.870.0% | |
| NRIX (Nurix Therapeutics Inc) | 67,450 | USD 1,301,785-0.3% | USD 19.3-0.3% | |
| GMAB (Genmab AS) | 38,895 | USD 1,299,871-0.9% | USD 33.42-0.9% | |
| TXG (10X Genomics Inc) | 77,496 | USD 1,277,909-1.2% | USD 16.49-1.2% | |
| VCEL (Vericel Corp Ord) | 33,649 | USD 1,267,2210.3% | USD 37.660.3% | |
| LEGN (Legend Biotech Corp) | 56,030 | USD 1,262,356-2.0% | USD 22.53-2.0% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,024 | USD 1,261,008-1.2% | USD 42-1.2% | |
| HROW (Harrow Health Inc) | 24,641 | USD 1,234,268-0.1% | USD 50.09-0.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,826 | USD 1,231,694-1.4% | USD 21.3-1.4% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,944 | USD 1,231,5350.3% | USD 82.410.3% | |
| STOK (Stoke Therapeutics Inc) | 38,006 | USD 1,213,152-0.8% | USD 31.92-0.8% | |
| DVAX (Dynavax Technologies Corporation) | 78,122 | USD 1,201,516 | USD 15.38 | |
| MNKD (MannKind Corp) | 204,294 | USD 1,182,862-2.4% | USD 5.79-2.4% | |
| PHVS (Pharvaris BV) | 42,620 | USD 1,097,891-0.7% | USD 25.76-0.7% | |
| AGIO (Agios Pharm) | 38,800 | USD 1,087,176-3.9% | USD 28.02-3.9% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,072 | USD 1,068,749-0.9% | USD 7.63-0.9% | |
| FTRE (Fortrea Holdings Inc.) | 61,380 | USD 1,068,012-1.7% | USD 17.4-1.7% | |
| TSHA (Taysha Gene Therapies Inc) | 182,239 | USD 1,062,453-1.4% | USD 5.83-1.4% | |
| COLL (Collegium Pharmaceutical Inc) | 21,037 | USD 1,048,4840.5% | USD 49.840.5% | |
| IMCR (Immunocore Holdings Ltd) | 28,995 | USD 1,047,589-1.2% | USD 36.13-1.2% | |
| QURE (Uniqure NV) | 41,449 | USD 1,028,350-1.5% | USD 24.81-1.5% | |
| NVCR (Novocure Ltd) | 74,506 | USD 1,004,3410.3% | USD 13.480.3% | |
| RLAY (Relay Therapeutics Inc) | 115,305 | USD 987,011-1.0% | USD 8.56-1.0% | |
| INVA (Innoviva Inc) | 49,745 | USD 984,9510.2% | USD 19.80.2% | |
| PGEN (Precigen Inc) | 235,390 | USD 979,222-0.7% | USD 4.16-0.7% | |
| ARDX (Ardelyx Inc) | 161,646 | USD 927,848-4.2% | USD 5.74-4.2% | |
| ANAB (AnaptysBio Inc) | 18,426 | USD 923,1430.2% | USD 50.10.2% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,063 | USD 900,867-1.3% | USD 12.33-1.3% | |
| SVRA (Savara Inc) | 135,364 | USD 873,0980.8% | USD 6.450.8% | |
| MNMD (Mind Medicine Inc) | 65,542 | USD 855,979-2.8% | USD 13.06-2.8% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,334 | USD 831,185-0.6% | USD 17.56-0.6% | |
| AMPH (Amphastar P) | 30,572 | USD 829,1131.2% | USD 27.121.2% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,376 | USD 813,4712.2% | USD 7.372.2% | |
| SANA (Sana Biotechnology Inc) | 176,229 | USD 777,170-2.6% | USD 4.41-2.6% | |
| TNGX (Tango Therapeutics Inc) | 89,588 | USD 776,728-0.3% | USD 8.67-0.3% | |
| CSTL (Castle Biosciences Inc) | 19,415 | USD 764,854-1.7% | USD 39.395-1.7% | |
| PCRX (Pacira BioSciences, Inc.) | 28,627 | USD 758,9021.9% | USD 26.511.9% | |
| SPRY (Silverback Therapeutics Inc) | 65,762 | USD 748,372-0.9% | USD 11.38-0.9% | |
| GRFS (Grifols SA ADR) | 81,152 | USD 738,4830.8% | USD 9.10.8% | |
| NVAX (Novavax Inc) | 107,876 | USD 736,793-1.6% | USD 6.83-1.6% | |
| NTLA (Intellia Therapeutics Inc) | 76,686 | USD 723,916-1.6% | USD 9.44-1.6% | |
| XNCR (Xencor Inc) | 47,508 | USD 723,072-1.5% | USD 15.22-1.5% | |
| URGN (UroGen Pharma Ltd) | 31,146 | USD 717,292-3.1% | USD 23.03-3.1% | |
| IOVA (Iovance Biotherapeutics Inc) | 250,495 | USD 713,911-0.7% | USD 2.85-0.7% | |
| ABCL (Abcellera Biologics Inc) | 197,787 | USD 708,077-3.8% | USD 3.58-3.8% | |
| ERAS (Erasca Inc) | 188,722 | USD 656,7531.5% | USD 3.481.5% | |
| RAPT (RAPT Therapeutics Inc) | 18,441 | USD 653,180-1.2% | USD 35.42-1.2% | |
| ELVN (Enliven Therapeutics Inc.) | 38,987 | USD 635,488-2.6% | USD 16.3-2.6% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,753 | USD 630,816-1.6% | USD 9.45-1.6% | |
| TBPH (Theravance Biopharma Inc) | 33,112 | USD 623,8300.6% | USD 18.840.6% | |
| KURA (Kura Oncology Inc) | 57,884 | USD 615,307-3.9% | USD 10.63-3.9% | |
| ABUS (Arbutus Biopharma Corp) | 127,932 | USD 611,515-0.2% | USD 4.78-0.2% | |
| GERN (Geron Corporation) | 414,795 | USD 568,269-2.1% | USD 1.37-2.1% | |
| JANX (Janux Therapeutics Inc) | 39,228 | USD 558,999-0.4% | USD 14.25-0.4% | |
| VIR (Vir Biotechnology Inc) | 90,239 | USD 541,434-1.8% | USD 6-1.8% | |
| PAHC (Phibro Animal Health Corporation) | 14,179 | USD 541,2121.1% | USD 38.171.1% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,123 | USD 520,765-2.1% | USD 8.25-2.1% | |
| ARVN (Arvinas Inc) | 42,724 | USD 519,524-0.1% | USD 12.16-0.1% | |
| REPL (Replimune Group Inc) | 51,900 | USD 516,924-1.3% | USD 9.96-1.3% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,631 | USD 510,182-3.9% | USD 15.17-3.9% | |
| ZLAB (Zai Lab Ltd) | 26,041 | USD 477,332-1.3% | USD 18.33-1.3% | |
| RGNX (Regenxbio Inc) | 33,671 | USD 476,781-2.1% | USD 14.16-2.1% | |
| LYEL (Lyell Immunopharma Inc) | 13,573 | USD 476,277-9.1% | USD 35.09-9.1% | |
| VTYX (Ventyx Biosciences Inc) | 47,460 | USD 439,4800.9% | USD 9.260010.9% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,484 | USD 432,194-2.0% | USD 3.5-2.0% | |
| KROS (Keros Therapeutics Inc) | 20,266 | USD 426,194-1.5% | USD 21.03-1.5% | |
| FULC (Fulcrum Therapeutics Inc) | 36,002 | USD 416,903-3.6% | USD 11.58-3.6% | |
| MGTX (MeiraGTx Holdings PLC) | 51,465 | USD 410,176-3.6% | USD 7.97-3.6% | |
| CGEM (Cullinan Oncology LLC) | 38,613 | USD 400,4171.1% | USD 10.371.1% | |
| PRTA (Prothena Corporation plc) | 38,806 | USD 370,209-1.5% | USD 9.53999-1.5% | |
| PACB (Pacific Biosciences of California) | 200,762 | USD 355,349-5.9% | USD 1.77-5.9% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,180 | USD 346,176-1.8% | USD 3.2-1.8% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,437 | USD 315,349-0.9% | USD 3.27-0.9% | |
| SIGA (SIGA Technologies Inc) | 49,753 | USD 311,951 | USD 6.26999 | |
| GLPG (Galapagos NV ADR) | 9,284 | USD 306,6510.1% | USD 33.03010.1% | |
| EOLS (Evolus Inc) | 43,107 | USD 297,4380.7% | USD 6.899990.7% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,358 | USD 281,803-1.6% | USD 7.96999-1.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,893 | USD 273,8071.9% | USD 7.040011.9% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,592 | USD 263,060-0.9% | USD 3.48-0.9% | |
| TRDA (Entrada Therapeutics Inc) | 25,044 | USD 260,708-1.6% | USD 10.41-1.6% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,537 | USD 228,722-2.4% | USD 6.81999-2.4% | |
| ACIU (AC Immune Ltd) | 70,752 | USD 221,454 | USD 3.13 | |
| AVXL (Anavex Life Sciences Corp) | 60,781 | USD 221,243-2.2% | USD 3.64-2.2% | |
| ACRS (Aclaris Therapeutics Inc) | 72,019 | USD 218,218-0.3% | USD 3.03001-0.3% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,371 | USD 216,7040.8% | USD 3.650.8% | |
| ALLO (Allogene Therapeutics Inc) | 155,171 | USD 214,136-1.4% | USD 1.38-1.4% | |
| AUTL (Autolus Therapeutics Ltd) | 125,814 | USD 210,109-0.6% | USD 1.67-0.6% | |
| OABI (OmniAb Inc.) | 87,393 | USD 168,668-1.5% | USD 1.92999-1.5% | |
| VYGR (Voyager Therapeutics Inc) | 36,440 | USD 148,6750.2% | USD 4.079990.2% | |
| EDIT (Editas Medicine Inc) | 67,919 | USD 147,384-1.8% | USD 2.17-1.8% | |
| CABA (Cabaletta Bio Inc) | 63,971 | USD 140,096 | USD 2.18999 | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,189 | USD 124,364-5.2% | USD 6.15999-5.2% | |
| HUMA (Humacyte Inc) | 115,218 | USD 123,283-0.9% | USD 1.07-0.9% | |
| CRBU (Caribou Biosciences Inc) | 62,117 | USD 105,599-1.2% | USD 1.7-1.2% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.